(+)-alpha-tocopherol multiple interactions ISO RGD:2199 6480464 alpha-Tocopherol inhibits the reaction [mancozeb results in decreased expression of BCL2 protein], alpha-Tocopherol inhibits the reaction [Triiodothyronine, Reverse results in increased activity of BCL2 protein] CTD PMID:16005924 , PMID:16135673 (+)-alpha-tocopherol decreases expression ISO RGD:733100 6480464 alpha-Tocopherol analog results in decreased expression of BCL2 mRNA, alpha-Tocopherol analog results in decreased expression of BCL2 protein CTD PMID:20686688 (+)-alpha-tocopherol multiple interactions ISO RGD:733100 6480464 alpha-Tocopherol affects the reaction [Lipopolysaccharides results in decreased expression of BCL2 protein] more ... CTD PMID:11805214 , PMID:20686688 (+)-catechin multiple interactions EXP 6480464 Quercetin affects the reaction [Catechin affects the expression of BCL2 mRNA] CTD PMID:26363153 (+)-catechin decreases expression ISO RGD:733100 6480464 Catechin results in decreased expression of BCL2 mRNA, Catechin results in decreased expression of BCL2 protein CTD PMID:23706674 (+)-catechin multiple interactions ISO RGD:2199 6480464 Catechin inhibits the reaction [Doxorubicin results in decreased expression of BCL2 mRNA], Catechin inhibits the reaction [Doxorubicin results in decreased expression of BCL2 protein] CTD PMID:18611398 (+)-catechin multiple interactions ISO RGD:733100 6480464 Catechin inhibits the reaction [Glucose results in increased degradation of and results in decreased expression of BCL2 protein] CTD PMID:19557821 (+)-catechin affects expression EXP 6480464 Catechin affects the expression of BCL2 mRNA CTD PMID:26363153 (+)-epicatechin-3-O-gallate multiple interactions EXP 6480464 epicatechin gallate inhibits the reaction [Benzo(a)pyrene results in increased expression of BCL2 mRNA] CTD PMID:18656336 (+)-pilocarpine decreases expression ISO RGD:2199 6480464 Pilocarpine results in decreased expression of BCL2 protein CTD PMID:19429016 (+)-sesamin multiple interactions EXP 6480464 sesamin inhibits the reaction [nickel sulfate results in decreased expression of BCL2 protein] CTD PMID:23317420 (+)-sesamin multiple interactions ISO RGD:2199 6480464 sesamin affects the reaction [Glucose affects the expression of BCL2 protein] CTD PMID:22524206 (+)-Tetrandrine decreases expression ISO RGD:733100 6480464 tetrandrine results in decreased expression of BCL2 mRNA, tetrandrine results in decreased expression of BCL2 protein CTD PMID:18495333 more ... (+)-Tetrandrine increases expression ISO RGD:733100 6480464 tetrandrine results in increased expression of BCL2 protein CTD PMID:31255635 (+)-Tetrandrine multiple interactions ISO RGD:733100 6480464 CYP3A5 protein promotes the reaction [tetrandrine results in decreased expression of BCL2 protein] CTD PMID:26302866 (+)-Tetrandrine affects response to substance ISO RGD:733100 6480464 BCL2 protein affects the susceptibility to tetrandrine CTD PMID:18495333 (-)-anisomycin multiple interactions ISO RGD:2199 6480464 [Colistin co-treated with Anisomycin] results in increased phosphorylation of BCL2 protein CTD PMID:28842171 (-)-citrinin decreases expression EXP 6480464 Citrinin results in decreased expression of BCL2 protein CTD PMID:21622943 (-)-citrinin affects expression EXP 6480464 Citrinin affects the expression of BCL2 protein CTD PMID:22771370 (-)-epigallocatechin 3-gallate multiple interactions ISO RGD:733100 6480464 [arsenic trioxide co-treated with epigallocatechin gallate] results in decreased expression of BCL2 protein more ... CTD PMID:12672908 more ... (-)-epigallocatechin 3-gallate affects expression ISO RGD:2199 6480464 epigallocatechin gallate affects the expression of BCL2 protein CTD PMID:22000973 (-)-epigallocatechin 3-gallate multiple interactions EXP 6480464 epigallocatechin gallate inhibits the reaction [Benzo(a)pyrene results in increased expression of BCL2 mRNA] CTD PMID:18656336 (-)-epigallocatechin 3-gallate decreases expression ISO RGD:733100 6480464 epigallocatechin gallate analog results in decreased expression of BCL2 protein, epigallocatechin gallate results in decreased expression of BCL2 protein CTD PMID:15657356 more ... (-)-epigallocatechin 3-gallate affects expression ISO RGD:733100 6480464 epigallocatechin gallate affects the expression of BCL2 protein CTD PMID:15975156 (-)-gambogic acid decreases expression ISO RGD:733100 6480464 gambogic acid results in decreased expression of BCL2 mRNA CTD PMID:15968715 , PMID:19084572 (-)-gambogic acid affects expression ISO RGD:733100 6480464 gambogic acid affects the expression of BCL2 protein CTD PMID:19433130 (-)-gambogic acid multiple interactions ISO RGD:733100 6480464 [Verapamil co-treated with gambogic acid] results in decreased expression of BCL2 protein, Fluorouracil promotes the reaction [gambogic acid results in decreased expression of BCL2 mRNA] CTD PMID:19084572 , PMID:24373880 (-)-noscapine decreases expression ISO RGD:733100 6480464 Noscapine results in decreased expression of BCL2 protein CTD PMID:20674069 (-)-noscapine multiple interactions ISO RGD:733100 6480464 Noscapine promotes the reaction [Cisplatin results in decreased expression of BCL2 protein] CTD PMID:20674069 (-)-perillyl alcohol multiple interactions EXP 6480464 perillyl alcohol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of BCL2 protein] CTD PMID:19161993 (-)-selegiline multiple interactions EXP 6480464 Selegiline inhibits the reaction [linsidomine results in decreased expression of BCL2 protein] CTD PMID:12880480 (20S)-ginsenoside Rg3 multiple interactions ISO RGD:733100 6480464 ginsenoside Rg3 inhibits the reaction [cagA protein, Helicobacter pylori results in increased expression of BCL2 protein] CTD PMID:26427350 (20S)-ginsenoside Rh2 decreases expression ISO RGD:733100 6480464 ginsenoside Rh2 results in decreased expression of BCL2 protein CTD PMID:26482938 (E)-roxithromycin decreases expression ISO RGD:733100 6480464 Roxithromycin results in decreased expression of BCL2 protein CTD PMID:12921874 (R)-carnitine increases phosphorylation ISO RGD:2199 6480464 Carnitine results in increased phosphorylation of BCL2 protein CTD PMID:29186614 (R)-carnitine multiple interactions ISO RGD:2199 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Carnitine results in increased phosphorylation of BCL2 protein], Carnitine inhibits the reaction [Ifosfamide results in decreased expression of BCL2 mRNA] CTD PMID:23213347 , PMID:29186614 (R)-lipoic acid multiple interactions ISO RGD:733100 6480464 Thioctic Acid inhibits the reaction [Zinc deficiency results in decreased expression of BCL2 protein] more ... CTD PMID:16990509 more ... (R)-lipoic acid multiple interactions EXP 6480464 Thioctic Acid inhibits the reaction [Dietary Fats results in decreased expression of BCL2 mRNA] CTD PMID:27260466 (R)-lipoic acid multiple interactions ISO RGD:2199 6480464 Thioctic Acid inhibits the reaction [[Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of BCL2 mRNA], Thioctic Acid inhibits the reaction [cadmium acetate results in decreased expression of BCL2 protein] CTD PMID:23830814 , PMID:30605698 (R)-lipoic acid decreases response to substance ISO RGD:733100 6480464 BCL2 protein results in decreased susceptibility to Thioctic Acid CTD PMID:16990509 (R)-mevalonic acid multiple interactions ISO RGD:2199 6480464 Mevalonic Acid inhibits the reaction [Lovastatin results in decreased expression of BCL2 protein] CTD PMID:11178870 (R)-mevalonic acid multiple interactions ISO RGD:733100 6480464 Mevalonic Acid inhibits the reaction [Lovastatin results in decreased expression of BCL2 protein] CTD PMID:12094262 (R)-noradrenaline multiple interactions ISO RGD:2199 6480464 Acetylcysteine inhibits the reaction [Norepinephrine results in decreased expression of BCL2 protein], N-(1-methyl-5-indolyl)-N'-(3-methyl-5-isothiazolyl)urea inhibits the reaction [Norepinephrine results in decreased expression of BCL2 protein] CTD PMID:17041759 , PMID:20374255 (R)-noradrenaline decreases expression ISO RGD:2199 6480464 Norepinephrine results in decreased expression of BCL2 protein CTD PMID:14732211 more ... (R)-Salsolinol decreases expression ISO RGD:2199 6480464 salsolinol results in decreased expression of BCL2 protein CTD PMID:23261589 (S)-amphetamine multiple interactions ISO RGD:733100 6480464 [N-Methyl-3, 4-methylenedioxyamphetamine co-treated with Methamphetamine co-treated with 4-methylthioamphetamine co-treated with Dextroamphetamine] results in decreased expression of BCL2 mRNA CTD PMID:23820845 (S)-amphetamine decreases expression ISO RGD:733100 6480464 Dextroamphetamine results in decreased expression of BCL2 mRNA CTD PMID:23820845 (S)-colchicine multiple interactions ISO RGD:2199 6480464 Colchicine inhibits the reaction [Ethanol results in increased expression of BCL2 mRNA] CTD PMID:22446813 (S)-colchicine decreases expression ISO RGD:733100 6480464 Colchicine results in decreased expression of BCL2 protein CTD PMID:22342440 (S)-naringenin multiple interactions ISO RGD:733100 6480464 ethyl 2-amino-6-bromo-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate inhibits the reaction [BCL2 protein results in decreased susceptibility to naringenin] more ... CTD PMID:19124070 more ... (S)-naringenin decreases expression ISO RGD:733100 6480464 naringenin results in decreased expression of BCL2 mRNA CTD PMID:30153467 (S)-naringenin multiple interactions ISO RGD:2199 6480464 naringenin inhibits the reaction [Glucose results in decreased expression of BCL2 mRNA], naringenin inhibits the reaction [Glucose results in decreased expression of BCL2 protein] CTD PMID:23192364 (S)-naringenin decreases response to substance ISO RGD:733100 6480464 BCL2 protein results in decreased susceptibility to naringenin CTD PMID:19124070 (S)-nicotine multiple interactions ISO RGD:733100 6480464 Curcumin inhibits the reaction [Nicotine results in increased expression of BCL2 protein] more ... CTD PMID:12421819 more ... (S)-nicotine multiple interactions ISO RGD:2199 6480464 Folic Acid inhibits the reaction [Nicotine results in decreased expression of BCL2 protein] CTD PMID:29972271 (S)-nicotine multiple interactions EXP 6480464 royal jelly inhibits the reaction [Nicotine results in decreased expression of BCL2 mRNA] CTD PMID:30896085 (S)-nicotine increases expression ISO RGD:733100 6480464 Nicotine results in increased expression of BCL2 mRNA more ... CTD PMID:18448488 more ... (S)-nicotine decreases expression EXP 6480464 Nicotine results in decreased expression of BCL2 mRNA CTD PMID:15831280 , PMID:30896085 (S)-nicotine increases phosphorylation ISO RGD:733100 6480464 Nicotine results in increased phosphorylation of BCL2 protein CTD PMID:12421819 (S)-nicotine decreases expression ISO RGD:2199 6480464 Nicotine results in decreased expression of BCL2 mRNA, Nicotine results in decreased expression of BCL2 protein CTD PMID:20339300 , PMID:29972271 (S)-ropivacaine multiple interactions ISO RGD:733100 6480464 BCL2 protein inhibits the reaction [Ropivacaine results in increased cleavage of CASP3 protein], BCL2 protein inhibits the reaction [Ropivacaine results in increased cleavage of PARP1 protein] CTD PMID:15538973 (S)-ropivacaine decreases response to substance ISO RGD:733100 6480464 BCL2 protein results in decreased susceptibility to Ropivacaine CTD PMID:15538973 1'-acetoxychavicol acetate multiple interactions ISO RGD:733100 6480464 1'-acetoxychavicol acetate inhibits the reaction [TNF protein results in increased expression of BCL2 protein] CTD PMID:15905586 1,1,1-trichloro-2,2-bis(4-hydroxyphenyl)ethane increases expression EXP 6480464 2 more ... CTD PMID:15525693 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane increases expression ISO RGD:733100 6480464 o more ... CTD PMID:10545406 , PMID:22609851 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane multiple interactions ISO RGD:733100 6480464 fulvestrant inhibits the reaction [o, p'-DDT results in increased expression of BCL2 protein] CTD PMID:10545406 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane increases expression ISO RGD:2199 6480464 o, p'-DDT results in increased expression of BCL2 mRNA CTD PMID:22937105 1,2-dichloroethane decreases expression EXP 6480464 ethylene dichloride results in decreased expression of BCL2 mRNA, ethylene dichloride results in decreased expression of BCL2 protein CTD PMID:28973639 1,2-dimethylhydrazine multiple interactions ISO RGD:2199 6480464 [1 more ... CTD PMID:15309441 more ... 1,2-dimethylhydrazine increases expression ISO RGD:2199 6480464 1, 2-Dimethylhydrazine results in increased expression of BCL2 protein CTD PMID:15309441 , PMID:29108773 1,3-dichloropropan-2-ol decreases expression EXP 6480464 1, 3-dichloro-2-propanol results in decreased expression of BCL2 protein CTD PMID:29248572 1,3-dichloropropan-2-ol multiple interactions EXP 6480464 Acetylcysteine inhibits the reaction [1, 3-dichloro-2-propanol results in decreased expression of BCL2 protein] CTD PMID:29248572 1,3-dinitrobenzene increases expression ISO RGD:2199 6480464 3-dinitrobenzene results in increased expression of BCL2 mRNA CTD PMID:16025311 1,3-dinitrobenzene decreases expression EXP 6480464 3-dinitrobenzene results in decreased expression of BCL2 mRNA, 3-dinitrobenzene results in decreased expression of BCL2 protein CTD PMID:19477251 1,3-thiazolidine-2,4-dione decreases expression ISO RGD:733100 6480464 2, 4-thiazolidinedione results in decreased expression of BCL2 protein CTD PMID:15916743 1,4-benzoquinone decreases expression ISO RGD:733100 6480464 quinone results in decreased expression of BCL2 protein CTD PMID:20499891 1,4-benzoquinone multiple interactions ISO RGD:733100 6480464 [HIF1A protein co-treated with quinone] results in increased expression of BCL2 protein CTD PMID:30448556 1,4-dithiothreitol multiple interactions ISO RGD:733100 6480464 Dithiothreitol inhibits the reaction [arsenic trioxide results in increased expression of BCL2 protein] CTD PMID:18022205 1,4-naphthoquinone multiple interactions ISO RGD:733100 6480464 FR 180204 promotes the reaction [1 more ... CTD PMID:30871965 1,4-naphthoquinone decreases expression ISO RGD:733100 6480464 1, 4-naphthoquinone analog results in decreased expression of BCL2 protein CTD PMID:30871965 1-[(2,3,4-trimethoxyphenyl)methyl]piperazine multiple interactions ISO RGD:2199 6480464 Trimetazidine inhibits the reaction [Oxygen deficiency results in decreased expression of BCL2 mRNA] CTD PMID:25937560 1-chloro-2,4-dinitrobenzene multiple interactions EXP 6480464 NFE2L2 protein promotes the reaction [Dinitrochlorobenzene results in increased expression of BCL2 mRNA] CTD PMID:28219650 1-chloro-2,4-dinitrobenzene affects expression EXP 6480464 Dinitrochlorobenzene affects the expression of BCL2 mRNA CTD PMID:28219650 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine multiple interactions EXP 6480464 2 more ... CTD PMID:23911879 more ... 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine decreases expression EXP 6480464 1-Methyl-4-phenyl-1 more ... CTD PMID:23911879 more ... 1-naphthyl isothiocyanate increases expression ISO RGD:2199 6480464 1-Naphthylisothiocyanate results in increased expression of BCL2 mRNA CTD PMID:12883083 1-octadec-9-enoylglycero-3-phosphate increases expression EXP 6480464 lysophosphatidic acid analog results in increased expression of BCL2 protein, lysophosphatidic acid results in increased expression of BCL2 protein CTD PMID:23251428 10-Hydroxycamptothecin affects response to substance ISO RGD:733100 6480464 BCL2 protein affects the susceptibility to 10-hydroxycamptothecin CTD PMID:16603448 11-deoxycorticosterone multiple interactions ISO RGD:2199 6480464 [Desoxycorticosterone co-treated with Sodium Chloride] results in decreased expression of BCL2 protein more ... CTD PMID:22431579 17alpha-ethynylestradiol increases expression ISO RGD:2199 6480464 Ethinyl Estradiol results in increased expression of BCL2 protein CTD PMID:12857939 17alpha-ethynylestradiol multiple interactions EXP 6480464 [Streptozocin co-treated with Ethinyl Estradiol] results in increased expression of BCL2 mRNA, Ethinyl Estradiol promotes the reaction [Streptozocin results in decreased expression of BCL2 protein] CTD PMID:24781736 17beta-estradiol decreases expression EXP 6480464 Estradiol results in decreased expression of BCL2 mRNA CTD PMID:25210133 17beta-estradiol increases expression ISO RGD:2199 6480464 Estradiol results in increased expression of BCL2 protein CTD PMID:16951259 17beta-estradiol multiple interactions EXP 6480464 [mono-(2-ethylhexyl)phthalate co-treated with Estradiol] results in decreased expression of BCL2 mRNA, Estradiol inhibits the reaction [manganese chloride results in decreased expression of BCL2 protein] CTD PMID:24412242 , PMID:29183790 17beta-estradiol increases expression EXP 6480464 Estradiol results in increased expression of BCL2 mRNA CTD PMID:17578864 17beta-estradiol increases expression ISO RGD:733100 6480464 Estradiol results in increased expression of BCL2 mRNA, Estradiol results in increased expression of BCL2 protein CTD PMID:10455518 more ... 17beta-estradiol multiple interactions ISO RGD:2199 6480464 [Estradiol co-treated with Progesterone co-treated with Methylnitrosourea] results in increased expression of BCL2 protein more ... CTD PMID:14659978 more ... 17beta-estradiol decreases expression ISO RGD:733100 6480464 Estradiol results in decreased expression of BCL2 mRNA, Estradiol results in decreased expression of BCL2 protein CTD PMID:20945400 17beta-estradiol multiple interactions ISO RGD:733100 6480464 [Estradiol results in increased activity of ESR1 protein] which results in increased expression of BCL2 mRNA more ... CTD PMID:10545406 more ... 17beta-estradiol affects expression ISO RGD:733100 6480464 Estradiol affects the expression of BCL2 mRNA CTD PMID:11896290 , PMID:22082530 17beta-estradiol 3-benzoate multiple interactions ISO RGD:2199 6480464 Quercetin inhibits the reaction [estradiol 3-benzoate results in increased expression of BCL2 mRNA], Quercetin inhibits the reaction [estradiol 3-benzoate results in increased expression of BCL2 protein] CTD PMID:24316378 17beta-estradiol 3-benzoate increases expression ISO RGD:2199 6480464 estradiol 3-benzoate results in increased expression of BCL2 mRNA, estradiol 3-benzoate results in increased expression of BCL2 protein CTD PMID:24316378 17beta-hydroxy-5alpha-androstan-3-one multiple interactions ISO RGD:2199 6480464 Dihydrotestosterone inhibits the reaction [Dehydroepiandrosterone results in increased expression of BCL2 protein] CTD PMID:16407456 17beta-hydroxy-5alpha-androstan-3-one multiple interactions ISO RGD:733100 6480464 [Dihydrotestosterone co-treated with Curcumin co-treated with Quercetin] results in increased expression of BCL2 protein CTD PMID:27132804 2,2',4,4',5,5'-hexachlorobiphenyl decreases expression EXP 6480464 2 more ... CTD PMID:21291966 2,2',4,4',5,5'-hexachlorobiphenyl affects cleavage EXP 6480464 2 more ... CTD PMID:25659934 2,2',4,4',5,5'-hexachlorobiphenyl decreases expression ISO RGD:733100 6480464 2 more ... CTD PMID:20638727 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions EXP 6480464 [2 more ... CTD PMID:21291966 2,2',4,4'-Tetrabromodiphenyl ether decreases expression EXP 6480464 2 more ... CTD PMID:25639565 2,2',4,4'-Tetrabromodiphenyl ether increases expression ISO RGD:733100 6480464 2 more ... CTD PMID:25697951 2,2',4,4'-Tetrabromodiphenyl ether multiple interactions ISO RGD:733100 6480464 ERN1 protein affects the reaction [2 more ... CTD PMID:22543052 2,2',4,4'-Tetrabromodiphenyl ether decreases expression ISO RGD:733100 6480464 2 more ... CTD PMID:22543052 2,2',4,4'-Tetrabromodiphenyl ether multiple interactions EXP 6480464 epoxomicin inhibits the reaction [troxerutin inhibits the reaction [2 more ... CTD PMID:25639565 2,2,2-tetramine decreases expression ISO RGD:733100 6480464 Trientine results in decreased expression of BCL2 protein CTD PMID:11369509 2,2,2-tetramine increases expression ISO RGD:733100 6480464 Trientine results in increased expression of BCL2 protein CTD PMID:14513838 2,2,2-tetramine multiple interactions ISO RGD:733100 6480464 Copper Sulfate inhibits the reaction [Trientine results in increased expression of BCL2 protein] CTD PMID:14513838 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:733100 6480464 Tetrachlorodibenzodioxin results in decreased expression of BCL2 protein CTD PMID:9677421 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of BCL2 mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of BCL2 mRNA CTD PMID:19770486 more ... 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:2199 6480464 Tetrachlorodibenzodioxin results in decreased expression of BCL2 mRNA, Tetrachlorodibenzodioxin results in decreased expression of BCL2 protein CTD PMID:15965093 , PMID:19520675 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:2199 6480464 Tetrachlorodibenzodioxin results in increased expression of BCL2 mRNA, Tetrachlorodibenzodioxin results in increased expression of BCL2 protein CTD PMID:15965093 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:733100 6480464 Tetrachlorodibenzodioxin results in increased expression of BCL2 mRNA CTD PMID:20044593 2,3-bis(4-hydroxyphenyl)propionitrile multiple interactions ISO RGD:733100 6480464 ESR1 protein affects the reaction [2 more ... CTD PMID:19264808 2,3-bis(4-hydroxyphenyl)propionitrile increases expression ISO RGD:733100 6480464 2 more ... CTD PMID:19264808 2,3-bis(4-hydroxyphenyl)propionitrile multiple interactions EXP 6480464 2, 3-bis(4-hydroxyphenyl)-propionitrile promotes the reaction [Chlorodiphenyl (54% Chlorine) results in decreased expression of BCL2 protein] CTD PMID:24216299 2,4,6-trinitrobenzenesulfonic acid multiple interactions ISO RGD:2199 6480464 Losartan promotes the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of BCL2 mRNA] more ... CTD PMID:15502641 more ... 2,4,6-trinitrobenzenesulfonic acid increases expression ISO RGD:2199 6480464 Trinitrobenzenesulfonic Acid results in increased expression of BCL2 mRNA, Trinitrobenzenesulfonic Acid results in increased expression of BCL2 protein CTD PMID:24637189 2,4,6-trinitrobenzenesulfonic acid decreases expression ISO RGD:2199 6480464 Trinitrobenzenesulfonic Acid results in decreased expression of BCL2 mRNA, Trinitrobenzenesulfonic Acid results in decreased expression of BCL2 protein CTD PMID:15502641 more ... 2,4-dibromophenyl 2,4,5-tribromophenyl ether decreases expression ISO RGD:2199 6480464 2 more ... CTD PMID:22024335 2,5-hexanedione increases expression ISO RGD:2199 6480464 2, 5-hexanedione results in increased expression of BCL2 protein CTD PMID:17492505 2,5-hexanedione decreases expression ISO RGD:2199 6480464 2, 5-hexanedione results in decreased expression of BCL2 mRNA CTD PMID:22337490 2,5-hexanedione decreases expression ISO RGD:733100 6480464 2 more ... CTD PMID:21901545 2-(3,4-dimethoxyphenyl)-5-\{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino\}-2-(propan-2-yl)pentanenitrile multiple interactions ISO RGD:733100 6480464 [Temozolomide co-treated with Verapamil] results in decreased expression of BCL2 mRNA more ... CTD PMID:24373880 , PMID:30003979 2-(3,4-dimethoxyphenyl)-5-\{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino\}-2-(propan-2-yl)pentanenitrile decreases expression ISO RGD:733100 6480464 Verapamil results in decreased expression of BCL2 mRNA, Verapamil results in decreased expression of BCL2 protein CTD PMID:30003979 2-acetamidofluorene multiple interactions ISO RGD:2199 6480464 [Diethylnitrosamine co-treated with 2-Acetylaminofluorene] affects the expression of BCL2 protein, IFNA2 protein affects the reaction [[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] affects the expression of BCL2 protein] CTD PMID:11915028 2-acetamidofluorene increases expression ISO RGD:2199 6480464 2-Acetylaminofluorene results in increased expression of BCL2 mRNA CTD PMID:19167416 , PMID:22213190 2-acetamidophenol decreases expression ISO RGD:733100 6480464 2-hydroxyacetanilide results in decreased expression of BCL2 mRNA, 2-hydroxyacetanilide results in decreased expression of BCL2 protein CTD PMID:31207345 2-amino-2-deoxy-D-galactopyranose multiple interactions EXP 6480464 [Galactosamine co-treated with Lipopolysaccharides] results in decreased expression of BCL2 protein more ... CTD PMID:20558151 , PMID:20850421 2-amino-2-deoxy-D-galactopyranose multiple interactions ISO RGD:2199 6480464 glycine propionyl carnitine inhibits the reaction [Galactosamine results in decreased expression of BCL2 mRNA], mangiferin inhibits the reaction [Galactosamine results in decreased expression of BCL2 protein] CTD PMID:22118634 , PMID:24565947 2-amino-2-deoxy-D-galactopyranose decreases expression ISO RGD:2199 6480464 Galactosamine results in decreased expression of BCL2 mRNA, Galactosamine results in decreased expression of BCL2 protein CTD PMID:22118634 , PMID:24565947 2-aminoethoxydiphenylborane multiple interactions ISO RGD:2199 6480464 2-aminoethoxydiphenylborane inhibits the reaction [cadmium acetate results in decreased expression of BCL2 protein] CTD PMID:29883672 2-deoxy-D-glucose multiple interactions ISO RGD:733100 6480464 Deoxyglucose affects the reaction [demycarosyl-3D-digitoxosylmithramycin SK affects the expression of BCL2 mRNA] CTD PMID:26079942 2-hydroxypropanoic acid increases expression ISO RGD:733100 6480464 Lactic Acid results in increased expression of BCL2 mRNA CTD PMID:30851411 2-methoxy-17beta-estradiol multiple interactions ISO RGD:2199 6480464 2-Methoxyestradiol inhibits the reaction [testosterone enanthate results in increased expression of BCL2 mRNA] CTD PMID:30154949 2-methoxy-17beta-estradiol decreases expression ISO RGD:733100 6480464 2-Methoxyestradiol results in decreased expression of BCL2 protein CTD PMID:17418156 2-methyl-6-(phenylethynyl)pyridine multiple interactions ISO RGD:2199 6480464 6-methyl-2-(phenylethynyl)pyridine inhibits the reaction [Cocaine results in increased phosphorylation of BCL2 protein] CTD PMID:19879923 2-tert-butylhydroquinone multiple interactions EXP 6480464 2-tert-butylhydroquinone promotes the reaction [NFE2L2 protein binds to BCL2 promoter] more ... CTD PMID:22275372 2-tert-butylhydroquinone multiple interactions ISO RGD:2199 6480464 2-tert-butylhydroquinone inhibits the reaction [ferrous sulfate results in decreased expression of BCL2 protein] CTD PMID:28583816 2-tert-butylhydroquinone multiple interactions ISO RGD:733100 6480464 2-tert-butylhydroquinone inhibits the reaction [sodium arsenite results in decreased expression of BCL2 protein] CTD PMID:26878773 2-tert-butylhydroquinone increases expression ISO RGD:733100 6480464 2-tert-butylhydroquinone results in increased expression of BCL2 protein CTD PMID:22275372 2-tert-butylhydroquinone increases expression EXP 6480464 2-tert-butylhydroquinone results in increased expression of BCL2 mRNA, 2-tert-butylhydroquinone results in increased expression of BCL2 protein CTD PMID:22275372 2-trans,6-trans,10-trans-geranylgeranyl diphosphate multiple interactions ISO RGD:733100 6480464 geranylgeranyl pyrophosphate inhibits the reaction [Simvastatin results in decreased expression of BCL2 mRNA] CTD PMID:18031796 20-hydroxypregn-4-en-3-one multiple interactions ISO RGD:733100 6480464 3-hydroxypregn-4-en-20-one inhibits the reaction [5-alpha-Dihydroprogesterone results in increased expression of BCL2 mRNA] CTD PMID:19931389 20-hydroxypregn-4-en-3-one decreases expression ISO RGD:733100 6480464 3-hydroxypregn-4-en-20-one results in decreased expression of BCL2 mRNA CTD PMID:19931389 3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine multiple interactions ISO RGD:2199 6480464 [Puromycin Aminonucleoside co-treated with Melatonin] results in increased expression of BCL2 protein CTD PMID:14993511 3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine increases expression ISO RGD:2199 6480464 Puromycin Aminonucleoside results in increased expression of BCL2 protein CTD PMID:15113391 , PMID:16152783 3,3',4,4',5-pentachlorobiphenyl multiple interactions ISO RGD:733100 6480464 3 more ... CTD PMID:20840854 3,3',4,4',5-pentachlorobiphenyl decreases expression EXP 6480464 3 more ... CTD PMID:31563530 3,3',5'-triiodo-L-thyronine multiple interactions ISO RGD:2199 6480464 alpha-Tocopherol inhibits the reaction [Triiodothyronine, Reverse results in increased activity of BCL2 protein] CTD PMID:16135673 3,3',5'-triiodo-L-thyronine increases activity ISO RGD:2199 6480464 Triiodothyronine, Reverse results in increased activity of BCL2 protein CTD PMID:16135673 3,3',5'-triiodothyronine multiple interactions ISO RGD:2199 6480464 alpha-Tocopherol inhibits the reaction [Triiodothyronine, Reverse results in increased activity of BCL2 protein] CTD PMID:16135673 3,3',5'-triiodothyronine increases activity ISO RGD:2199 6480464 Triiodothyronine, Reverse results in increased activity of BCL2 protein CTD PMID:16135673 3,3',5,5'-tetrabromobisphenol A decreases expression EXP 6480464 tetrabromobisphenol A results in decreased expression of BCL2 mRNA, tetrabromobisphenol A results in decreased expression of BCL2 protein CTD PMID:22677475 , PMID:27592553 3,3',5-triiodo-L-thyronine multiple interactions ISO RGD:733100 6480464 Triiodothyronine promotes the reaction [tamibarotene results in decreased expression of BCL2 mRNA] CTD PMID:11201846 3,3',5-triiodo-L-thyronine increases expression ISO RGD:2199 6480464 Triiodothyronine results in increased expression of BCL2 protein CTD PMID:16021636 3,3',5-triiodo-L-thyronine increases expression ISO RGD:733100 6480464 Triiodothyronine results in increased expression of BCL2 protein CTD PMID:16021636 3,3'-Dichlorobenzidine affects expression ISO RGD:733100 6480464 3, 3'-Dichlorobenzidine affects the expression of BCL2 protein CTD PMID:24604609 3,3'-diindolylmethane decreases expression ISO RGD:733100 6480464 3 more ... CTD PMID:16051428 more ... 3,3'-diindolylmethane decreases expression EXP 6480464 3, 3'-diindolylmethane analog results in decreased expression of BCL2 mRNA CTD PMID:26593444 3,3'-diindolylmethane multiple interactions ISO RGD:733100 6480464 3, 3'-diindolylmethane promotes the reaction [Paclitaxel results in decreased expression of BCL2 protein] CTD PMID:16580691 3,4-dihydroxybenzoic acid multiple interactions ISO RGD:2199 6480464 protocatechuic acid inhibits the reaction [Rotenone results in decreased expression of BCL2 protein] CTD PMID:18082360 3,4-methylenedioxymethamphetamine increases expression EXP 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in increased expression of BCL2 mRNA CTD PMID:20188158 3,4-methylenedioxymethamphetamine multiple interactions ISO RGD:733100 6480464 [N-Methyl-3, 4-methylenedioxyamphetamine co-treated with Methamphetamine co-treated with 4-methylthioamphetamine co-treated with Dextroamphetamine] results in decreased expression of BCL2 mRNA CTD PMID:23820845 3,4-methylenedioxymethamphetamine decreases expression ISO RGD:733100 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in decreased expression of BCL2 mRNA CTD PMID:23820845 3,7-dihydropurine-6-thione decreases expression EXP 6480464 Mercaptopurine results in decreased expression of BCL2 protein CTD PMID:9058596 3,7-dihydropurine-6-thione multiple interactions ISO RGD:733100 6480464 [Doxorubicin co-treated with Dexamethasone co-treated with Vincristine co-treated with Cytarabine co-treated with Mercaptopurine co-treated with Methotrexate co-treated with Cyclophosphamide co-treated with Enzymes and Coenzymes] results in increased expression of BCL2 protein CTD PMID:21182165 3-[3-(tert-butylsulfanyl)-1-(4-chlorobenzyl)-5-(propan-2-yl)-1H-indol-2-yl]-2,2-dimethylpropanoic acid multiple interactions ISO RGD:733100 6480464 MK-886 inhibits the reaction [Nicotine results in increased expression of BCL2 protein] CTD PMID:20061081 3-chloropropane-1,2-diol decreases expression ISO RGD:733100 6480464 alpha-Chlorohydrin results in decreased expression of BCL2 mRNA, alpha-Chlorohydrin results in decreased expression of BCL2 protein CTD PMID:27732882 , PMID:28070108 3-chloropropane-1,2-diol multiple interactions ISO RGD:2199 6480464 Apigenin inhibits the reaction [alpha-Chlorohydrin results in decreased expression of BCL2 mRNA] CTD PMID:30107153 3-chloropropane-1,2-diol decreases expression ISO RGD:2199 6480464 alpha-Chlorohydrin results in decreased expression of BCL2 mRNA, alpha-Chlorohydrin results in decreased expression of BCL2 protein CTD PMID:30107153 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:733100 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of BCL2 mRNA CTD PMID:28628672 3-methyladenine multiple interactions ISO RGD:733100 6480464 3-methyladenine inhibits the reaction [arsenic trioxide results in decreased expression of BCL2], [3-methyladenine co-treated with Amiodarone] results in decreased expression of BCL2 protein CTD PMID:23912912 , PMID:25110043 3-methyladenine multiple interactions ISO RGD:2199 6480464 3-methyladenine inhibits the reaction [citreoviridin results in decreased expression of BCL2 protein] CTD PMID:31419397 3-methylcholanthrene increases expression ISO RGD:2199 6480464 Methylcholanthrene results in increased expression of BCL2 mRNA CTD PMID:23273579 3-methylthiopropanal affects response to substance EXP 6480464 BCL2 protein affects the susceptibility to methional CTD PMID:8611183 3-nitropropanoic acid multiple interactions ISO RGD:2199 6480464 [Tacrolimus co-treated with 3-nitropropionic acid] affects the localization of BCL2 protein more ... CTD PMID:15571979 more ... 3-nitropropanoic acid decreases expression ISO RGD:2199 6480464 3-nitropropionic acid results in decreased expression of BCL2 mRNA CTD PMID:21945202 3-phenylprop-2-enal multiple interactions ISO RGD:733100 6480464 Vitamin E inhibits the reaction [cinnamic aldehyde results in decreased expression of BCL2 protein] CTD PMID:15566391 3-phenylprop-2-enal decreases expression ISO RGD:733100 6480464 cinnamic aldehyde analog results in decreased expression of BCL2 protein, cinnamic aldehyde results in decreased expression of BCL2 protein CTD PMID:15566391 more ... 4'-epidoxorubicin increases expression ISO RGD:733100 6480464 Epirubicin analog results in increased expression of BCL2 mRNA, Epirubicin results in increased expression of BCL2 mRNA CTD PMID:14503796 more ... 4'-epidoxorubicin decreases expression EXP 6480464 Epirubicin results in decreased expression of BCL2 protein CTD PMID:26646421 , PMID:29505745 4'-epidoxorubicin multiple interactions EXP 6480464 paeonol inhibits the reaction [Epirubicin results in decreased expression of BCL2 protein] CTD PMID:26646421 , PMID:29505745 4'-epidoxorubicin multiple interactions ISO RGD:733100 6480464 [Epirubicin analog co-treated with chrysophsin analog] results in increased expression of BCL2 mRNA, [Epirubicin co-treated with chrysophsin] results in increased expression of BCL2 mRNA CTD PMID:26335193 4,4'-sulfonyldiphenol multiple interactions ISO RGD:733100 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of BCL2 mRNA CTD PMID:28628672 4,5,6,7-TETRABROMOBENZOTRIAZOLE multiple interactions ISO RGD:733100 6480464 [4 more ... CTD PMID:16489027 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one increases expression ISO RGD:733100 6480464 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of BCL2 mRNA, 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of BCL2 protein CTD PMID:16582591 more ... 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one multiple interactions ISO RGD:733100 6480464 Bungarotoxins inhibits the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of BCL2 mRNA] more ... CTD PMID:16835749 , PMID:18508827 4-amino-1,8-naphthalimide multiple interactions ISO RGD:733100 6480464 4-amino-1, 8-naphthalimide inhibits the reaction [arsenic trioxide results in increased expression of BCL2 protein] CTD PMID:25972196 4-hydroxyphenyl retinamide affects response to substance ISO RGD:733100 6480464 BCL2 protein affects the susceptibility to Fenretinide CTD PMID:7811993 4-hydroxyphenyl retinamide decreases expression EXP 6480464 Fenretinide results in decreased expression of BCL2 mRNA CTD PMID:28973697 4-hydroxyphenyl retinamide decreases expression ISO RGD:733100 6480464 Fenretinide results in decreased expression of BCL2 mRNA, Fenretinide results in decreased expression of BCL2 protein CTD PMID:16187019 more ... 4-hydroxyphenyl retinamide multiple interactions ISO RGD:733100 6480464 [Fenretinide co-treated with Carmustine] results in decreased expression of BCL2 protein, Fenretinide inhibits the reaction [TNF protein results in increased expression of BCL2 protein] CTD PMID:16187019 , PMID:16230421 4-nitroaniline multiple interactions ISO RGD:733100 6480464 BCL2 protein inhibits the reaction [resveratrol promotes the reaction [[CASP3 protein results in increased cleavage of aspartyl-glutamyl-valyl-aspartyl-p-nitroanilide] which results in increased chemical synthesis of 4-nitroaniline]] CTD PMID:11577002 4-nonylphenol increases expression ISO RGD:733100 6480464 4-nonylphenol results in increased expression of BCL2 mRNA CTD PMID:15461258 4-nonylphenol multiple interactions ISO RGD:2199 6480464 [bisphenol A co-treated with 4-nonylphenol] results in decreased expression of BCL2 mRNA CTD PMID:30228064 4-nonylphenol decreases expression ISO RGD:2199 6480464 4-nonylphenol results in decreased expression of BCL2 mRNA, 4-nonylphenol results in decreased expression of BCL2 protein CTD PMID:26804764 more ... 4-phenylbutyric acid multiple interactions ISO RGD:733100 6480464 4-phenylbutyric acid inhibits the reaction [Silver Compounds results in decreased expression of BCL2 protein] more ... CTD PMID:27816613 , PMID:29306025 5-(1,4-diazepane-1-sulfonyl)isoquinoline increases expression ISO RGD:2199 6480464 fasudil results in increased expression of BCL2 protein CTD PMID:17761835 5-(1,4-diazepane-1-sulfonyl)isoquinoline multiple interactions ISO RGD:2199 6480464 fasudil inhibits the reaction [Streptozocin results in decreased expression of BCL2 protein] CTD PMID:22429817 5-aminolevulinic acid decreases expression ISO RGD:733100 6480464 Aminolevulinic Acid analog results in decreased expression of BCL2 mRNA CTD PMID:20676910 5-aza-2'-deoxycytidine multiple interactions ISO RGD:2199 6480464 [Paraquat co-treated with Decitabine] results in decreased expression of BCL2 protein, Decitabine inhibits the reaction [Benzene results in decreased expression of BCL2 mRNA] CTD PMID:21143203 , PMID:22796470 5-aza-2'-deoxycytidine increases expression ISO RGD:733100 6480464 Decitabine results in increased expression of BCL2 mRNA CTD PMID:21515334 5-aza-2'-deoxycytidine decreases expression ISO RGD:733100 6480464 Decitabine results in decreased expression of BCL2 mRNA, Decitabine results in decreased expression of BCL2 protein CTD PMID:18636160 , PMID:22082530 5-aza-2'-deoxycytidine increases expression EXP 6480464 Decitabine results in increased expression of BCL2 mRNA CTD PMID:27915011 5-aza-2'-deoxycytidine multiple interactions ISO RGD:733100 6480464 [Decitabine co-treated with epigallocatechin gallate] affects the expression of BCL2 mRNA more ... CTD PMID:18250043 more ... 5-fluorouracil multiple interactions ISO RGD:733100 6480464 [Docosahexaenoic Acids co-treated with Fluorouracil] results in decreased expression of BCL2 mRNA more ... CTD PMID:15754201 more ... 5-fluorouracil multiple interactions ISO RGD:2199 6480464 Fluorouracil inhibits the reaction [Diethylnitrosamine results in increased expression of BCL2 mRNA], Fluorouracil inhibits the reaction [Diethylnitrosamine results in increased expression of BCL2 protein] CTD PMID:31129132 5-fluorouracil affects expression ISO RGD:733100 6480464 Fluorouracil affects the expression of BCL2 protein CTD PMID:23941782 5-fluorouracil affects response to substance ISO RGD:733100 6480464 BCL2 protein affects the susceptibility to Fluorouracil CTD PMID:15177426 more ... 5-fluorouracil decreases expression EXP 6480464 Fluorouracil results in decreased expression of BCL2 protein CTD PMID:18567086 , PMID:20844880 5-fluorouracil increases expression ISO RGD:2199 6480464 Fluorouracil results in increased expression of BCL2 mRNA CTD PMID:16888818 5-fluorouracil multiple interactions EXP 6480464 [Fluorouracil co-treated with Chitosan co-treated with polyaspartate] results in decreased expression of BCL2 protein, IL1RN protein inhibits the reaction [Fluorouracil results in decreased expression of BCL2 protein] CTD PMID:18567086 , PMID:20844880 5-fluorouracil increases phosphorylation ISO RGD:733100 6480464 Fluorouracil results in increased phosphorylation of BCL2 protein CTD PMID:7654318 5-fluorouracil increases expression ISO RGD:733100 6480464 Fluorouracil results in increased expression of BCL2 mRNA CTD PMID:14503796 5-fluorouracil decreases expression ISO RGD:733100 6480464 Fluorouracil results in decreased expression of BCL2 more ... CTD PMID:15754201 more ... 5-fluorouracil decreases response to substance ISO RGD:733100 6480464 BCL2 protein results in decreased susceptibility to Fluorouracil CTD PMID:17439414 5-methoxy-2-\{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl\}-1H-benzimidazole multiple interactions ISO RGD:733100 6480464 Omeprazole inhibits the reaction [Cisplatin results in decreased expression of BCL2 protein] CTD PMID:30452898 5alpha-pregnane-3,20-dione increases expression ISO RGD:733100 6480464 5-alpha-Dihydroprogesterone results in increased expression of BCL2 mRNA CTD PMID:19931389 5alpha-pregnane-3,20-dione multiple interactions ISO RGD:733100 6480464 3-hydroxypregn-4-en-20-one inhibits the reaction [5-alpha-Dihydroprogesterone results in increased expression of BCL2 mRNA] CTD PMID:19931389 6-anilino-5,8-quinolinedione multiple interactions ISO RGD:733100 6480464 6-anilino-5, 8-quinolinedione inhibits the reaction [sodium bichromate results in increased ubiquitination of BCL2 protein] CTD PMID:18544562 6-anilino-5,8-quinolinedione decreases expression ISO RGD:733100 6480464 6-anilino-5, 8-quinolinedione results in decreased expression of BCL2 protein CTD PMID:18544562 6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide decreases expression ISO RGD:2199 6480464 6-chloro-2 more ... CTD PMID:29653943 6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide multiple interactions ISO RGD:2199 6480464 DDIT3 protein affects the reaction [6-chloro-2 more ... CTD PMID:29653943 6alpha-methylprednisolone multiple interactions ISO RGD:2199 6480464 Methylprednisolone inhibits the reaction [Hydrogen Peroxide affects the expression of BCL2 mRNA], Methylprednisolone inhibits the reaction [Hydrogen Peroxide affects the expression of BCL2 protein] CTD PMID:17570061 7,12-dimethyltetraphene multiple interactions EXP 6480464 [9 more ... CTD PMID:18791811 more ... 7,12-dimethyltetraphene multiple interactions ISO RGD:2199 6480464 Taurine inhibits the reaction [9 more ... CTD PMID:30101532 7,12-dimethyltetraphene increases expression ISO RGD:2199 6480464 9 more ... CTD PMID:30101532 7,12-dimethyltetraphene increases expression EXP 6480464 9 more ... CTD PMID:18791811 more ... 7,8-dihydroxycoumarin multiple interactions ISO RGD:733100 6480464 daphnetin inhibits the reaction [sodium arsenite results in decreased expression of BCL2 protein] CTD PMID:30738023 7-ketocholesterol multiple interactions ISO RGD:2199 6480464 Acetylcysteine inhibits the reaction [7-ketocholesterol results in decreased expression of BCL2 protein] more ... CTD PMID:25845326 7-ketocholesterol decreases expression ISO RGD:2199 6480464 7-ketocholesterol results in decreased expression of BCL2 protein CTD PMID:25845326 8-bromo-3',5'-cyclic AMP decreases expression ISO RGD:733100 6480464 8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of BCL2 CTD PMID:11802967 8-OH-DPAT multiple interactions EXP 6480464 acetovanillone inhibits the reaction [8-Hydroxy-2-(di-n-propylamino)tetralin results in decreased expression of BCL2 protein] more ... CTD PMID:30366073 8-OH-DPAT decreases expression EXP 6480464 8-Hydroxy-2-(di-n-propylamino)tetralin results in decreased expression of BCL2 protein CTD PMID:30366073 9,10-anthraquinone decreases expression ISO RGD:733100 6480464 9 more ... CTD PMID:26915975 9,10-phenanthroquinone decreases expression ISO RGD:733100 6480464 9, 10-phenanthrenequinone results in decreased expression of BCL2 protein CTD PMID:29108775 9,11,13-octadecatrienoic acid decreases expression ISO RGD:733100 6480464 eleostearic acid results in decreased expression of BCL2 protein CTD PMID:15961301 9-cis-retinoic acid decreases expression ISO RGD:733100 6480464 Alitretinoin results in decreased expression of BCL2, Alitretinoin results in decreased expression of BCL2 protein CTD PMID:12189556 more ... 9-cis-retinoic acid decreases response to substance ISO RGD:733100 6480464 BCL2 protein results in decreased susceptibility to Alitretinoin CTD PMID:12189556 [6]-Shogaol decreases expression ISO RGD:733100 6480464 shogaol results in decreased expression of BCL2 protein CTD PMID:18384088 acetaldehyde decreases expression ISO RGD:733100 6480464 Acetaldehyde results in decreased expression of BCL2 mRNA CTD PMID:16814256 acetaldehyde multiple interactions ISO RGD:733100 6480464 ADIPOQ protein inhibits the reaction [Acetaldehyde results in decreased expression of BCL2 mRNA] CTD PMID:16814256 acetic acid multiple interactions ISO RGD:2199 6480464 Mesalamine inhibits the reaction [Acetic Acid results in decreased expression of BCL2 mRNA] more ... CTD PMID:29518435 , PMID:30594690 acetic acid decreases expression ISO RGD:2199 6480464 Acetic Acid results in decreased expression of BCL2 mRNA, Acetic Acid results in decreased expression of BCL2 protein CTD PMID:29518435 , PMID:30594690 acetylsalicylic acid multiple interactions ISO RGD:733100 6480464 Aspirin inhibits the reaction [Methotrexate results in decreased expression of BCL2 protein] more ... CTD PMID:16199534 , PMID:23799623 acetylsalicylic acid multiple interactions EXP 6480464 Aspirin inhibits the reaction [[Azoxymethane co-treated with Dextran Sulfate] results in increased expression of BCL2 protein] CTD PMID:25449198 acetylsalicylic acid decreases expression ISO RGD:733100 6480464 Aspirin results in decreased expression of BCL2 mRNA, Aspirin results in decreased expression of BCL2 protein CTD PMID:12490308 more ... acetylsalicylic acid multiple interactions ISO RGD:2199 6480464 Aspirin inhibits the reaction [Azoxymethane results in increased expression of BCL2 mRNA] CTD PMID:20043115 acetylsalicylic acid decreases expression EXP 6480464 Aspirin results in decreased expression of BCL2 protein CTD PMID:20886344 acetylsalicylic acid increases expression ISO RGD:733100 6480464 Aspirin results in increased expression of BCL2 mRNA, Aspirin results in increased expression of BCL2 protein CTD PMID:17342322 , PMID:18636671 acifluorfen decreases response to substance ISO RGD:733100 6480464 BCL2 protein results in decreased susceptibility to acifluorfen CTD PMID:15475374 aconitine decreases expression ISO RGD:2199 6480464 Aconitine results in decreased expression of BCL2 protein CTD PMID:24840785 acrolein decreases expression EXP 6480464 Acrolein results in decreased expression of BCL2 protein CTD PMID:24376112 acrolein multiple interactions EXP 6480464 capsazepine inhibits the reaction [Acrolein results in decreased expression of BCL2 protein], Glutathione inhibits the reaction [Acrolein results in decreased expression of BCL2 protein] CTD PMID:24376112 acrylamide decreases expression ISO RGD:2199 6480464 Acrylamide results in decreased expression of BCL2 mRNA CTD PMID:28959563 acrylonitrile decreases expression ISO RGD:733100 6480464 Acrylonitrile results in decreased expression of BCL2 protein CTD PMID:16173056 actinomycin D multiple interactions ISO RGD:733100 6480464 BCL2 protein inhibits the reaction [Dactinomycin results in increased susceptibility to TNF protein] more ... CTD PMID:11726273 more ... actinomycin D decreases expression ISO RGD:733100 6480464 Dactinomycin results in decreased expression of BCL2 mRNA, Dactinomycin results in decreased expression of BCL2 protein CTD PMID:12927789 , PMID:17581298 afimoxifene decreases expression ISO RGD:733100 6480464 afimoxifene results in decreased expression of BCL2 mRNA CTD PMID:19698761 afimoxifene multiple interactions ISO RGD:733100 6480464 [annonacin co-treated with afimoxifene] results in decreased expression of BCL2 protein CTD PMID:21840388 aflatoxin B1 decreases expression ISO RGD:733100 6480464 Aflatoxin B1 results in decreased expression of BCL2 protein CTD PMID:22743290 aflatoxin B1 decreases methylation ISO RGD:733100 6480464 Aflatoxin B1 results in decreased methylation of BCL2 intron CTD PMID:30157460 aflatoxin B1 decreases expression ISO RGD:2199 6480464 Aflatoxin B1 results in decreased expression of BCL2 mRNA CTD PMID:27288928 , PMID:28442411 aflatoxin B1 multiple interactions ISO RGD:2199 6480464 [Curcumin analog co-treated with Hydrogels] inhibits the reaction [Aflatoxin B1 results in decreased expression of BCL2 mRNA] CTD PMID:27288928 aflatoxin B1 multiple interactions EXP 6480464 deoxynivalenol promotes the reaction [Aflatoxin B1 results in decreased expression of BCL2 mRNA] CTD PMID:25445755 aflatoxin B1 decreases expression EXP 6480464 Aflatoxin B1 results in decreased expression of BCL2 mRNA, Aflatoxin B1 results in decreased expression of BCL2 protein CTD PMID:19770486 more ... aflatoxin B1 multiple interactions ISO RGD:733100 6480464 Methoxsalen inhibits the reaction [Aflatoxin B1 results in decreased expression of BCL2 protein], Nicotine inhibits the reaction [Aflatoxin B1 results in decreased expression of BCL2 protein] CTD PMID:22743290 AH23848 multiple interactions ISO RGD:733100 6480464 [6-isopropoxy-9-oxoxanthene-2-carboxylic acid co-treated with AH 23848] promotes the reaction [BAD protein binds to BCL2 protein] more ... CTD PMID:19407222 AICA ribonucleotide multiple interactions ISO RGD:2199 6480464 AICA ribonucleotide inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of BCL2 protein] CTD PMID:26989860 alachlor increases expression ISO RGD:733100 6480464 alachlor results in increased expression of BCL2 protein CTD PMID:10545406 alachlor multiple interactions ISO RGD:733100 6480464 fulvestrant inhibits the reaction [alachlor results in increased expression of BCL2 protein], PK 11195 inhibits the reaction [BCL2 protein results in decreased susceptibility to alachlor] CTD PMID:10545406 , PMID:12730627 alachlor decreases response to substance ISO RGD:733100 6480464 BCL2 protein results in decreased susceptibility to alachlor CTD PMID:12730627 alantolactone increases expression ISO RGD:733100 6480464 alantolactone results in increased expression of BCL2 protein CTD PMID:22721982 alantolactone decreases expression ISO RGD:733100 6480464 alantolactone results in decreased expression of BCL2 protein CTD PMID:24252419 alborixin decreases expression ISO RGD:733100 6480464 alborixin results in decreased expression of BCL2 protein CTD PMID:27378626 albuterol decreases expression ISO RGD:733100 6480464 Albuterol results in decreased expression of BCL2 CTD PMID:11802967 aldehydo-D-glucose multiple interactions ISO RGD:2199 6480464 15-Hydroxy-11 alpha more ... CTD PMID:21803128 more ... aldehydo-D-glucose multiple interactions EXP 6480464 [Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of BCL2 mRNA more ... CTD PMID:23108914 more ... aldehydo-D-glucose decreases expression ISO RGD:2199 6480464 Glucose results in decreased expression of BCL2 mRNA, Glucose results in decreased expression of BCL2 protein CTD PMID:21818840 more ... aldehydo-D-glucose affects expression ISO RGD:2199 6480464 Glucose affects the expression of BCL2 mRNA, Glucose affects the expression of BCL2 protein CTD PMID:22524206 , PMID:24349266 aldehydo-D-glucose decreases expression ISO RGD:733100 6480464 Glucose results in decreased expression of BCL2 mRNA, Glucose results in decreased expression of BCL2 protein CTD PMID:18088078 more ... aldehydo-D-glucose multiple interactions ISO RGD:733100 6480464 [Resveratrol co-treated with Glucose] results in increased expression of BCL2 protein more ... CTD PMID:18088078 more ... all-trans-acitretin decreases expression ISO RGD:733100 6480464 Acitretin results in decreased expression of BCL2 protein CTD PMID:16109552 , PMID:16196285 all-trans-retinoic acid multiple interactions ISO RGD:733100 6480464 [1 more ... CTD PMID:10713328 more ... all-trans-retinoic acid decreases expression EXP 6480464 Tretinoin results in decreased expression of BCL2 protein CTD PMID:11851873 more ... all-trans-retinoic acid decreases expression ISO RGD:2199 6480464 Tretinoin results in decreased expression of BCL2 protein CTD PMID:17962954 all-trans-retinoic acid increases expression ISO RGD:733100 6480464 Tretinoin results in increased expression of BCL2 mRNA, Tretinoin results in increased expression of BCL2 protein CTD PMID:10750663 more ... all-trans-retinoic acid increases phosphorylation ISO RGD:733100 6480464 Tretinoin results in increased phosphorylation of BCL2 protein CTD PMID:18098270 all-trans-retinoic acid decreases expression ISO RGD:733100 6480464 Tretinoin results in decreased expression of BCL2 more ... CTD PMID:10713328 more ... all-trans-retinol decreases expression ISO RGD:2199 6480464 Vitamin A results in decreased expression of BCL2 protein CTD PMID:16216918 allethrin decreases expression ISO RGD:2199 6480464 Allethrins results in decreased expression of BCL2 protein CTD PMID:25072698 allethrin decreases expression ISO RGD:733100 6480464 Allethrins results in decreased expression of BCL2 protein CTD PMID:24055895 alloxan decreases expression ISO RGD:2199 6480464 Alloxan results in decreased expression of BCL2 protein CTD PMID:21982801 more ... alloxan multiple interactions ISO RGD:2199 6480464 Taurine inhibits the reaction [Alloxan results in decreased expression of BCL2 protein] CTD PMID:22138235 , PMID:23092809 Allyl chloride decreases expression ISO RGD:2199 6480464 allyl chloride results in decreased expression of BCL2 protein CTD PMID:17194518 Aloe emodin decreases expression ISO RGD:733100 6480464 aloe emodin results in decreased expression of BCL2 mRNA, aloe emodin results in decreased expression of BCL2 protein CTD PMID:19928967 , PMID:22210228 Aloperine increases expression ISO RGD:2199 6480464 aloperine results in increased expression of BCL2 mRNA CTD PMID:11218852 alpha-D-galactose multiple interactions ISO RGD:2199 6480464 Saponins inhibits the reaction [Galactose results in decreased expression of BCL2 protein] CTD PMID:25892055 alpha-D-galactose multiple interactions ISO RGD:733100 6480464 Phycocyanin inhibits the reaction [Galactose results in decreased expression of BCL2 protein] CTD PMID:23036742 alpha-D-galactose decreases expression ISO RGD:733100 6480464 Galactose results in decreased expression of BCL2 protein CTD PMID:23036742 alpha-D-galactose decreases expression ISO RGD:2199 6480464 Galactose results in decreased expression of BCL2 protein CTD PMID:25892055 alpha-mangostin decreases expression ISO RGD:733100 6480464 mangostin results in decreased expression of BCL2 protein CTD PMID:24480042 alpha-mangostin multiple interactions ISO RGD:733100 6480464 mangostin inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of BCL2 mRNA] CTD PMID:26357513 alpha-Zearalanol multiple interactions ISO RGD:733100 6480464 Zeranol inhibits the reaction [Homocysteine results in decreased expression of BCL2 protein] CTD PMID:16757814 alpha-Zearalanol increases expression ISO RGD:733100 6480464 Zeranol results in increased expression of BCL2 protein CTD PMID:27224899 alpinumisoflavone decreases expression ISO RGD:733100 6480464 alpinumisoflavone results in decreased expression of BCL2 protein CTD PMID:23850732 alvocidib decreases expression ISO RGD:733100 6480464 alvocidib results in decreased expression of BCL2 mRNA, alvocidib results in decreased expression of BCL2 protein CTD PMID:10887097 more ... alvocidib decreases expression EXP 6480464 alvocidib results in decreased expression of BCL2 protein CTD PMID:12734434 alvocidib decreases response to substance ISO RGD:733100 6480464 BCL2 protein mutant form results in decreased susceptibility to alvocidib, BCL2 protein results in decreased susceptibility to alvocidib CTD PMID:12170773 , PMID:12517783 alvocidib multiple interactions ISO RGD:733100 6480464 [alvocidib co-treated with gemcitabine] results in decreased expression of BCL2 protein more ... CTD PMID:12170773 more ... alvocidib increases expression ISO RGD:733100 6480464 alvocidib results in increased expression of BCL2 CTD PMID:10995888 amentoflavone multiple interactions ISO RGD:733100 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [amentoflavone inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of BCL2 protein]], amentoflavone inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of BCL2 protein] CTD PMID:28185818 amentoflavone multiple interactions EXP 6480464 amentoflavone inhibits the reaction [1-Methyl-4-phenyl-1 more ... CTD PMID:28185818 amidotrizoic acid multiple interactions ISO RGD:733100 6480464 [Diatrizoate co-treated with Iodine] results in increased expression of BCL2 protein CTD PMID:17173243 amifostine multiple interactions ISO RGD:733100 6480464 [Amifostine co-treated with Doxorubicin] results in decreased expression of BCL2 mRNA CTD PMID:15985719 amino acid multiple interactions EXP 6480464 Amino Acids inhibits the reaction [KL gene mutant form results in decreased expression of BCL2 protein], H 1356 inhibits the reaction [Amino Acids inhibits the reaction [KL gene mutant form results in decreased expression of BCL2 protein]] CTD PMID:25309793 aminoguanidine multiple interactions EXP 6480464 [pimagedine results in decreased activity of NOS2 protein] which results in decreased expression of BCL2 mRNA, pimagedine inhibits the reaction [Cardiotoxins results in increased phosphorylation of BCL2 protein] CTD PMID:17135264 , PMID:17786558 aminoguanidine multiple interactions ISO RGD:733100 6480464 [pimagedine results in decreased nitrosation of and results in increased ubiquitination of and results in increased degradation of BCL2 protein] which results in increased susceptibility to Chromates more ... CTD PMID:16980304 amiodarone multiple interactions ISO RGD:733100 6480464 [3-methyladenine co-treated with Amiodarone] results in decreased expression of BCL2 protein CTD PMID:23912912 amiodarone decreases expression ISO RGD:2199 6480464 Amiodarone results in decreased expression of BCL2 protein CTD PMID:21224497 amitriptyline multiple interactions ISO RGD:2199 6480464 Amitriptyline inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of BCL2 protein] CTD PMID:19135049 amlodipine multiple interactions ISO RGD:733100 6480464 Amlodipine inhibits the reaction [AGT results in decreased expression of BCL2 mRNA], Amlodipine inhibits the reaction [AGT results in decreased expression of BCL2 protein] CTD PMID:21376258 amlodipine multiple interactions ISO RGD:2199 6480464 Amlodipine inhibits the reaction [Doxorubicin results in decreased expression of BCL2 protein], Amlodipine inhibits the reaction [Gentamicins results in decreased expression of BCL2 protein] CTD PMID:17234320 , PMID:19698708 ammonium chloride affects expression ISO RGD:2199 6480464 Ammonium Chloride affects the expression of BCL2 mRNA CTD PMID:16483693 amphetamine decreases expression EXP 6480464 Amphetamine results in decreased expression of BCL2 protein CTD PMID:15731293 amphetamine decreases expression ISO RGD:2199 6480464 Amphetamine results in decreased expression of BCL2 mRNA CTD PMID:30779732 amsacrine decreases response to substance ISO RGD:733100 6480464 BCL2 protein results in decreased susceptibility to Amsacrine CTD PMID:10920913 Anacardic acid multiple interactions ISO RGD:733100 6480464 anacardic acid inhibits the reaction [TNF protein results in increased expression of BCL2 protein] CTD PMID:18349320 andrographolide multiple interactions ISO RGD:733100 6480464 [andrographolide co-treated with Cisplatin] results in decreased expression of BCL2 mRNA CTD PMID:24563380 andrographolide decreases expression ISO RGD:733100 6480464 andrographolide results in decreased expression of BCL2 protein CTD PMID:23845849 anthocyanin multiple interactions ISO RGD:2199 6480464 Anthocyanins inhibits the reaction [Paraquat results in decreased expression of BCL2 mRNA] more ... CTD PMID:28856781 , PMID:30403199 anthra[1,9-cd]pyrazol-6(2H)-one multiple interactions ISO RGD:733100 6480464 pyrazolanthrone inhibits the reaction [1 more ... CTD PMID:14724571 more ... anthra[1,9-cd]pyrazol-6(2H)-one decreases phosphorylation ISO RGD:2199 6480464 pyrazolanthrone results in decreased phosphorylation of BCL2 protein CTD PMID:24833599 anthra[1,9-cd]pyrazol-6(2H)-one multiple interactions ISO RGD:2199 6480464 pyrazolanthrone inhibits the reaction [[cupric chloride binds to pyrrolidine dithiocarbamic acid] which results in decreased expression of BCL2 mRNA] more ... CTD PMID:19428505 more ... anthra[1,9-cd]pyrazol-6(2H)-one multiple interactions EXP 6480464 pyrazolanthrone inhibits the reaction [Cardiotoxins results in increased phosphorylation of BCL2 protein] CTD PMID:17786558 antimycin A decreases response to substance ISO RGD:733100 6480464 BCL2 protein results in decreased susceptibility to Antimycin A CTD PMID:12730627 antimycin A multiple interactions ISO RGD:733100 6480464 PK 11195 inhibits the reaction [BCL2 protein results in decreased susceptibility to Antimycin A] CTD PMID:12730627 apigenin decreases expression ISO RGD:733100 6480464 Apigenin results in decreased expression of BCL2 protein CTD PMID:15486995 apigenin multiple interactions ISO RGD:2199 6480464 Apigenin inhibits the reaction [alpha-Chlorohydrin results in decreased expression of BCL2 mRNA] more ... CTD PMID:25557508 more ... apigenin multiple interactions ISO RGD:733100 6480464 [polylactic acid-polyglycolic acid copolymer co-treated with Apigenin] results in decreased expression of BCL2 mRNA more ... CTD PMID:24070738 , PMID:29247770 apigenin decreases response to substance ISO RGD:733100 6480464 BCL2 protein results in decreased susceptibility to Apigenin CTD PMID:15486995 apocynin multiple interactions ISO RGD:2199 6480464 acetovanillone inhibits the reaction [[Desoxycorticosterone co-treated with Sodium Chloride] results in decreased expression of BCL2 protein] CTD PMID:22431579 apocynin multiple interactions EXP 6480464 acetovanillone inhibits the reaction [8-Hydroxy-2-(di-n-propylamino)tetralin results in decreased expression of BCL2 protein] CTD PMID:30366073 aprepitant multiple interactions ISO RGD:733100 6480464 [Arsenic Trioxide co-treated with Aprepitant] results in decreased expression of BCL2 mRNA CTD PMID:30145367 arachidonic acid decreases expression ISO RGD:733100 6480464 Arachidonic Acid results in decreased expression of BCL2 protein CTD PMID:19540902 , PMID:19720122 arachidonic acid multiple interactions ISO RGD:733100 6480464 1 more ... CTD PMID:19540902 , PMID:19620254 arecoline decreases expression ISO RGD:733100 6480464 Arecoline results in decreased expression of BCL2 protein CTD PMID:22108589 aristolochic acid decreases expression ISO RGD:733100 6480464 aristolochic acid I results in decreased expression of BCL2 protein CTD PMID:31048001 aristolochic acid decreases expression EXP 6480464 aristolochic acid I results in decreased expression of BCL2 protein CTD PMID:26656393 , PMID:31048001 arjunolic acid multiple interactions ISO RGD:2199 6480464 arjunolic acid inhibits the reaction [Streptozocin results in increased expression of BCL2 protein] CTD PMID:19682444 arjunolic acid multiple interactions EXP 6480464 arjunolic acid inhibits the reaction [Cadmium Chloride results in decreased expression of BCL2 protein] CTD PMID:21420465 Aroclor 1254 increases expression ISO RGD:2199 6480464 Chlorodiphenyl (54% Chlorine) results in increased expression of BCL2 mRNA, Chlorodiphenyl (54% Chlorine) results in increased expression of BCL2 protein CTD PMID:23281070 Aroclor 1254 decreases expression EXP 6480464 Chlorodiphenyl (54% Chlorine) results in decreased expression of BCL2 protein CTD PMID:24216299 Aroclor 1254 multiple interactions EXP 6480464 2 more ... CTD PMID:24216299 Aroclor 1254 multiple interactions ISO RGD:2199 6480464 Quercetin inhibits the reaction [Chlorodiphenyl (54% Chlorine) results in increased expression of BCL2 mRNA], Quercetin inhibits the reaction [Chlorodiphenyl (54% Chlorine) results in increased expression of BCL2 protein] CTD PMID:23281070 arotinoid acid decreases expression ISO RGD:733100 6480464 4-(2-(5 more ... CTD PMID:16109544 , PMID:16909596 arsane increases expression ISO RGD:2199 6480464 Arsenic results in increased expression of BCL2 protein CTD PMID:11756236 arsane affects expression EXP 6480464 Arsenic affects the expression of BCL2 protein CTD PMID:27289040 arsane affects methylation ISO RGD:733100 6480464 Arsenic affects the methylation of BCL2 gene CTD PMID:25304211 arsane increases expression ISO RGD:733100 6480464 Arsenic results in increased expression of BCL2 mRNA, Arsenic results in increased expression of BCL2 protein CTD PMID:12899209 more ... arsenic acid increases expression EXP 6480464 arsenic acid results in increased expression of BCL2 mRNA CTD PMID:8946558 arsenic atom increases expression ISO RGD:733100 6480464 Arsenic results in increased expression of BCL2 mRNA, Arsenic results in increased expression of BCL2 protein CTD PMID:12899209 more ... arsenic atom affects expression EXP 6480464 Arsenic affects the expression of BCL2 protein CTD PMID:27289040 arsenic atom affects methylation ISO RGD:733100 6480464 Arsenic affects the methylation of BCL2 gene CTD PMID:25304211 arsenic atom increases expression ISO RGD:2199 6480464 Arsenic results in increased expression of BCL2 protein CTD PMID:11756236 arsenite(3-) decreases expression ISO RGD:733100 6480464 arsenite results in decreased expression of BCL2 mRNA alternative form, arsenite results in decreased expression of BCL2 protein CTD PMID:20083129 , PMID:26677073 arsenite(3-) decreases expression ISO RGD:2199 6480464 arsenite results in decreased expression of BCL2 protein CTD PMID:29324385 arsenite(3-) multiple interactions ISO RGD:733100 6480464 Heparin inhibits the reaction [arsenite results in decreased expression of BCL2 protein], Thapsigargin promotes the reaction [arsenite results in decreased expression of BCL2 protein] CTD PMID:26677073 arsenite(3-) increases expression ISO RGD:733100 6480464 arsenite results in increased expression of BCL2 mRNA, arsenite results in increased expression of BCL2 protein CTD PMID:28444938 arsenite(3-) increases expression ISO RGD:2199 6480464 arsenite results in increased expression of BCL2 protein CTD PMID:18077580 arsenite(3-) multiple interactions ISO RGD:2199 6480464 Acetylcysteine inhibits the reaction [arsenite results in increased expression of BCL2 protein] CTD PMID:18077580 arsenous acid decreases expression ISO RGD:733100 6480464 Arsenic Trioxide results in decreased expression of BCL2 more ... CTD PMID:10340400 more ... arsenous acid decreases response to substance ISO RGD:733100 6480464 BCL2 protein results in decreased susceptibility to Arsenic Trioxide, BCL2 results in decreased susceptibility to Arsenic Trioxide CTD PMID:11775218 more ... arsenous acid affects expression ISO RGD:2199 6480464 Arsenic Trioxide affects the expression of BCL2 mRNA, Arsenic Trioxide affects the expression of BCL2 protein CTD PMID:12725324 , PMID:18618274 arsenous acid increases phosphorylation ISO RGD:733100 6480464 Arsenic Trioxide results in increased phosphorylation of BCL2 protein CTD PMID:12181429 , PMID:18412143 arsenous acid decreases expression ISO RGD:2199 6480464 Arsenic Trioxide results in decreased expression of BCL2 mRNA, Arsenic Trioxide results in decreased expression of BCL2 protein CTD PMID:19260322 more ... arsenous acid multiple interactions EXP 6480464 [Genistein co-treated with Arsenic Trioxide] results in decreased expression of BCL2 protein more ... CTD PMID:21078540 , PMID:28587418 arsenous acid increases cleavage EXP 6480464 Arsenic Trioxide results in increased cleavage of BCL2 protein CTD PMID:15761769 arsenous acid multiple interactions ISO RGD:733100 6480464 2-(4-nitrophenyl)-4-(4-fluorophenyl)-5-(4-pyridinyl)-1H-imidazole inhibits the reaction [Arsenic Trioxide results in increased phosphorylation of BCL2 protein] more ... CTD PMID:11775218 more ... arsenous acid increases cleavage ISO RGD:733100 6480464 Arsenic Trioxide results in increased cleavage of BCL2 protein CTD PMID:11739184 arsenous acid multiple interactions ISO RGD:2199 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [salvianolic acid B inhibits the reaction [Arsenic Trioxide results in decreased expression of BCL2 protein]] more ... CTD PMID:17487067 more ... arsenous acid affects response to substance ISO RGD:733100 6480464 BCL2 protein affects the susceptibility to Arsenic Trioxide CTD PMID:10648417 , PMID:18726487 arsenous acid decreases expression EXP 6480464 Arsenic Trioxide results in decreased expression of BCL2 mRNA, Arsenic Trioxide results in decreased expression of BCL2 protein CTD PMID:10721769 more ... arsenous acid increases degradation ISO RGD:733100 6480464 Arsenic Trioxide results in increased degradation of BCL2 protein CTD PMID:19468689 arsenous acid affects folding ISO RGD:733100 6480464 Arsenic Trioxide affects the folding of BCL2 protein CTD PMID:20403207 arsenous acid increases expression ISO RGD:2199 6480464 Arsenic Trioxide results in increased expression of BCL2 mRNA CTD PMID:17487067 arsenous acid increases expression ISO RGD:733100 6480464 Arsenic Trioxide results in increased expression of BCL2 mRNA, Arsenic Trioxide results in increased expression of BCL2 protein CTD PMID:16966277 more ... arsenous acid increases expression EXP 6480464 Arsenic Trioxide results in increased expression of BCL2 protein CTD PMID:10712780 arsenous acid affects expression ISO RGD:733100 6480464 Arsenic Trioxide affects the expression of BCL2 protein CTD PMID:12962562 more ... arsenous acid increases response to substance ISO RGD:733100 6480464 BCL2 mutant form results in increased susceptibility to Arsenic Trioxide CTD PMID:14642526 artesunate multiple interactions ISO RGD:2199 6480464 [1, 2-Dimethylhydrazine co-treated with artesunate] results in decreased expression of BCL2 protein CTD PMID:29031619 artesunate decreases expression ISO RGD:733100 6480464 artesunate results in decreased expression of BCL2 protein CTD PMID:24704559 asarone decreases expression ISO RGD:733100 6480464 asarone results in decreased expression of BCL2 mRNA CTD PMID:29174417 asbestos increases expression ISO RGD:733100 6480464 Asbestos results in increased expression of BCL2 mRNA CTD PMID:22076105 , PMID:22398240 asiatic acid multiple interactions ISO RGD:2199 6480464 asiatic acid inhibits the reaction [1, 2-Dimethylhydrazine results in increased expression of BCL2 protein] CTD PMID:29108773 asiatic acid multiple interactions ISO RGD:733100 6480464 asiatic acid inhibits the reaction [Glucose results in decreased expression of BCL2 mRNA] more ... CTD PMID:30802477 aspartame multiple interactions ISO RGD:2199 6480464 [Aspartame co-treated with Methotrexate] results in decreased expression of BCL2 mRNA, [Aspartame co-treated with Methotrexate] results in decreased expression of BCL2 protein CTD PMID:25009784 Aspidin decreases expression ISO RGD:733100 6480464 aspidin BB results in decreased expression of BCL2 protein CTD PMID:23628508 astemizole decreases expression ISO RGD:2199 6480464 Astemizole results in decreased expression of BCL2 mRNA CTD PMID:20221588 astilbin multiple interactions ISO RGD:733100 6480464 astilbin inhibits the reaction [Cisplatin results in decreased expression of BCL2 protein] CTD PMID:29471006 atorvastatin calcium decreases expression ISO RGD:733100 6480464 Atorvastatin results in decreased expression of BCL2 mRNA, Atorvastatin results in decreased expression of BCL2 protein CTD PMID:16470222 atorvastatin calcium multiple interactions ISO RGD:733100 6480464 RHOA mutant form inhibits the reaction [Atorvastatin results in decreased expression of BCL2 protein] CTD PMID:16470222 ATP multiple interactions ISO RGD:733100 6480464 [Adenosine Triphosphate binds to P2RY11 protein] which results in decreased expression of BCL2 protein CTD PMID:21503959 Atranorin decreases expression ISO RGD:733100 6480464 atranorin results in decreased expression of BCL2 protein CTD PMID:22285236 atrasentan multiple interactions ISO RGD:2199 6480464 atrasentan inhibits the reaction [[Desoxycorticosterone co-treated with Sodium Chloride] results in decreased expression of BCL2 protein] CTD PMID:22431579 atrazine affects expression ISO RGD:2199 6480464 Atrazine affects the expression of BCL2, Atrazine affects the expression of BCL2 mRNA CTD PMID:21726175 , PMID:26075868 atrazine multiple interactions ISO RGD:2199 6480464 kolaviron inhibits the reaction [Atrazine affects the expression of BCL2] CTD PMID:21726175 atrazine multiple interactions ISO RGD:733100 6480464 kolaviron inhibits the reaction [Atrazine results in decreased expression of BCL2 mRNA], kolaviron inhibits the reaction [Atrazine results in decreased expression of BCL2 protein] CTD PMID:21333729 atrazine decreases expression ISO RGD:733100 6480464 Atrazine results in decreased expression of BCL2 mRNA, Atrazine results in decreased expression of BCL2 protein CTD PMID:21333729 auranofin multiple interactions ISO RGD:733100 6480464 BCL2 protein inhibits the reaction [Auranofin results in increased activity of CASP3 protein] CTD PMID:18789312 azadirachtin A decreases expression ISO RGD:733100 6480464 azadirachtin results in decreased expression of BCL2 mRNA, azadirachtin results in decreased expression of BCL2 protein CTD PMID:20429769 azide multiple interactions ISO RGD:733100 6480464 BCL2 protein inhibits the reaction [Azides affects the localization of BAX protein], BCL2 protein inhibits the reaction [Azides results in increased activity of BAX protein] CTD PMID:21160028 azide decreases response to substance ISO RGD:733100 6480464 BCL2 protein results in decreased susceptibility to Azides CTD PMID:21160028 aziridines decreases expression ISO RGD:733100 6480464 Aziridines analog results in decreased expression of BCL2 protein CTD PMID:15174162 baicalein multiple interactions EXP 6480464 baicalein inhibits the reaction [[Lipopolysaccharides co-treated with Galactosamine] results in decreased expression of BCL2 protein modified form] CTD PMID:20850421 baicalin multiple interactions ISO RGD:2199 6480464 baicalin inhibits the reaction [Rotenone affects the expression of BCL2 protein] CTD PMID:25423838 bathocuproine disulfonic acid decreases expression ISO RGD:733100 6480464 bathocuproine sulfonate results in decreased expression of BCL2 protein CTD PMID:24614111 beauvericin increases expression ISO RGD:733100 6480464 beauvericin results in increased expression of BCL2 mRNA CTD PMID:29203277 belinostat decreases expression ISO RGD:733100 6480464 belinostat results in decreased expression of BCL2 mRNA CTD PMID:26272509 belinostat multiple interactions ISO RGD:733100 6480464 [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of BCL2 mRNA CTD PMID:27188386 benazepril increases expression ISO RGD:2199 6480464 benazepril results in increased expression of BCL2 protein CTD PMID:20026869 benomyl multiple interactions ISO RGD:733100 6480464 Benomyl inhibits the reaction [BCL2 protein binds to BAX protein] CTD PMID:16903866 benomyl increases phosphorylation ISO RGD:733100 6480464 Benomyl results in increased phosphorylation of BCL2 protein CTD PMID:16903866 benzene increases expression ISO RGD:733100 6480464 Benzene results in increased expression of BCL2 protein CTD PMID:20850422 benzene decreases expression ISO RGD:2199 6480464 Benzene results in decreased expression of BCL2 mRNA CTD PMID:21143203 benzene multiple interactions ISO RGD:2199 6480464 decitabine inhibits the reaction [Benzene results in decreased expression of BCL2 mRNA], trichostatin A inhibits the reaction [Benzene results in decreased expression of BCL2 mRNA] CTD PMID:21143203 benzene decreases expression ISO RGD:733100 6480464 Benzene results in decreased expression of BCL2 mRNA CTD PMID:18724895 , PMID:19162166 benzene multiple interactions EXP 6480464 TRP53 protein affects the reaction [Benzene results in increased expression of BCL2 mRNA] CTD PMID:11896287 benzene affects expression EXP 6480464 Benzene affects the expression of BCL2 mRNA CTD PMID:11896287 benzo[a]pyrene multiple interactions ISO RGD:733100 6480464 2 more ... CTD PMID:16041517 more ... benzo[a]pyrene multiple interactions ISO RGD:2199 6480464 Lycopene inhibits the reaction [Benzo(a)pyrene results in decreased expression of BCL2 mRNA], Lycopene inhibits the reaction [Benzo(a)pyrene results in decreased expression of BCL2 protein] CTD PMID:31568845 benzo[a]pyrene increases expression ISO RGD:733100 6480464 Benzo(a)pyrene results in increased expression of BCL2 protein CTD PMID:18174961 , PMID:20850422 benzo[a]pyrene increases expression EXP 6480464 Benzo(a)pyrene results in increased expression of BCL2 mRNA, Benzo(a)pyrene results in increased expression of BCL2 protein CTD PMID:18656336 more ... benzo[a]pyrene decreases expression ISO RGD:2199 6480464 Benzo(a)pyrene results in decreased expression of BCL2 mRNA, Benzo(a)pyrene results in decreased expression of BCL2 protein CTD PMID:23510837 , PMID:31568845 benzo[a]pyrene decreases expression ISO RGD:733100 6480464 Benzo(a)pyrene results in decreased expression of BCL2 mRNA, Benzo(a)pyrene results in decreased expression of BCL2 protein CTD PMID:11782367 more ... benzo[a]pyrene decreases expression EXP 6480464 Benzo(a)pyrene results in decreased expression of BCL2 mRNA, Benzo(a)pyrene results in decreased expression of BCL2 protein CTD PMID:19770486 more ... benzo[a]pyrene multiple interactions EXP 6480464 epicatechin gallate inhibits the reaction [Benzo(a)pyrene results in increased expression of BCL2 mRNA] more ... CTD PMID:18656336 more ... benzo[a]pyrene diol epoxide I increases expression ISO RGD:733100 6480464 7 more ... CTD PMID:28593498 benzo[b]fluoranthene increases expression ISO RGD:733100 6480464 benzo(b)fluoranthene results in increased expression of BCL2 protein CTD PMID:21776270 benzoates decreases expression ISO RGD:733100 6480464 Benzoates analog results in decreased expression of BCL2 mRNA CTD PMID:29472718 benzoic acid multiple interactions ISO RGD:733100 6480464 Benzoic Acid analog inhibits the reaction [STAT3 protein binds to BCL2 promoter] CTD PMID:26088127 benzophenanthridine decreases expression ISO RGD:733100 6480464 Benzophenanthridines analog results in decreased expression of BCL2 mRNA CTD PMID:23117580 benzothiazoles decreases expression ISO RGD:733100 6480464 Benzothiazoles metabolite results in decreased expression of BCL2 mRNA CTD PMID:23339777 berberine decreases expression ISO RGD:733100 6480464 Berberine results in decreased expression of BCL2 mRNA, Berberine results in decreased expression of BCL2 protein CTD PMID:16505103 , PMID:20656010 berberine increases expression ISO RGD:2199 6480464 Berberine results in increased expression of BCL2 protein CTD PMID:25600690 berberine multiple interactions ISO RGD:2199 6480464 Berberine inhibits the reaction [Mercuric Chloride results in decreased expression of BCL2 protein], Berberine inhibits the reaction [Thioacetamide results in increased expression of BCL2 mRNA] CTD PMID:24751971 more ... berberine increases expression ISO RGD:733100 6480464 Berberine results in increased expression of BCL2 protein CTD PMID:23954465 berberine multiple interactions ISO RGD:733100 6480464 [Berberine co-treated with Niacinamide] results in decreased expression of BCL2 protein, Berberine inhibits the reaction [Glucose results in decreased expression of BCL2 protein] CTD PMID:23954465 , PMID:26712469 Besigomsin multiple interactions EXP 6480464 schizandrol B promotes the reaction [Acetaminophen results in increased expression of BCL2 protein] CTD PMID:25319358 Besigomsin increases expression EXP 6480464 schizandrol B results in increased expression of BCL2 protein CTD PMID:25319358 beta-aminopropionitrile decreases expression ISO RGD:733100 6480464 Aminopropionitrile results in decreased expression of BCL2 protein CTD PMID:24614111 beta-carotene decreases expression ISO RGD:733100 6480464 beta Carotene results in decreased expression of BCL2 protein CTD PMID:26733226 beta-ionone decreases expression ISO RGD:733100 6480464 beta-ionone results in decreased expression of BCL2 protein CTD PMID:23100158 , PMID:31506784 beta-naphthoflavone increases expression ISO RGD:2199 6480464 beta-Naphthoflavone results in increased expression of BCL2 mRNA CTD PMID:22687991 beta-naphthoflavone multiple interactions ISO RGD:2199 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of BCL2 mRNA CTD PMID:21295105 betulinic acid decreases expression ISO RGD:733100 6480464 betulinic acid results in decreased expression of BCL2 protein CTD PMID:30136359 bezafibrate decreases expression ISO RGD:2199 6480464 Bezafibrate results in decreased expression of BCL2 mRNA CTD PMID:12704018 bezafibrate multiple interactions ISO RGD:2199 6480464 Bezafibrate inhibits the reaction [Lipopolysaccharides results in increased expression of BCL2 protein] CTD PMID:12704018 bicalutamide increases expression ISO RGD:733100 6480464 bicalutamide results in increased expression of BCL2 CTD PMID:11845989 bicalutamide multiple interactions ISO RGD:733100 6480464 bicalutamide promotes the reaction [Niclosamide results in decreased expression of BCL2 protein], Niclosamide promotes the reaction [bicalutamide results in decreased expression of BCL2 protein] CTD PMID:28500234 bifenthrin decreases expression EXP 6480464 bifenthrin results in decreased expression of BCL2 mRNA CTD PMID:26071804 , PMID:27916261 biochanin A decreases expression ISO RGD:733100 6480464 biochanin A results in decreased expression of BCL2 protein CTD PMID:12791511 bis(2-chloroethyl) sulfide decreases expression ISO RGD:733100 6480464 Mustard Gas results in decreased expression of BCL2 protein CTD PMID:11428642 , PMID:9665388 bis(2-chloroethyl) sulfide affects localization EXP 6480464 Mustard Gas affects the localization of BCL2 protein CTD PMID:19560481 bis(2-ethylhexyl) phthalate decreases expression EXP 6480464 Diethylhexyl Phthalate results in decreased expression of BCL2 mRNA, Diethylhexyl Phthalate results in decreased expression of BCL2 protein CTD PMID:26678702 , PMID:31211961 bis(2-ethylhexyl) phthalate multiple interactions EXP 6480464 [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in increased expression of BCL2 mRNA CTD PMID:28013214 bis(2-ethylhexyl) phthalate increases expression EXP 6480464 Diethylhexyl Phthalate results in increased expression of BCL2 mRNA CTD PMID:25701202 bis(2-ethylhexyl) phthalate decreases expression ISO RGD:733100 6480464 Diethylhexyl Phthalate results in decreased expression of BCL2 mRNA, Diethylhexyl Phthalate results in decreased expression of BCL2 protein CTD PMID:22155658 , PMID:31163220 bisphenol A decreases expression ISO RGD:733100 6480464 bisphenol A results in decreased expression of BCL2 mRNA, bisphenol A results in decreased expression of BCL2 protein CTD PMID:21277958 more ... bisphenol A increases methylation ISO RGD:2199 6480464 bisphenol A results in increased methylation of BCL2 gene CTD PMID:28505145 bisphenol A increases expression ISO RGD:733100 6480464 bisphenol A results in increased expression of BCL2 mRNA, bisphenol A results in increased expression of BCL2 protein CTD PMID:15461258 more ... bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of BCL2 mRNA, bisphenol A results in increased expression of BCL2 protein CTD PMID:23900028 more ... bisphenol A multiple interactions ISO RGD:2199 6480464 [bisphenol A co-treated with 4-nonylphenol] results in decreased expression of BCL2 mRNA, Curcumin inhibits the reaction [bisphenol A results in decreased expression of BCL2 mRNA] CTD PMID:25963729 , PMID:30228064 bisphenol A decreases expression ISO RGD:2199 6480464 bisphenol A results in decreased expression of BCL2 mRNA, bisphenol A results in decreased expression of BCL2 protein CTD PMID:16909604 more ... bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of BCL2 mRNA, bisphenol A results in decreased expression of BCL2 protein CTD PMID:11906184 more ... bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of BCL2 mRNA CTD PMID:26746108 bisphenol A affects expression ISO RGD:733100 6480464 bisphenol A affects the expression of BCL2 protein CTD PMID:24156707 bisphenol A multiple interactions EXP 6480464 [Streptozocin co-treated with bisphenol A] results in increased expression of BCL2 mRNA more ... CTD PMID:22269103 more ... bisphenol A multiple interactions ISO RGD:733100 6480464 [bisphenol A results in increased activity of ESR1 protein] which results in increased expression of BCL2 mRNA more ... CTD PMID:19270784 more ... Bisphenol A diglycidyl ether multiple interactions ISO RGD:733100 6480464 2, 2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [1-(methylimino-N-oxy)-6-(2-morpholinoethoxy)-3-phenyl-1H-indene-2-carboxylic acid ethyl ester inhibits the reaction [VEGFA protein results in increased expression of BCL2 protein]] CTD PMID:21769449 Bisphenol A diglycidyl ether multiple interactions ISO RGD:2199 6480464 2, 2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [Calcitriol inhibits the reaction [Streptozocin results in decreased expression of BCL2 protein]] CTD PMID:29953732 bleomycin A2 increases expression ISO RGD:2199 6480464 Bleomycin results in increased expression of BCL2 protein CTD PMID:23656969 bleomycin A2 decreases expression ISO RGD:2199 6480464 Bleomycin results in decreased expression of BCL2 mRNA CTD PMID:24822179 , PMID:26093215 bleomycin A2 multiple interactions ISO RGD:733100 6480464 [Polyphenols co-treated with Bleomycin] results in increased expression of BCL2 mRNA, [Tea co-treated with Bleomycin] results in increased expression of BCL2 mRNA CTD PMID:26800624 bleomycin A2 multiple interactions ISO RGD:2199 6480464 [Bleomycin co-treated with Bee Venoms] results in decreased expression of BCL2 mRNA more ... CTD PMID:23656969 more ... borrelidin decreases response to substance ISO RGD:733100 6480464 BCL2 protein results in decreased susceptibility to borrelidin CTD PMID:24155182 bortezomib multiple interactions ISO RGD:733100 6480464 [arsenic trioxide co-treated with Bortezomib] results in decreased expression of BCL2 mRNA more ... CTD PMID:15173093 more ... bortezomib increases expression ISO RGD:733100 6480464 Bortezomib results in increased expression of BCL2 mRNA, Bortezomib results in increased expression of BCL2 protein CTD PMID:17895889 , PMID:20051518 bortezomib increases cleavage ISO RGD:733100 6480464 Bortezomib results in increased cleavage of BCL2 protein modified form CTD PMID:16118318 bortezomib decreases expression ISO RGD:733100 6480464 Bortezomib results in decreased expression of BCL2 mRNA, Bortezomib results in decreased expression of BCL2 protein CTD PMID:16022909 more ... BQ 123 multiple interactions ISO RGD:733100 6480464 [cyclo(Trp-Asp-Pro-Val-Leu) co-treated with BQ 788] inhibits the reaction [EDN1 protein results in increased expression of BCL2 protein] CTD PMID:20369390 BQ 123 multiple interactions ISO RGD:2199 6480464 [cyclo(Trp-Asp-Pro-Val-Leu) binds to and results in decreased activity of EDNRA protein] which results in decreased expression of BCL2 protein CTD PMID:14736733 BQ 485 multiple interactions ISO RGD:2199 6480464 [BQ 485 binds to and results in decreased activity of EDNRA protein] which results in decreased expression of BCL2 protein CTD PMID:14736733 brassinin decreases expression ISO RGD:733100 6480464 brassinin analog results in decreased expression of BCL2 mRNA CTD PMID:24747292 brassinolide decreases expression ISO RGD:733100 6480464 brassinolide results in decreased expression of BCL2 protein CTD PMID:17557751 , PMID:20833159 brazilin decreases expression ISO RGD:733100 6480464 brazilin results in decreased expression of BCL2 protein CTD PMID:28063998 brucine decreases expression ISO RGD:733100 6480464 brucine results in decreased expression of BCL2 protein CTD PMID:16443926 bucladesine multiple interactions ISO RGD:733100 6480464 adenosine-3' more ... CTD PMID:16822680 bucladesine decreases expression ISO RGD:733100 6480464 Bucladesine results in decreased expression of BCL2 protein CTD PMID:10697531 budesonide decreases expression ISO RGD:733100 6480464 Budesonide results in decreased expression of BCL2 protein CTD PMID:15475437 bufalin decreases expression ISO RGD:733100 6480464 bufalin results in decreased expression of BCL2 mRNA, bufalin results in decreased expression of BCL2 protein CTD PMID:27444971 , PMID:7658701 butanal decreases expression ISO RGD:733100 6480464 butyraldehyde results in decreased expression of BCL2 mRNA CTD PMID:26079696 butein decreases expression EXP 6480464 butein results in decreased expression of BCL2 protein CTD PMID:11055382 Butylbenzyl phthalate multiple interactions EXP 6480464 [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in increased expression of BCL2 mRNA CTD PMID:28013214 butyric acid multiple interactions EXP 6480464 [Butyric Acid co-treated with Niacinamide co-treated with Glucaric Acid] inhibits the reaction [9 more ... CTD PMID:25478867 cadmium atom multiple interactions ISO RGD:2199 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Cadmium results in decreased expression of BCL2 protein], Lithium inhibits the reaction [Cadmium results in decreased expression of BCL2 protein] CTD PMID:20455018 , PMID:25955216 cadmium atom decreases expression EXP 6480464 Cadmium results in decreased expression of BCL2 protein CTD PMID:22356713 , PMID:26424772 cadmium atom multiple interactions EXP 6480464 flavocoxid inhibits the reaction [Cadmium results in decreased expression of BCL2 protein] CTD PMID:26424772 cadmium atom increases expression ISO RGD:2199 6480464 Cadmium results in increased expression of BCL2 protein CTD PMID:11781163 , PMID:23741317 cadmium atom increases expression ISO RGD:733100 6480464 Cadmium results in increased expression of BCL2 mRNA CTD PMID:21694771 cadmium atom decreases response to substance ISO RGD:733100 6480464 BCL2 protein results in decreased susceptibility to Cadmium CTD PMID:11781163 cadmium atom decreases response to substance ISO RGD:2199 6480464 BCL2 results in decreased susceptibility to Cadmium CTD PMID:12189181 cadmium atom decreases expression ISO RGD:2199 6480464 Cadmium results in decreased expression of BCL2 mRNA, Cadmium results in decreased expression of BCL2 protein CTD PMID:20455018 more ... cadmium dichloride multiple interactions EXP 6480464 arjunolic acid inhibits the reaction [Cadmium Chloride results in decreased expression of BCL2 protein] more ... CTD PMID:17706638 more ... cadmium dichloride multiple interactions ISO RGD:2199 6480464 [Cadmium Chloride co-treated with lead acetate] results in decreased expression of BCL2 protein more ... CTD PMID:24492640 more ... cadmium dichloride decreases expression ISO RGD:2199 6480464 Cadmium Chloride results in decreased expression of BCL2 mRNA, Cadmium Chloride results in decreased expression of BCL2 protein CTD PMID:23405080 more ... cadmium dichloride decreases expression ISO RGD:733100 6480464 Cadmium Chloride results in decreased expression of BCL2 mRNA, Cadmium Chloride results in decreased expression of BCL2 protein CTD PMID:23485651 more ... cadmium dichloride decreases expression EXP 6480464 Cadmium Chloride results in decreased expression of BCL2 mRNA, Cadmium Chloride results in decreased expression of BCL2 protein CTD PMID:15501611 more ... cadmium dichloride increases expression ISO RGD:733100 6480464 Cadmium Chloride results in increased expression of BCL2 protein CTD PMID:25111876 cadmium dichloride increases expression EXP 6480464 Cadmium Chloride results in increased expression of BCL2 protein CTD PMID:25111876 cadmium dichloride multiple interactions ISO RGD:733100 6480464 [Cadmium Chloride co-treated with Buthionine Sulfoximine] results in increased expression of BCL2 protein more ... CTD PMID:11341981 more ... cadmium dichloride affects expression ISO RGD:733100 6480464 Cadmium Chloride affects the expression of BCL2 mRNA, Cadmium Chloride affects the expression of BCL2 protein CTD PMID:23941782 cadmium dichloride increases expression ISO RGD:2199 6480464 Cadmium Chloride results in increased expression of BCL2 CTD PMID:11170127 cadmium sulfide decreases expression ISO RGD:733100 6480464 cadmium sulfide results in decreased expression of BCL2 mRNA CTD PMID:27866839 cafestol decreases expression ISO RGD:733100 6480464 cafestol results in decreased expression of BCL2 protein CTD PMID:21334318 cafestol decreases response to substance ISO RGD:733100 6480464 BCL2 protein results in decreased susceptibility to cafestol CTD PMID:21334318 cajanol multiple interactions ISO RGD:733100 6480464 [[[cajanol results in decreased expression of BCL2 protein] co-treated with [cajanol results in increased expression of BAX protein]] affects the localization of CYCS protein] which results in increased activity of CASP3 protein more ... CTD PMID:20638373 cajanol decreases expression ISO RGD:733100 6480464 cajanol results in decreased expression of BCL2 protein CTD PMID:20638373 calcidiol increases expression ISO RGD:733100 6480464 Calcifediol results in increased expression of BCL2 mRNA, Calcifediol results in increased expression of BCL2 protein CTD PMID:21542014 calcidiol multiple interactions ISO RGD:733100 6480464 Ketoconazole inhibits the reaction [Calcifediol results in increased expression of BCL2 mRNA] CTD PMID:21542014 calciol increases expression ISO RGD:733100 6480464 Cholecalciferol results in increased expression of BCL2 protein CTD PMID:18628207 calcitriol multiple interactions ISO RGD:733100 6480464 [Calcitriol co-treated with Genistein] results in decreased expression of BCL2 mRNA more ... CTD PMID:10713328 more ... calcitriol multiple interactions ISO RGD:2199 6480464 2 more ... CTD PMID:29953732 calcitriol increases expression ISO RGD:733100 6480464 Calcitriol results in increased expression of BCL2 mRNA, Calcitriol results in increased expression of BCL2 protein CTD PMID:21542014 calcitriol increases expression ISO RGD:2199 6480464 Calcitriol results in increased expression of BCL2 protein CTD PMID:17570329 calcitriol increases expression EXP 6480464 Calcitriol results in increased expression of BCL2 CTD PMID:19603526 calcitriol decreases expression ISO RGD:733100 6480464 Calcitriol results in decreased expression of BCL2 more ... CTD PMID:10614618 more ... camalexin decreases expression ISO RGD:733100 6480464 camalexin metabolite results in decreased expression of BCL2 mRNA CTD PMID:23339777 camptothecin multiple interactions ISO RGD:733100 6480464 3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole promotes the reaction [Camptothecin results in decreased expression of BCL2 protein] CTD PMID:19481069 camptothecin multiple interactions EXP 6480464 Camptothecin inhibits the reaction [[Azoxymethane co-treated with Dextran Sulfate] results in increased expression of BCL2 protein] CTD PMID:25449198 camptothecin increases expression ISO RGD:733100 6480464 Camptothecin results in increased expression of BCL2 mRNA CTD PMID:24726431 camptothecin decreases expression ISO RGD:733100 6480464 Camptothecin results in decreased expression of BCL2 mRNA, Camptothecin results in decreased expression of BCL2 protein CTD PMID:10692111 more ... camptothecin decreases response to substance ISO RGD:733100 6480464 BCL2 results in decreased susceptibility to Camptothecin CTD PMID:10896673 Candesartan cilexetil increases expression ISO RGD:2199 6480464 candesartan cilexetil results in increased expression of BCL2 protein CTD PMID:22120037 cantharidin decreases expression ISO RGD:733100 6480464 Cantharidin results in decreased expression of BCL2 protein CTD PMID:16117893 , PMID:27113412 capsaicin decreases response to substance ISO RGD:733100 6480464 BCL2 protein results in decreased susceptibility to Capsaicin CTD PMID:9580328 capsaicin increases expression ISO RGD:733100 6480464 Capsaicin results in increased expression of BCL2 mRNA CTD PMID:19502594 more ... capsaicin decreases expression EXP 6480464 Capsaicin results in decreased expression of BCL2 protein CTD PMID:15595419 more ... capsaicin decreases expression ISO RGD:733100 6480464 Capsaicin results in decreased expression of BCL2, Capsaicin results in decreased expression of BCL2 protein CTD PMID:11275362 more ... capsazepine multiple interactions EXP 6480464 capsazepine inhibits the reaction [Acrolein results in decreased expression of BCL2 protein] CTD PMID:24376112 carbachol multiple interactions EXP 6480464 Carbachol inhibits the reaction [APP protein modified form results in decreased expression of BCL2 protein] CTD PMID:10758335 carbachol increases expression EXP 6480464 Carbachol results in increased expression of BCL2 protein CTD PMID:19200344 carbachol increases expression ISO RGD:2199 6480464 Carbachol results in increased expression of BCL2 protein CTD PMID:17708838 carbamate ester affects expression EXP 6480464 Carbamates affects the expression of BCL2 mRNA CTD PMID:21303328 carbamazepine increases expression ISO RGD:2199 6480464 Carbamazepine results in increased expression of BCL2 mRNA, Carbamazepine results in increased expression of BCL2 protein CTD PMID:18719996 CARBENOXOLONE affects expression ISO RGD:733100 6480464 Carbenoxolone affects the expression of BCL2 mRNA CTD PMID:23678415 carbofuran decreases expression ISO RGD:2199 6480464 Carbofuran results in decreased expression of BCL2 protein CTD PMID:30471306 carbon disulfide decreases expression EXP 6480464 Carbon Disulfide results in decreased expression of BCL2 mRNA, Carbon Disulfide results in decreased expression of BCL2 protein CTD PMID:24080331 carbon nanotube decreases expression EXP 6480464 Nanotubes, Carbon analog results in decreased expression of BCL2 mRNA CTD PMID:21624382 carbon nanotube decreases expression ISO RGD:733100 6480464 Nanotubes, Carbon results in decreased expression of BCL2 protein CTD PMID:28673683 carbon nanotube multiple interactions ISO RGD:2199 6480464 Vitamin E inhibits the reaction [Nanotubes, Carbon results in decreased expression of BCL2 protein] CTD PMID:22020378 carbon nanotube decreases expression ISO RGD:2199 6480464 Nanotubes, Carbon results in decreased expression of BCL2 protein CTD PMID:22020378 carbon nanotube increases expression ISO RGD:733100 6480464 Nanotubes, Carbon results in increased expression of BCL2 mRNA CTD PMID:22076105 carboplatin decreases expression ISO RGD:733100 6480464 Carboplatin results in decreased expression of BCL2 mRNA, Carboplatin results in decreased expression of BCL2 protein CTD PMID:15576332 more ... carboxy-PTIO multiple interactions ISO RGD:733100 6480464 1 more ... CTD PMID:16980304 carmustine multiple interactions ISO RGD:733100 6480464 [Fenretinide co-treated with Carmustine] results in decreased expression of BCL2 protein CTD PMID:16187019 carmustine affects response to substance ISO RGD:733100 6480464 BCL2 protein affects the susceptibility to Carmustine CTD PMID:15332326 , PMID:18430789 carmustine decreases expression ISO RGD:733100 6480464 Carmustine results in decreased expression of BCL2 protein CTD PMID:15332326 , PMID:20920327 carnosic acid multiple interactions ISO RGD:733100 6480464 Acetylcysteine inhibits the reaction [salvin results in decreased expression of BCL2 protein] more ... CTD PMID:25446857 more ... carnosic acid multiple interactions EXP 6480464 salvin inhibits the reaction [sodium arsenite results in decreased expression of BCL2 protein] CTD PMID:29854073 carnosic acid decreases expression ISO RGD:733100 6480464 salvin results in decreased expression of BCL2 protein CTD PMID:28918123 carnosic acid multiple interactions ISO RGD:2199 6480464 salvin inhibits the reaction [Oxidopamine results in decreased expression of BCL2 protein] CTD PMID:25446857 carnosine multiple interactions ISO RGD:733100 6480464 asiatic acid promotes the reaction [Carnosine inhibits the reaction [Glucose results in decreased expression of BCL2 mRNA]] more ... CTD PMID:30802477 carnosine multiple interactions ISO RGD:2199 6480464 Carnosine inhibits the reaction [Sodium Nitrite results in decreased expression of BCL2 protein] CTD PMID:28266762 carvedilol multiple interactions ISO RGD:2199 6480464 carvedilol inhibits the reaction [Doxorubicin results in decreased expression of BCL2 mRNA] more ... CTD PMID:15380674 more ... carvedilol affects expression ISO RGD:2199 6480464 carvedilol affects the expression of BCL2 protein CTD PMID:22000973 carvedilol increases expression ISO RGD:2199 6480464 carvedilol results in increased expression of BCL2 mRNA CTD PMID:16780994 , PMID:16909474 casticin decreases expression ISO RGD:733100 6480464 casticin results in decreased expression of BCL2 protein CTD PMID:27862857 , PMID:29098808 celastrol decreases expression ISO RGD:733100 6480464 tripterine results in decreased expression of BCL2 protein CTD PMID:21466843 celecoxib multiple interactions ISO RGD:733100 6480464 BCL2 protein inhibits the reaction [ABT-737 promotes the reaction [Celecoxib results in increased cleavage of CASP3 protein]] more ... CTD PMID:15688368 more ... celecoxib multiple interactions EXP 6480464 Celecoxib promotes the reaction [Dihematoporphyrin Ether results in increased cleavage of BCL2 protein] CTD PMID:16230411 celecoxib increases expression ISO RGD:733100 6480464 Celecoxib results in increased expression of BCL2 mRNA CTD PMID:17342322 celecoxib decreases expression ISO RGD:733100 6480464 Celecoxib results in decreased expression of BCL2 protein CTD PMID:15911099 more ... ceric oxide decreases expression ISO RGD:733100 6480464 ceric oxide results in decreased expression of BCL2 protein CTD PMID:24987704 cetrorelix decreases expression ISO RGD:733100 6480464 cetrorelix results in decreased expression of BCL2 protein CTD PMID:21062912 cetrorelix decreases expression ISO RGD:2199 6480464 cetrorelix results in decreased expression of BCL2 mRNA CTD PMID:18829022 chalcones decreases expression ISO RGD:733100 6480464 Chalcones analog results in decreased expression of BCL2 protein, Chalcones results in decreased expression of BCL2 protein CTD PMID:23562496 , PMID:30576621 chalcones multiple interactions ISO RGD:733100 6480464 BCL2 protein inhibits the reaction [Chalcones analog results in decreased expression of BID protein] more ... CTD PMID:30576621 chelerythrine multiple interactions ISO RGD:2199 6480464 chelerythrine inhibits the reaction [sodium arsenite inhibits the reaction [Cisplatin results in decreased expression of BCL2 protein]] CTD PMID:12690470 chelidonine affects expression ISO RGD:733100 6480464 chelidonine affects the expression of BCL2 mRNA CTD PMID:25265580 Chikusetsusaponin-IV decreases expression ISO RGD:733100 6480464 araloside A results in decreased expression of BCL2 protein CTD PMID:31004595 Chikusetsusaponin-V multiple interactions ISO RGD:733100 6480464 chikusetsusaponin V inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of BCL2 protein] CTD PMID:25073091 chitosan multiple interactions EXP 6480464 [Fluorouracil co-treated with Chitosan co-treated with polyaspartate] results in decreased expression of BCL2 protein CTD PMID:18567086 chitosan multiple interactions ISO RGD:2199 6480464 [Cromolyn Sodium co-treated with Chitosan] inhibits the reaction [Dimethylhydrazines results in increased expression of BCL2 protein], Chitosan analog inhibits the reaction [Doxorubicin results in decreased expression of BCL2 protein] CTD PMID:28732690 , PMID:30928397 chlorambucil decreases expression ISO RGD:733100 6480464 Chlorambucil results in decreased expression of BCL2 mRNA, Chlorambucil results in decreased expression of BCL2 protein CTD PMID:11699414 , PMID:8822937 chlorambucil multiple interactions ISO RGD:733100 6480464 IL4 protein inhibits the reaction [Chlorambucil results in decreased expression of BCL2 protein] CTD PMID:8822937 chlordecone increases expression EXP 6480464 Chlordecone results in increased expression of BCL2 mRNA CTD PMID:17578864 chloroacetic acid decreases expression EXP 6480464 chloroacetic acid results in decreased expression of BCL2 mRNA CTD PMID:23103613 chloroacetic acid multiple interactions EXP 6480464 SB 203580 inhibits the reaction [chloroacetic acid results in decreased expression of BCL2 mRNA] CTD PMID:23103613 chlorogenic acid multiple interactions EXP 6480464 Chlorogenic Acid inhibits the reaction [aluminum chloride results in decreased expression of BCL2 protein] CTD PMID:28623112 chlorogenic acid multiple interactions ISO RGD:2199 6480464 Chlorogenic Acid inhibits the reaction [Methotrexate results in decreased expression of BCL2 protein] CTD PMID:28479099 chloroprene decreases expression EXP 6480464 Chloroprene results in decreased expression of BCL2 mRNA CTD PMID:23125180 chloroquine multiple interactions ISO RGD:733100 6480464 Chloroquine inhibits the reaction [formosanin C results in decreased expression of BCL2 protein] CTD PMID:27180204 chlorothalonil decreases expression EXP 6480464 tetrachloroisophthalonitrile results in decreased expression of BCL2 protein CTD PMID:30586609 chlorpyrifos decreases expression ISO RGD:733100 6480464 Chlorpyrifos results in decreased expression of BCL2 mRNA CTD PMID:18155347 chlorpyrifos multiple interactions EXP 6480464 [Chlorpyrifos co-treated with Ethylenethiourea] results in decreased expression of BCL2 mRNA CTD PMID:27905518 chlorpyrifos decreases expression ISO RGD:2199 6480464 Chlorpyrifos results in decreased expression of BCL2 protein CTD PMID:30990955 chlorpyrifos multiple interactions ISO RGD:2199 6480464 Quercetin inhibits the reaction [Chlorpyrifos results in decreased expression of BCL2 protein] CTD PMID:30990955 chlorpyrifos decreases expression EXP 6480464 Chlorpyrifos results in decreased expression of BCL2 mRNA CTD PMID:27117976 , PMID:27905518 cholesterol decreases expression ISO RGD:2199 6480464 Cholesterol analog results in decreased expression of BCL2 mRNA CTD PMID:19477266 cholesterol multiple interactions EXP 6480464 Cholesterol inhibits the reaction [Cadmium Chloride results in decreased expression of BCL2 protein] CTD PMID:29486218 choline multiple interactions EXP 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of and results in increased expression of BCL2 more ... CTD PMID:20938992 chromium(3+) trichloride decreases expression ISO RGD:733100 6480464 chromic chloride results in decreased expression of BCL2 protein CTD PMID:14741615 chromium(6+) affects response to substance ISO RGD:733100 6480464 BCL2 protein affects the susceptibility to chromium hexavalent ion CTD PMID:19556603 chromium(6+) multiple interactions ISO RGD:2199 6480464 [Potassium Dichromate results in increased abundance of chromium hexavalent ion] which results in decreased expression of BCL2 protein CTD PMID:30974164 chromium(6+) increases expression ISO RGD:733100 6480464 chromium hexavalent ion results in increased expression of BCL2 protein CTD PMID:22666341 more ... chromium(6+) multiple interactions ISO RGD:733100 6480464 Luteolin inhibits the reaction [chromium hexavalent ion results in increased expression of BCL2 protein] CTD PMID:25448439 chrysazin decreases expression ISO RGD:733100 6480464 danthron results in decreased expression of BCL2 protein CTD PMID:21126053 chrysin decreases response to substance ISO RGD:733100 6480464 BCL2 protein results in decreased susceptibility to chrysin CTD PMID:16215670 chrysin multiple interactions ISO RGD:2199 6480464 chrysin inhibits the reaction [Testosterone results in increased expression of BCL2 mRNA] CTD PMID:29247772 chrysin multiple interactions ISO RGD:733100 6480464 BCL2 protein inhibits the reaction [chrysin results in decreased expression of XIAP protein] more ... CTD PMID:16215670 , PMID:25770930 cidofovir anhydrous decreases expression ISO RGD:733100 6480464 Cidofovir results in decreased expression of BCL2 CTD PMID:12700662 ciglitazone decreases expression ISO RGD:733100 6480464 ciglitazone results in decreased expression of BCL2 protein CTD PMID:15492468 cilostazol multiple interactions ISO RGD:733100 6480464 cilostazol inhibits the reaction [Lipopolysaccharides results in decreased expression of BCL2 protein] CTD PMID:16822680 cilostazol affects expression ISO RGD:2199 6480464 cilostazol affects the expression of BCL2 protein CTD PMID:15978173 cilostazol decreases expression ISO RGD:733100 6480464 cilostazol results in decreased expression of BCL2 protein CTD PMID:20131233 cimetidine decreases expression ISO RGD:733100 6480464 Cimetidine results in decreased expression of BCL2 protein CTD PMID:20127008 cimetidine multiple interactions EXP 6480464 Cimetidine inhibits the reaction [Ethanol results in decreased expression of BCL2 protein] CTD PMID:27983966 cinnamic acid multiple interactions ISO RGD:2199 6480464 cinnamic acid inhibits the reaction [Glucose results in decreased expression of BCL2 protein] CTD PMID:30144576 Cinobufagin decreases expression ISO RGD:733100 6480464 cinobufagin results in decreased expression of BCL2 protein CTD PMID:23164673 ciprofloxacin multiple interactions ISO RGD:733100 6480464 [Etoposide co-treated with Ciprofloxacin] results in decreased expression of BCL2 protein, BCL2 protein inhibits the reaction [Ciprofloxacin results in increased localization of BAX protein] CTD PMID:11832715 , PMID:12063570 cisplatin multiple interactions ISO RGD:733100 6480464 [[[Cisplatin co-treated with 2 more ... CTD PMID:10891529 more ... cisplatin affects expression ISO RGD:2199 6480464 Cisplatin affects the expression of BCL2 protein CTD PMID:30125553 cisplatin increases expression ISO RGD:2199 6480464 Cisplatin results in increased expression of BCL2 protein CTD PMID:28414026 cisplatin affects response to substance ISO RGD:733100 6480464 BCL2 protein affects the susceptibility to Cisplatin CTD PMID:25611565 cisplatin increases expression ISO RGD:733100 6480464 Cisplatin results in increased expression of BCL2 protein CTD PMID:17619073 more ... cisplatin decreases expression ISO RGD:733100 6480464 Cisplatin results in decreased expression of BCL2 more ... CTD PMID:10891529 more ... cisplatin decreases expression EXP 6480464 Cisplatin results in decreased expression of BCL2 mRNA, Cisplatin results in decreased expression of BCL2 protein CTD PMID:20566416 more ... cisplatin increases expression EXP 6480464 Cisplatin results in increased expression of BCL2 mRNA, Cisplatin results in increased expression of BCL2 protein CTD PMID:19833167 more ... cisplatin affects expression ISO RGD:733100 6480464 Cisplatin affects the expression of BCL2 protein CTD PMID:24799992 cisplatin decreases response to substance ISO RGD:733100 6480464 BCL2 protein results in decreased susceptibility to Cisplatin, BCL2 results in decreased susceptibility to Cisplatin CTD PMID:10896673 more ... cisplatin decreases expression ISO RGD:2199 6480464 Cisplatin results in decreased expression of BCL2 mRNA, Cisplatin results in decreased expression of BCL2 protein CTD PMID:12690470 more ... cisplatin multiple interactions ISO RGD:2199 6480464 [CTNNA1 protein affects the susceptibility to Cisplatin] which results in decreased expression of BCL2 protein more ... CTD PMID:12690470 more ... cisplatin decreases response to substance ISO RGD:2199 6480464 BCL2 protein results in decreased susceptibility to Cisplatin CTD PMID:15315938 cisplatin affects response to substance EXP 6480464 BCL2 protein affects the susceptibility to Cisplatin CTD PMID:15746559 cisplatin multiple interactions EXP 6480464 [Cisplatin co-treated with TNF protein] results in decreased expression of BCL2 mRNA more ... CTD PMID:19833167 more ... Citreoviridin decreases expression EXP 6480464 citreoviridin results in decreased expression of BCL2 protein CTD PMID:31419397 Citreoviridin multiple interactions ISO RGD:2199 6480464 3-methyladenine inhibits the reaction [citreoviridin results in decreased expression of BCL2 protein] more ... CTD PMID:31419397 Citreoviridin decreases expression ISO RGD:2199 6480464 citreoviridin results in decreased expression of BCL2 protein CTD PMID:31419397 Citreoviridin multiple interactions EXP 6480464 Sodium Selenite inhibits the reaction [citreoviridin results in decreased expression of BCL2 protein], Thiamine inhibits the reaction [citreoviridin results in decreased expression of BCL2 protein] CTD PMID:31419397 citric acid multiple interactions ISO RGD:733100 6480464 [Citric Acid co-treated with zinc chloride] results in decreased expression of BCL2 protein, [Silver analog co-treated with Citric Acid] results in increased expression of BCL2 mRNA CTD PMID:16624386 , PMID:27021274 cladribine multiple interactions ISO RGD:733100 6480464 [Cladribine co-treated with Cyclophosphamide co-treated with Mitoxantrone] results in decreased expression of BCL2 protein more ... CTD PMID:15516989 , PMID:15582267 cladribine decreases expression ISO RGD:733100 6480464 Cladribine results in decreased expression of BCL2 protein CTD PMID:15582267 clofibrate multiple interactions EXP 6480464 Clofibrate inhibits the reaction [[Fatty Acids, Nonesterified binds to ALB protein] which results in decreased expression of BCL2 protein] CTD PMID:21338618 clonazepam increases expression ISO RGD:2199 6480464 Clonazepam results in increased expression of BCL2 protein CTD PMID:17456340 clonidine decreases expression ISO RGD:733100 6480464 Clonidine results in decreased expression of BCL2 protein CTD PMID:28115640 clonidine (amino form) decreases expression ISO RGD:733100 6480464 Clonidine results in decreased expression of BCL2 protein CTD PMID:28115640 clonidine (imino form) decreases expression ISO RGD:733100 6480464 Clonidine results in decreased expression of BCL2 protein CTD PMID:28115640 clozapine increases expression ISO RGD:2199 6480464 Clozapine results in increased expression of BCL2 mRNA, Clozapine results in increased expression of BCL2 protein CTD PMID:15126120 cobalt atom decreases expression ISO RGD:733100 6480464 Cobalt results in decreased expression of BCL2 protein CTD PMID:21598295 cobalt dichloride increases expression ISO RGD:733100 6480464 cobaltous chloride results in increased expression of BCL2 protein CTD PMID:16827160 cobalt dichloride multiple interactions ISO RGD:2199 6480464 Plant Extracts inhibits the reaction [cobaltous chloride results in decreased expression of BCL2 protein] CTD PMID:30551423 cobalt dichloride decreases expression EXP 6480464 cobaltous chloride results in decreased expression of BCL2 mRNA CTD PMID:24265542 cobalt dichloride multiple interactions EXP 6480464 [cobaltous chloride co-treated with 3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole] results in decreased expression of BCL2 mRNA CTD PMID:24265542 cobalt dichloride decreases expression ISO RGD:733100 6480464 cobaltous chloride results in decreased expression of BCL2 mRNA, cobaltous chloride results in decreased expression of BCL2 protein CTD PMID:14741615 , PMID:17786326 cobalt dichloride decreases expression ISO RGD:2199 6480464 cobaltous chloride results in decreased expression of BCL2 protein CTD PMID:19520152 , PMID:30551423 cobalt dichloride multiple interactions ISO RGD:733100 6480464 cobaltous chloride inhibits the reaction [Cyclosporine results in decreased expression of BCL2 protein] more ... CTD PMID:17786326 more ... cocaine affects expression EXP 6480464 Cocaine affects the expression of BCL2 mRNA CTD PMID:15681117 cocaine multiple interactions EXP 6480464 IL6 protein affects the reaction [Cocaine results in decreased expression of BCL2 protein] more ... CTD PMID:29673861 , PMID:30393195 cocaine decreases expression EXP 6480464 Cocaine results in decreased expression of BCL2 protein CTD PMID:29673861 , PMID:30393195 cocaine multiple interactions ISO RGD:2199 6480464 6-methyl-2-(phenylethynyl)pyridine inhibits the reaction [Cocaine results in increased phosphorylation of BCL2 protein] more ... CTD PMID:19879923 cocaine increases phosphorylation ISO RGD:2199 6480464 Cocaine results in increased phosphorylation of BCL2 protein CTD PMID:19879923 cocaine decreases expression ISO RGD:2199 6480464 Cocaine results in decreased expression of BCL2 mRNA, Cocaine results in decreased expression of BCL2 protein CTD PMID:11392460 more ... cocaine increases expression ISO RGD:2199 6480464 Cocaine results in increased expression of BCL2 protein CTD PMID:17084983 , PMID:18974856 codeinone decreases expression ISO RGD:733100 6480464 6-codeinone results in decreased expression of BCL2 protein CTD PMID:12894543 coenzyme Q10 multiple interactions ISO RGD:2199 6480464 coenzyme Q10 inhibits the reaction [Doxorubicin results in decreased expression of BCL2 protein] CTD PMID:27087047 coenzyme Q10 increases expression ISO RGD:2199 6480464 coenzyme Q10 results in increased expression of BCL2 mRNA CTD PMID:18817789 colistin decreases expression ISO RGD:2199 6480464 Colistin results in decreased expression of BCL2 protein CTD PMID:28465020 , PMID:30138604 colistin multiple interactions ISO RGD:2199 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [rhodioloside inhibits the reaction [Colistin results in decreased expression of BCL2 protein]] more ... CTD PMID:28465020 more ... colistin increases phosphorylation ISO RGD:2199 6480464 Colistin results in increased phosphorylation of BCL2 protein CTD PMID:28842171 conjugated linoleic acid decreases expression ISO RGD:733100 6480464 Linoleic Acids, Conjugated results in decreased expression of BCL2 protein CTD PMID:15961301 conjugated linoleic acid decreases expression EXP 6480464 Linoleic Acids, Conjugated results in decreased expression of BCL2 protein CTD PMID:20155912 copper atom decreases expression EXP 6480464 Copper analog results in decreased expression of BCL2 protein CTD PMID:22000994 copper atom increases expression ISO RGD:2199 6480464 Copper results in increased expression of BCL2 protein CTD PMID:30556269 copper atom multiple interactions EXP 6480464 [Copper Sulfate results in increased abundance of Copper] which results in decreased expression of BCL2 mRNA, [Copper Sulfate results in increased abundance of Copper] which results in decreased expression of BCL2 protein CTD PMID:31491480 copper atom multiple interactions ISO RGD:733100 6480464 [Copper co-treated with Disulfiram] results in decreased expression of BCL2 protein CTD PMID:23033007 copper atom decreases expression ISO RGD:733100 6480464 Copper results in decreased expression of BCL2 mRNA, Copper results in decreased expression of BCL2 protein CTD PMID:16391388 , PMID:16962711 copper atom multiple interactions ISO RGD:2199 6480464 [Copper co-treated with pyrrolidine dithiocarbamic acid] results in decreased expression of BCL2 mRNA more ... CTD PMID:22085843 copper(0) decreases expression EXP 6480464 Copper analog results in decreased expression of BCL2 protein CTD PMID:22000994 copper(0) increases expression ISO RGD:2199 6480464 Copper results in increased expression of BCL2 protein CTD PMID:30556269 copper(0) multiple interactions EXP 6480464 [Copper Sulfate results in increased abundance of Copper] which results in decreased expression of BCL2 mRNA, [Copper Sulfate results in increased abundance of Copper] which results in decreased expression of BCL2 protein CTD PMID:31491480 copper(0) multiple interactions ISO RGD:733100 6480464 [Copper co-treated with Disulfiram] results in decreased expression of BCL2 protein CTD PMID:23033007 copper(0) multiple interactions ISO RGD:2199 6480464 [Copper co-treated with pyrrolidine dithiocarbamic acid] results in decreased expression of BCL2 mRNA more ... CTD PMID:22085843 copper(0) decreases expression ISO RGD:733100 6480464 Copper results in decreased expression of BCL2 mRNA, Copper results in decreased expression of BCL2 protein CTD PMID:16391388 , PMID:16962711 copper(II) chloride multiple interactions ISO RGD:2199 6480464 [cupric chloride binds to pyrrolidine dithiocarbamic acid] which results in decreased expression of BCL2 mRNA more ... CTD PMID:20920558 copper(II) chloride multiple interactions ISO RGD:733100 6480464 [Disulfiram co-treated with cupric chloride] results in decreased expression of BCL2 protein CTD PMID:21911303 copper(II) chloride decreases expression EXP 6480464 cupric chloride results in decreased expression of BCL2 protein CTD PMID:23313662 , PMID:24170445 copper(II) sulfate decreases expression ISO RGD:733100 6480464 Copper Sulfate results in decreased expression of BCL2 mRNA CTD PMID:19549813 copper(II) sulfate multiple interactions ISO RGD:2199 6480464 Curcumin analog inhibits the reaction [Copper Sulfate results in decreased expression of BCL2 mRNA] more ... CTD PMID:30431687 copper(II) sulfate decreases expression ISO RGD:2199 6480464 Copper Sulfate results in decreased expression of BCL2 mRNA CTD PMID:30431687 copper(II) sulfate multiple interactions EXP 6480464 [Copper Sulfate results in increased abundance of Copper] which results in decreased expression of BCL2 mRNA, [Copper Sulfate results in increased abundance of Copper] which results in decreased expression of BCL2 protein CTD PMID:31491480 copper(II) sulfate decreases expression EXP 6480464 Copper Sulfate results in decreased expression of BCL2 mRNA CTD PMID:25216733 copper(II) sulfate multiple interactions ISO RGD:733100 6480464 Copper Sulfate inhibits the reaction [Trientine results in increased expression of BCL2 protein] CTD PMID:14513838 coptisine decreases expression ISO RGD:733100 6480464 coptisine analog results in decreased expression of BCL2 protein CTD PMID:30472432 cordycepin decreases expression ISO RGD:733100 6480464 cordycepin results in decreased expression of BCL2 mRNA, cordycepin results in decreased expression of BCL2 protein CTD PMID:21310227 more ... cordycepin multiple interactions ISO RGD:733100 6480464 Acetylcysteine inhibits the reaction [cordycepin results in decreased expression of BCL2 protein] CTD PMID:21310227 corosolic acid decreases expression ISO RGD:733100 6480464 corosolic acid results in decreased expression of BCL2 mRNA, corosolic acid results in decreased expression of BCL2 protein CTD PMID:28506699 corticosterone affects expression ISO RGD:2199 6480464 Corticosterone affects the expression of BCL2 mRNA CTD PMID:27988398 corticosterone multiple interactions ISO RGD:2199 6480464 Estradiol inhibits the reaction [Corticosterone results in decreased expression of BCL2 protein] more ... CTD PMID:27988398 , PMID:29625166 corticosterone decreases expression ISO RGD:2199 6480464 Corticosterone results in decreased expression of BCL2 protein CTD PMID:29625166 Corynoxine B multiple interactions ISO RGD:733100 6480464 corynoxine B inhibits the reaction [manganese chloride promotes the reaction [BCL2 protein binds to BECN1 protein]] CTD PMID:30578841 coumarin decreases expression ISO RGD:733100 6480464 coumarin results in decreased expression of BCL2 protein CTD PMID:15964220 coumarins decreases expression ISO RGD:733100 6480464 Coumarins analog results in decreased expression of BCL2 protein CTD PMID:25231984 coumestrol multiple interactions ISO RGD:733100 6480464 [Coumestrol co-treated with 2, 3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of BCL2 mRNA CTD PMID:19167446 coumestrol affects binding ISO RGD:733100 6480464 Coumestrol binds to BCL2 protein CTD PMID:28986287 coumestrol decreases expression ISO RGD:733100 6480464 Coumestrol results in decreased expression of BCL2 protein CTD PMID:20623010 , PMID:28986287 crocetin multiple interactions EXP 6480464 crocetin inhibits the reaction [cupric oxide results in decreased expression of BCL2 mRNA] CTD PMID:25701151 crocidolite asbestos multiple interactions ISO RGD:733100 6480464 [Asbestos, Crocidolite results in decreased susceptibility to Asbestos, Crocidolite] which results in increased expression of BCL2 protein CTD PMID:22608188 crocidolite asbestos increases expression ISO RGD:2199 6480464 Asbestos, Crocidolite results in increased expression of BCL2 mRNA CTD PMID:12909582 CU-O LINKAGE multiple interactions EXP 6480464 crocetin inhibits the reaction [cupric oxide results in decreased expression of BCL2 mRNA] CTD PMID:25701151 CU-O LINKAGE decreases expression EXP 6480464 cupric oxide results in decreased expression of BCL2 mRNA CTD PMID:25701151 cucurbitacin B multiple interactions EXP 6480464 cucurbitacin B inhibits the reaction [Carbon Tetrachloride results in increased expression of BCL2 mRNA] CTD PMID:29250925 cucurbitacin E decreases expression ISO RGD:733100 6480464 cucurbitacin E results in decreased expression of BCL2 protein CTD PMID:27106530 cucurbitacin E decreases expression ISO RGD:2199 6480464 cucurbitacin E results in decreased expression of BCL2 protein CTD PMID:27363783 cudraflavone B multiple interactions ISO RGD:733100 6480464 resveratrol inhibits the reaction [cudraflavone B results in decreased expression of BCL2 protein], sirtinol promotes the reaction [cudraflavone B results in decreased expression of BCL2 protein] CTD PMID:23881456 cudraflavone B decreases expression ISO RGD:733100 6480464 cudraflavone B results in decreased expression of BCL2 protein CTD PMID:23881456 curcumin multiple interactions ISO RGD:733100 6480464 [Arsenic Trioxide co-treated with Curcumin] affects the expression of BCL2 protein more ... CTD PMID:14724571 more ... curcumin increases expression ISO RGD:2199 6480464 Curcumin results in increased expression of BCL2 mRNA, Curcumin results in increased expression of BCL2 protein CTD PMID:25963729 more ... curcumin increases expression EXP 6480464 Curcumin results in increased expression of BCL2 protein CTD PMID:21793155 more ... curcumin decreases expression EXP 6480464 Curcumin results in decreased expression of BCL2 mRNA, Curcumin results in decreased expression of BCL2 protein CTD PMID:18829502 more ... curcumin decreases expression ISO RGD:733100 6480464 Curcumin analog results in decreased expression of BCL2 mRNA more ... CTD PMID:12497104 more ... curcumin decreases expression ISO RGD:2199 6480464 Curcumin results in decreased expression of BCL2 mRNA, Curcumin results in decreased expression of BCL2 protein CTD PMID:17531121 curcumin multiple interactions EXP 6480464 [Curcumin co-treated with gemcitabine] results in decreased expression of BCL2 protein, NFE2L2 gene mutant form inhibits the reaction [Curcumin results in increased expression of BCL2 protein] CTD PMID:17440100 , PMID:29571711 curcumin multiple interactions ISO RGD:2199 6480464 2-chloro-5-nitrobenzanilide inhibits the reaction [Curcumin results in decreased expression of BCL2 mRNA] more ... CTD PMID:15569404 more ... cyanamide multiple interactions ISO RGD:2199 6480464 [Ethanol co-treated with Cyanamide] results in increased expression of BCL2 mRNA CTD PMID:12003908 cycloheximide multiple interactions ISO RGD:733100 6480464 BCL2 protein inhibits the reaction [[Cycloheximide co-treated with TNFSF10 protein] results in increased activity of CASP3 protein], Cycloheximide inhibits the reaction [Paclitaxel results in increased phosphorylation of BCL2 protein] CTD PMID:11726273 , PMID:22343715 Cyclopamine multiple interactions EXP 6480464 cyclopamine inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of BCL2 mRNA], cyclopamine inhibits the reaction [polydatin promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of BCL2 mRNA]] CTD PMID:27481074 cyclophosphamide multiple interactions ISO RGD:733100 6480464 [Cladribine co-treated with Cyclophosphamide co-treated with Mitoxantrone] results in decreased expression of BCL2 protein more ... CTD PMID:11723234 more ... cyclophosphamide decreases expression EXP 6480464 Cyclophosphamide results in decreased expression of BCL2 protein CTD PMID:29753871 , PMID:30506662 cyclophosphamide multiple interactions EXP 6480464 Fungal Polysaccharides inhibits the reaction [Cyclophosphamide results in decreased expression of BCL2 protein], ganoderic acid A inhibits the reaction [Cyclophosphamide results in decreased expression of BCL2 protein] CTD PMID:29753871 , PMID:30506662 cyclophosphamide multiple interactions ISO RGD:2199 6480464 Plant Extracts inhibits the reaction [Cyclophosphamide results in decreased expression of BCL2 mRNA] CTD PMID:25446862 cyclophosphamide decreases expression ISO RGD:2199 6480464 Cyclophosphamide results in decreased expression of BCL2 mRNA CTD PMID:25446862 cyclophosphamide increases expression ISO RGD:733100 6480464 Cyclophosphamide results in increased expression of BCL2 mRNA CTD PMID:14503796 cyclosporin A multiple interactions ISO RGD:733100 6480464 [Cyclosporine co-treated with NGF protein] results in decreased expression of BCL2 mRNA more ... CTD PMID:12086014 more ... cyclosporin A increases methylation ISO RGD:733100 6480464 Cyclosporine results in increased methylation of BCL2 promoter CTD PMID:27989131 cyclosporin A decreases expression ISO RGD:733100 6480464 Cyclosporine results in decreased expression of BCL2 mRNA, Cyclosporine results in decreased expression of BCL2 protein CTD PMID:12086014 , PMID:22343435 cyclosporin A affects expression ISO RGD:2199 6480464 Cyclosporine affects the expression of BCL2 CTD PMID:25299210 cyclosporin A increases expression EXP 6480464 Cyclosporine results in increased expression of BCL2 protein CTD PMID:10205001 cylindrospermopsin decreases expression ISO RGD:733100 6480464 cylindrospermopsin results in decreased expression of BCL2 mRNA CTD PMID:23726867 cypermethrin multiple interactions ISO RGD:2199 6480464 HBEGF protein inhibits the reaction [cypermethrin results in decreased expression of BCL2 protein] CTD PMID:22048644 cypermethrin increases expression ISO RGD:733100 6480464 cypermethrin results in increased expression of BCL2 mRNA CTD PMID:27704156 cypermethrin decreases expression ISO RGD:2199 6480464 cypermethrin results in decreased expression of BCL2 mRNA, cypermethrin results in decreased expression of BCL2 protein CTD PMID:22048644 , PMID:22528246 cytarabine multiple interactions ISO RGD:733100 6480464 [Doxorubicin co-treated with Dexamethasone co-treated with Vincristine co-treated with Cytarabine co-treated with Mercaptopurine co-treated with Methotrexate co-treated with Cyclophosphamide co-treated with Enzymes and Coenzymes] results in increased expression of BCL2 protein more ... CTD PMID:21182165 more ... cytarabine increases degradation ISO RGD:733100 6480464 Cytarabine results in increased degradation of BCL2 protein CTD PMID:12853972 cytarabine decreases expression ISO RGD:733100 6480464 Cytarabine results in decreased expression of BCL2 mRNA, Cytarabine results in decreased expression of BCL2 protein CTD PMID:1450413 more ... cytochalasin B decreases expression ISO RGD:733100 6480464 Cytochalasin B results in decreased expression of BCL2 protein CTD PMID:27640744 cytochalasin B multiple interactions ISO RGD:733100 6480464 1 more ... CTD PMID:27640744 D-glucose multiple interactions ISO RGD:2199 6480464 15-Hydroxy-11 alpha more ... CTD PMID:21803128 more ... D-glucose multiple interactions EXP 6480464 [Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of BCL2 mRNA more ... CTD PMID:23108914 more ... D-glucose decreases expression ISO RGD:2199 6480464 Glucose results in decreased expression of BCL2 mRNA, Glucose results in decreased expression of BCL2 protein CTD PMID:21818840 more ... D-glucose affects expression ISO RGD:2199 6480464 Glucose affects the expression of BCL2 mRNA, Glucose affects the expression of BCL2 protein CTD PMID:22524206 , PMID:24349266 D-glucose decreases expression ISO RGD:733100 6480464 Glucose results in decreased expression of BCL2 mRNA, Glucose results in decreased expression of BCL2 protein CTD PMID:18088078 more ... D-glucose multiple interactions ISO RGD:733100 6480464 [Resveratrol co-treated with Glucose] results in increased expression of BCL2 protein more ... CTD PMID:18088078 more ... D-mannitol increases expression ISO RGD:2199 6480464 Mannitol results in increased expression of BCL2 protein CTD PMID:15786717 D-penicillamine decreases expression ISO RGD:733100 6480464 Penicillamine results in decreased expression of BCL2 mRNA, Penicillamine results in decreased expression of BCL2 protein CTD PMID:22843330 daidzein decreases expression ISO RGD:733100 6480464 daidzein results in decreased expression of BCL2 protein CTD PMID:12791511 dantrolene increases expression ISO RGD:2199 6480464 Dantrolene results in increased expression of BCL2 protein CTD PMID:10854250 dapoxetine multiple interactions ISO RGD:2199 6480464 dapoxetine inhibits the reaction [Testosterone results in increased expression of BCL2 protein] CTD PMID:27687055 DAPT decreases expression ISO RGD:2199 6480464 N-(N-(3, 5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester results in decreased expression of BCL2 protein CTD PMID:21209419 daunorubicin multiple interactions ISO RGD:733100 6480464 [Bortezomib co-treated with Daunorubicin] results in decreased expression of BCL2 mRNA more ... CTD PMID:19421372 more ... daunorubicin affects expression ISO RGD:733100 6480464 Daunorubicin affects the expression of BCL2 mRNA CTD PMID:27780733 daunorubicin decreases expression ISO RGD:733100 6480464 Daunorubicin results in decreased expression of BCL2 mRNA CTD PMID:19421372 daunorubicin decreases response to substance ISO RGD:733100 6480464 BCL2 results in decreased susceptibility to Daunorubicin CTD PMID:21595920 DDE increases expression ISO RGD:733100 6480464 Dichlorodiphenyl Dichloroethylene results in increased expression of BCL2 mRNA, Dichlorodiphenyl Dichloroethylene results in increased expression of BCL2 protein CTD PMID:19545618 DDT multiple interactions ISO RGD:733100 6480464 [DDT results in increased activity of ESR1 protein] which results in increased expression of BCL2 mRNA CTD PMID:22403704 DDT decreases expression EXP 6480464 DDT results in decreased expression of BCL2 protein CTD PMID:28263910 decabromodiphenyl ether decreases expression EXP 6480464 decabromobiphenyl ether results in decreased expression of BCL2 protein CTD PMID:28572024 , PMID:31039416 decabromodiphenyl ether decreases expression ISO RGD:733100 6480464 decabromobiphenyl ether results in decreased expression of BCL2 mRNA CTD PMID:26206603 Deguelin decreases expression ISO RGD:733100 6480464 deguelin results in decreased expression of BCL2 mRNA, deguelin results in decreased expression of BCL2 protein CTD PMID:19365708 more ... Deguelin multiple interactions ISO RGD:733100 6480464 deguelin inhibits the reaction [TNF protein results in increased expression of BCL2 mRNA] CTD PMID:22623043 dehydroascorbic acid multiple interactions ISO RGD:733100 6480464 [Dehydroascorbic Acid co-treated with Lipopolysaccharides] results in increased expression of BCL2 protein CTD PMID:20166893 dehydroascorbic acid increases expression ISO RGD:733100 6480464 Dehydroascorbic Acid results in increased expression of BCL2 protein CTD PMID:20166893 dehydroepiandrosterone multiple interactions ISO RGD:2199 6480464 Dexamethasone inhibits the reaction [Dehydroepiandrosterone results in increased expression of BCL2 protein] more ... CTD PMID:16407456 dehydroepiandrosterone decreases expression ISO RGD:2199 6480464 Dehydroepiandrosterone results in decreased expression of BCL2 protein CTD PMID:21062263 dehydroepiandrosterone increases expression ISO RGD:2199 6480464 Dehydroepiandrosterone results in increased expression of BCL2 protein CTD PMID:16407456 dehydroepiandrosterone sulfate increases expression ISO RGD:2199 6480464 Dehydroepiandrosterone Sulfate results in increased expression of BCL2 protein CTD PMID:16407456 dehydroepiandrosterone sulfate multiple interactions ISO RGD:2199 6480464 Pertussis Toxin inhibits the reaction [Dehydroepiandrosterone Sulfate results in increased expression of BCL2 protein] CTD PMID:16407456 delphinidin decreases expression ISO RGD:733100 6480464 delphinidin results in decreased expression of BCL2 protein CTD PMID:15740068 , PMID:29451351 delphinidin multiple interactions ISO RGD:733100 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [delphinidin inhibits the reaction [TGFB1 results in decreased expression of BCL2 protein]], delphinidin inhibits the reaction [TGFB1 results in decreased expression of BCL2 protein] CTD PMID:30365941 delphinidin increases expression ISO RGD:733100 6480464 delphinidin results in increased expression of BCL2 protein CTD PMID:19818742 demethoxyfumitremorgin C decreases expression ISO RGD:733100 6480464 demethoxyfumitremorgin C results in decreased expression of BCL2 protein CTD PMID:28359723 deoxycholic acid decreases response to substance ISO RGD:733100 6480464 BCL2 protein results in decreased susceptibility to Deoxycholic Acid CTD PMID:12507930 deoxynivalenol increases expression ISO RGD:733100 6480464 deoxynivalenol results in increased expression of BCL2 mRNA CTD PMID:22269384 deoxynivalenol multiple interactions EXP 6480464 deoxynivalenol promotes the reaction [Aflatoxin B1 results in decreased expression of BCL2 mRNA] CTD PMID:25445755 deoxynivalenol multiple interactions ISO RGD:733100 6480464 Ascorbic Acid inhibits the reaction [deoxynivalenol results in decreased expression of BCL2 protein] CTD PMID:17166419 deoxynivalenol decreases expression ISO RGD:733100 6480464 deoxynivalenol results in decreased expression of BCL2 mRNA, deoxynivalenol results in decreased expression of BCL2 protein CTD PMID:17166419 , PMID:22269384 desferrioxamine B multiple interactions ISO RGD:2199 6480464 Deferoxamine inhibits the reaction [Copper Sulfate results in decreased expression of BCL2 mRNA] CTD PMID:30431687 desipramine increases expression ISO RGD:2199 6480464 Desipramine results in increased expression of BCL2 mRNA, Desipramine results in increased expression of BCL2 protein CTD PMID:17510525 dexamethasone multiple interactions ISO RGD:733100 6480464 [Doxorubicin co-treated with Dexamethasone co-treated with Vincristine co-treated with Cytarabine co-treated with Mercaptopurine co-treated with Methotrexate co-treated with Cyclophosphamide co-treated with Enzymes and Coenzymes] results in increased expression of BCL2 protein more ... CTD PMID:15867202 more ... dexamethasone decreases response to substance EXP 6480464 BCL2 protein results in decreased susceptibility to Dexamethasone CTD PMID:19997594 dexamethasone increases expression EXP 6480464 Dexamethasone results in increased expression of BCL2 mRNA CTD PMID:21041162 dexamethasone decreases expression EXP 6480464 Dexamethasone results in decreased expression of BCL2 mRNA, Dexamethasone results in decreased expression of BCL2 protein CTD PMID:16644695 more ... dexamethasone increases expression ISO RGD:2199 6480464 Dexamethasone results in increased expression of BCL2 protein CTD PMID:11319611 dexamethasone decreases expression ISO RGD:2199 6480464 Dexamethasone results in decreased expression of BCL2 mRNA, Dexamethasone results in decreased expression of BCL2 protein CTD PMID:19080409 , PMID:30506661 dexamethasone multiple interactions ISO RGD:2199 6480464 Dexamethasone inhibits the reaction [Dehydroepiandrosterone results in increased expression of BCL2 protein], fludarabine inhibits the reaction [Dexamethasone results in decreased expression of BCL2 protein] CTD PMID:16407456 , PMID:30506661 dexamethasone multiple interactions EXP 6480464 [2-amino-1-methyl-6-phenylimidazo(4 more ... CTD PMID:11751460 more ... dexamethasone increases expression ISO RGD:733100 6480464 Dexamethasone results in increased expression of BCL2, Dexamethasone results in increased expression of BCL2 protein CTD PMID:11319611 , PMID:21244764 dexamethasone decreases response to substance ISO RGD:733100 6480464 BCL2 protein results in decreased susceptibility to Dexamethasone CTD PMID:16505121 dexamethasone increases response to substance ISO RGD:733100 6480464 BCL2 protein results in increased susceptibility to Dexamethasone CTD PMID:10200551 dexmedetomidine multiple interactions ISO RGD:2199 6480464 Dexmedetomidine inhibits the reaction [Isoflurane results in decreased expression of BCL2 protein] CTD PMID:20003127 dextran sulfate multiple interactions EXP 6480464 [Azoxymethane co-treated with Dextran Sulfate] results in increased expression of BCL2 protein more ... CTD PMID:25449198 dextromethorphan decreases expression ISO RGD:2199 6480464 Dextromethorphan results in decreased expression of BCL2 protein CTD PMID:28916251 dextromethorphan multiple interactions ISO RGD:2199 6480464 traxoprodil mesylate inhibits the reaction [Dextromethorphan results in decreased expression of BCL2 protein] CTD PMID:28916251 diallyl disulfide decreases expression ISO RGD:2199 6480464 diallyl disulfide results in decreased expression of BCL2 protein CTD PMID:16052692 diallyl disulfide decreases expression ISO RGD:733100 6480464 diallyl disulfide results in decreased expression of BCL2 mRNA, diallyl disulfide results in decreased expression of BCL2 protein CTD PMID:14522920 more ... Diallyl sulfide multiple interactions ISO RGD:733100 6480464 [allyl sulfide co-treated with resveratrol] results in decreased expression of BCL2 mRNA CTD PMID:18512326 Diallyl sulfide multiple interactions ISO RGD:2199 6480464 allyl sulfide promotes the reaction [Bleomycin results in increased expression of BCL2 protein] CTD PMID:23656969 Diallyl sulfide decreases expression ISO RGD:733100 6480464 allyl sulfide results in decreased expression of BCL2 mRNA CTD PMID:17647244 diallyl trisulfide decreases expression ISO RGD:733100 6480464 diallyl trisulfide results in decreased expression of BCL2 more ... CTD PMID:17513609 more ... diallyl trisulfide multiple interactions ISO RGD:2199 6480464 diallyl trisulfide inhibits the reaction [Doxorubicin results in decreased expression of BCL2 protein] CTD PMID:29087013 diallyl trisulfide multiple interactions ISO RGD:733100 6480464 Acetylcysteine inhibits the reaction [diallyl trisulfide results in decreased expression of BCL2 protein] CTD PMID:22578287 diarsenic trioxide decreases response to substance ISO RGD:733100 6480464 BCL2 protein results in decreased susceptibility to Arsenic Trioxide, BCL2 results in decreased susceptibility to Arsenic Trioxide CTD PMID:11775218 more ... diarsenic trioxide increases degradation ISO RGD:733100 6480464 Arsenic Trioxide results in increased degradation of BCL2 protein CTD PMID:19468689 diarsenic trioxide increases cleavage EXP 6480464 Arsenic Trioxide results in increased cleavage of BCL2 protein CTD PMID:15761769 diarsenic trioxide increases cleavage ISO RGD:733100 6480464 Arsenic Trioxide results in increased cleavage of BCL2 protein CTD PMID:11739184 diarsenic trioxide affects expression ISO RGD:733100 6480464 Arsenic Trioxide affects the expression of BCL2 protein CTD PMID:12962562 more ... diarsenic trioxide increases expression ISO RGD:2199 6480464 Arsenic Trioxide results in increased expression of BCL2 mRNA CTD PMID:17487067 diarsenic trioxide decreases expression ISO RGD:733100 6480464 Arsenic Trioxide results in decreased expression of BCL2 more ... CTD PMID:10340400 more ... diarsenic trioxide affects response to substance ISO RGD:733100 6480464 BCL2 protein affects the susceptibility to Arsenic Trioxide CTD PMID:10648417 , PMID:18726487 diarsenic trioxide multiple interactions EXP 6480464 [Genistein co-treated with Arsenic Trioxide] results in decreased expression of BCL2 protein more ... CTD PMID:21078540 , PMID:28587418 diarsenic trioxide multiple interactions ISO RGD:2199 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [salvianolic acid B inhibits the reaction [Arsenic Trioxide results in decreased expression of BCL2 protein]] more ... CTD PMID:17487067 more ... diarsenic trioxide increases phosphorylation ISO RGD:733100 6480464 Arsenic Trioxide results in increased phosphorylation of BCL2 protein CTD PMID:12181429 , PMID:18412143 diarsenic trioxide multiple interactions ISO RGD:733100 6480464 2-(4-nitrophenyl)-4-(4-fluorophenyl)-5-(4-pyridinyl)-1H-imidazole inhibits the reaction [Arsenic Trioxide results in increased phosphorylation of BCL2 protein] more ... CTD PMID:11775218 more ... diarsenic trioxide decreases expression ISO RGD:2199 6480464 Arsenic Trioxide results in decreased expression of BCL2 mRNA, Arsenic Trioxide results in decreased expression of BCL2 protein CTD PMID:19260322 more ... diarsenic trioxide increases response to substance ISO RGD:733100 6480464 BCL2 mutant form results in increased susceptibility to Arsenic Trioxide CTD PMID:14642526 diarsenic trioxide decreases expression EXP 6480464 Arsenic Trioxide results in decreased expression of BCL2 mRNA, Arsenic Trioxide results in decreased expression of BCL2 protein CTD PMID:10721769 more ... diarsenic trioxide increases expression EXP 6480464 Arsenic Trioxide results in increased expression of BCL2 protein CTD PMID:10712780 diarsenic trioxide affects folding ISO RGD:733100 6480464 Arsenic Trioxide affects the folding of BCL2 protein CTD PMID:20403207 diarsenic trioxide increases expression ISO RGD:733100 6480464 Arsenic Trioxide results in increased expression of BCL2 mRNA, Arsenic Trioxide results in increased expression of BCL2 protein CTD PMID:16966277 more ... diarsenic trioxide affects expression ISO RGD:2199 6480464 Arsenic Trioxide affects the expression of BCL2 mRNA, Arsenic Trioxide affects the expression of BCL2 protein CTD PMID:12725324 , PMID:18618274 diazinon affects expression ISO RGD:2199 6480464 Diazinon affects the expression of BCL2 mRNA CTD PMID:22546817 diazinon decreases expression ISO RGD:733100 6480464 Diazinon results in decreased expression of BCL2 mRNA CTD PMID:27920530 diazinon multiple interactions ISO RGD:733100 6480464 [Selenium analog co-treated with Magnesium Oxide analog] inhibits the reaction [Diazinon results in decreased expression of BCL2 mRNA] more ... CTD PMID:27920530 diazoxide multiple interactions ISO RGD:2199 6480464 Diazoxide inhibits the reaction [Streptozocin results in decreased expression of BCL2 protein] CTD PMID:20650802 dibenzoylmethane multiple interactions ISO RGD:733100 6480464 dibenzoylmethane inhibits the reaction [ESR1 protein binds to BCL2 enhancer], dibenzoylmethane inhibits the reaction [Estradiol results in increased expression of BCL2 mRNA] CTD PMID:16051634 dibromoacetic acid decreases expression EXP 6480464 dibromoacetic acid results in decreased expression of BCL2 mRNA CTD PMID:18628252 dibutyl phthalate increases expression EXP 6480464 Dibutyl Phthalate results in increased expression of BCL2 mRNA CTD PMID:21266533 dibutyl phthalate multiple interactions EXP 6480464 [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in increased expression of BCL2 mRNA, DDIT3 protein promotes the reaction [Dibutyl Phthalate results in decreased expression of BCL2 protein] CTD PMID:26804720 , PMID:28013214 dibutyl phthalate decreases expression EXP 6480464 Dibutyl Phthalate results in decreased expression of BCL2 mRNA, Dibutyl Phthalate results in decreased expression of BCL2 protein CTD PMID:23242528 , PMID:26804720 dichloroacetic acid decreases expression EXP 6480464 Dichloroacetic Acid results in decreased expression of BCL2 protein CTD PMID:22705712 dichromium trioxide affects expression ISO RGD:733100 6480464 chromic oxide affects the expression of BCL2 protein CTD PMID:26086747 dicrotophos decreases expression ISO RGD:733100 6480464 dicrotophos results in decreased expression of BCL2 protein CTD PMID:28302478 dieldrin decreases response to substance ISO RGD:733100 6480464 BCL2 protein results in decreased susceptibility to Dieldrin CTD PMID:15183012 dieldrin multiple interactions ISO RGD:733100 6480464 BCL2 protein inhibits the reaction [Dieldrin results in increased activity of CASP3 protein], BCL2 protein inhibits the reaction [Dieldrin results in increased activity of PRKCD protein] CTD PMID:15033812 , PMID:15183012 diepoxybutane increases expression ISO RGD:733100 6480464 diepoxybutane results in increased expression of BCL2 mRNA CTD PMID:29792945 diethyl maleate multiple interactions EXP 6480464 [diethyl maleate results in decreased abundance of Glutathione] which results in increased expression of BCL2 mRNA CTD PMID:22564015 diethyl phthalate multiple interactions EXP 6480464 [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in increased expression of BCL2 mRNA CTD PMID:28013214 diethyl sulfate decreases expression ISO RGD:733100 6480464 diethyl sulfate results in decreased expression of BCL2 protein CTD PMID:23830811 diethylstilbestrol increases expression EXP 6480464 Diethylstilbestrol results in increased expression of BCL2 mRNA CTD PMID:17943652 diethylstilbestrol decreases expression EXP 6480464 Diethylstilbestrol results in decreased expression of BCL2 mRNA CTD PMID:15545218 diethylstilbestrol decreases expression ISO RGD:2199 6480464 Diethylstilbestrol results in decreased expression of BCL2 protein CTD PMID:17009535 diiodine multiple interactions ISO RGD:733100 6480464 [Diatrizoate co-treated with Iodine] results in increased expression of BCL2 protein CTD PMID:17173243 diisobutyl phthalate multiple interactions EXP 6480464 [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in increased expression of BCL2 mRNA CTD PMID:28013214 diisononyl phthalate multiple interactions EXP 6480464 [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in increased expression of BCL2 mRNA CTD PMID:28013214 dimethylarsinic acid increases expression EXP 6480464 Cacodylic Acid results in increased expression of BCL2 mRNA, Cacodylic Acid results in increased expression of BCL2 protein CTD PMID:22246474 dimethylarsinous acid increases expression ISO RGD:733100 6480464 dimethylarsinous acid results in increased expression of BCL2 protein CTD PMID:30262279 dioscin multiple interactions EXP 6480464 dioscin inhibits the reaction [Acetaminophen results in decreased expression of BCL2 protein] CTD PMID:22939915 dioscin increases expression EXP 6480464 dioscin results in increased expression of BCL2 protein CTD PMID:24742230 dioscin decreases expression ISO RGD:733100 6480464 dioscin results in decreased expression of BCL2 mRNA, dioscin results in decreased expression of BCL2 protein CTD PMID:22334414 , PMID:29990575 diosgenin multiple interactions ISO RGD:733100 6480464 Diosgenin inhibits the reaction [TNF protein results in increased expression of BCL2 protein] CTD PMID:16331273 diosgenin decreases expression ISO RGD:733100 6480464 Diosgenin results in decreased expression of BCL2 protein CTD PMID:16331273 diosmin multiple interactions ISO RGD:2199 6480464 [Diosmin co-treated with Lipopolysaccharides] results in increased expression of BCL2 protein CTD PMID:21477647 dioxygen increases expression ISO RGD:2199 6480464 Oxygen deficiency results in increased expression of BCL2 protein, Oxygen results in increased expression of BCL2 protein CTD PMID:10657591 more ... dioxygen decreases expression ISO RGD:733100 6480464 Oxygen deficiency results in decreased expression of BCL2 mRNA CTD PMID:26516004 dioxygen affects expression EXP 6480464 Oxygen deficiency affects the expression of BCL2 protein CTD PMID:24680926 dioxygen increases expression ISO RGD:733100 6480464 Oxygen deficiency results in increased expression of BCL2 mRNA CTD PMID:23452621 dioxygen multiple interactions EXP 6480464 [Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of BCL2 mRNA more ... CTD PMID:23108914 more ... dioxygen multiple interactions ISO RGD:733100 6480464 [Oxygen co-treated with Oxygen deficiency] results in decreased expression of BCL2 protein more ... CTD PMID:23452621 more ... dioxygen decreases expression ISO RGD:2199 6480464 Oxygen deficiency results in decreased expression of BCL2 mRNA, Oxygen deficiency results in decreased expression of BCL2 protein CTD PMID:11042672 more ... dioxygen multiple interactions ISO RGD:2199 6480464 15-Hydroxy-11 alpha more ... CTD PMID:11042672 more ... diquat multiple interactions EXP 6480464 procyanidin B2 affects the reaction [Diquat affects the expression of BCL2 mRNA] CTD PMID:27057282 diquat decreases expression ISO RGD:2199 6480464 Diquat results in decreased expression of BCL2 protein CTD PMID:29484840 diquat affects expression EXP 6480464 Diquat affects the expression of BCL2 mRNA CTD PMID:26785375 , PMID:27057282 disodium cromoglycate multiple interactions ISO RGD:2199 6480464 [Cromolyn Sodium co-treated with Chitosan] inhibits the reaction [Dimethylhydrazines results in increased expression of BCL2 protein] CTD PMID:28732690 disodium selenite multiple interactions EXP 6480464 Sodium Selenite inhibits the reaction [citreoviridin results in decreased expression of BCL2 protein], Sodium Selenite promotes the reaction [Buthionine Sulfoximine results in decreased expression of BCL2 mRNA] CTD PMID:17989939 , PMID:31419397 disodium selenite multiple interactions ISO RGD:733100 6480464 [Sodium Selenite co-treated with (1 more ... CTD PMID:28757135 disodium selenite decreases expression EXP 6480464 Sodium Selenite results in decreased expression of BCL2 mRNA CTD PMID:16542727 more ... disodium selenite multiple interactions ISO RGD:2199 6480464 Sodium Selenite inhibits the reaction [2-cresol results in increased expression of BCL2 mRNA] more ... CTD PMID:16039982 more ... disodium selenite increases expression ISO RGD:2199 6480464 Sodium Selenite results in increased expression of BCL2 protein CTD PMID:18209489 disulfiram multiple interactions ISO RGD:733100 6480464 [arsenic trioxide co-treated with Ascorbic Acid co-treated with Disulfiram] results in decreased expression of BCL2 protein more ... CTD PMID:21911303 more ... dithionite(2-) multiple interactions ISO RGD:2199 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Quercetin inhibits the reaction [[Dithionite co-treated with Glucose deficiency] results in decreased expression of BCL2 protein]] more ... CTD PMID:21803128 dobutamine decreases expression EXP 6480464 Dobutamine results in decreased expression of BCL2 protein CTD PMID:15052282 domoic acid affects expression ISO RGD:733100 6480464 domoic acid affects the expression of BCL2 mRNA CTD PMID:18293405 donepezil hydrochloride multiple interactions ISO RGD:2199 6480464 Donepezil inhibits the reaction [Hydrogen Peroxide results in decreased expression of BCL2 protein] CTD PMID:19345205 dopamine decreases expression ISO RGD:733100 6480464 Dopamine results in decreased expression of BCL2 protein CTD PMID:17603292 , PMID:28980048 dopamine multiple interactions ISO RGD:733100 6480464 polydatin inhibits the reaction [Dopamine results in decreased expression of BCL2 protein], Resveratrol inhibits the reaction [Dopamine results in decreased expression of BCL2 protein] CTD PMID:17603292 , PMID:28980048 dorsomorphin multiple interactions ISO RGD:733100 6480464 [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 dorsomorphin multiple interactions ISO RGD:2199 6480464 dorsomorphin inhibits the reaction [Resveratrol inhibits the reaction [Glucose results in decreased expression of BCL2 protein]] CTD PMID:26054749 doxazosin multiple interactions ISO RGD:733100 6480464 BCL2 inhibits the reaction [Doxazosin results in decreased expression of VEGFA] CTD PMID:12576871 doxorubicin decreases expression ISO RGD:2199 6480464 Doxorubicin results in decreased expression of BCL2 mRNA, Doxorubicin results in decreased expression of BCL2 protein CTD PMID:12505058 more ... doxorubicin affects expression ISO RGD:733100 6480464 Doxorubicin affects the expression of BCL2 mRNA CTD PMID:16705698 more ... doxorubicin affects expression ISO RGD:2199 6480464 Doxorubicin affects the expression of BCL2 mRNA CTD PMID:24742701 doxorubicin decreases expression ISO RGD:733100 6480464 Doxorubicin results in decreased expression of BCL2 mRNA, Doxorubicin results in decreased expression of BCL2 protein CTD PMID:11779855 more ... doxorubicin decreases expression EXP 6480464 Doxorubicin results in decreased expression of BCL2 mRNA, Doxorubicin results in decreased expression of BCL2 protein CTD PMID:15811867 more ... doxorubicin increases expression EXP 6480464 Doxorubicin results in increased expression of BCL2 mRNA CTD PMID:15505089 more ... doxorubicin increases expression ISO RGD:2199 6480464 Doxorubicin results in increased expression of BCL2 protein CTD PMID:11291592 more ... doxorubicin increases expression ISO RGD:733100 6480464 Doxorubicin results in increased expression of BCL2 mRNA, Doxorubicin results in increased expression of BCL2 protein CTD PMID:15571967 more ... doxorubicin decreases response to substance ISO RGD:733100 6480464 BCL2 protein results in decreased susceptibility to Doxorubicin CTD PMID:8781438 doxorubicin affects response to substance ISO RGD:733100 6480464 BCL2 protein affects the susceptibility to Doxorubicin CTD PMID:16322301 more ... doxorubicin multiple interactions ISO RGD:733100 6480464 [[[Doxorubicin co-treated with 2 more ... CTD PMID:15571967 more ... doxorubicin multiple interactions ISO RGD:2199 6480464 2 more ... CTD PMID:15380674 more ... doxorubicin multiple interactions EXP 6480464 [Zoledronic Acid co-treated with Doxorubicin] results in decreased expression of BCL2 protein more ... CTD PMID:15538571 more ... doxycycline multiple interactions EXP 6480464 Doxycycline inhibits the reaction [Doxorubicin results in decreased expression of BCL2 protein] CTD PMID:17673183 drimenol decreases expression ISO RGD:733100 6480464 drimenol results in decreased expression of BCL2 protein CTD PMID:30935903 ebselen multiple interactions ISO RGD:2199 6480464 ebselen inhibits the reaction [sodium arsenite results in decreased expression of BCL2 protein] CTD PMID:30558456 EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor multiple interactions ISO RGD:2199 6480464 Angiotensin-Converting Enzyme Inhibitors inhibits the reaction [Streptozocin results in decreased expression of BCL2 protein] CTD PMID:22429817 Echinocystic acid multiple interactions ISO RGD:2199 6480464 echinocystic acid affects the reaction [Isoproterenol affects the expression of BCL2 mRNA] CTD PMID:19573579 edaravone multiple interactions ISO RGD:2199 6480464 Edaravone inhibits the reaction [APP protein modified form results in decreased expression of BCL2 mRNA] CTD PMID:26111763 edelfosine multiple interactions ISO RGD:733100 6480464 edelfosine inhibits the reaction [Nicotine results in increased phosphorylation of BCL2 protein] more ... CTD PMID:12421819 , PMID:9295281 elemental selenium decreases expression ISO RGD:733100 6480464 Selenium results in decreased expression of BCL2 protein CTD PMID:17523932 elemental selenium multiple interactions ISO RGD:733100 6480464 [Selenium analog co-treated with Magnesium Oxide analog] inhibits the reaction [Diazinon results in decreased expression of BCL2 mRNA], Selenium analog inhibits the reaction [Diazinon results in decreased expression of BCL2 mRNA] CTD PMID:27920530 ellagic acid multiple interactions EXP 6480464 [Ellagic Acid co-treated with resveratrol] inhibits the reaction [9 more ... CTD PMID:20103723 ellagic acid multiple interactions ISO RGD:2199 6480464 Ellagic Acid inhibits the reaction [sodium arsenate results in decreased expression of BCL2 mRNA] CTD PMID:29854611 ellagic acid increases expression ISO RGD:733100 6480464 Ellagic Acid results in increased expression of BCL2 protein CTD PMID:22386815 ellipticine decreases expression ISO RGD:733100 6480464 ellipticine results in decreased expression of BCL2 protein CTD PMID:16027529 embelin decreases expression ISO RGD:733100 6480464 embelin results in decreased expression of BCL2 protein CTD PMID:24694877 emodin decreases expression ISO RGD:733100 6480464 Emodin results in decreased expression of BCL2 mRNA, Emodin results in decreased expression of BCL2 protein CTD PMID:23848338 emodin affects expression ISO RGD:2199 6480464 Emodin affects the expression of BCL2 protein CTD PMID:19549930 emodin multiple interactions ISO RGD:733100 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one affects the reaction [Emodin affects the expression of BCL2 protein] more ... CTD PMID:27032576 emodin affects expression ISO RGD:733100 6480464 Emodin affects the expression of BCL2 protein CTD PMID:27032576 enalapril increases expression ISO RGD:2199 6480464 Enalapril results in increased expression of BCL2 protein CTD PMID:21153712 enalapril multiple interactions ISO RGD:2199 6480464 Enalapril inhibits the reaction [Isoproterenol results in decreased expression of BCL2 protein] CTD PMID:30623541 enalaprilat dihydrate increases expression EXP 6480464 Enalaprilat results in increased expression of BCL2 mRNA CTD PMID:17342403 endosulfan increases expression ISO RGD:733100 6480464 Endosulfan results in increased expression of BCL2 protein CTD PMID:10821422 endosulfan decreases expression ISO RGD:733100 6480464 Endosulfan results in decreased expression of BCL2 protein CTD PMID:29705383 endosulfan decreases expression ISO RGD:2199 6480464 Endosulfan results in decreased expression of BCL2 mRNA CTD PMID:29391264 Enterolactone multiple interactions ISO RGD:733100 6480464 [Coumestrol co-treated with 2, 3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of BCL2 mRNA CTD PMID:19167446 entinostat decreases expression ISO RGD:733100 6480464 entinostat results in decreased expression of BCL2 mRNA CTD PMID:26272509 entinostat multiple interactions ISO RGD:733100 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of BCL2 mRNA CTD PMID:27188386 entinostat decreases expression EXP 6480464 entinostat results in decreased expression of BCL2 protein CTD PMID:21041383 epichlorohydrin increases expression ISO RGD:733100 6480464 Epichlorohydrin results in increased expression of BCL2 mRNA CTD PMID:29792945 epoxomicin multiple interactions EXP 6480464 epoxomicin inhibits the reaction [troxerutin inhibits the reaction [2 more ... CTD PMID:25639565 erlotinib hydrochloride increases expression ISO RGD:733100 6480464 Erlotinib Hydrochloride results in increased expression of BCL2 mRNA, Erlotinib Hydrochloride results in increased expression of BCL2 protein CTD PMID:23894143 erlotinib hydrochloride multiple interactions ISO RGD:733100 6480464 [Erlotinib Hydrochloride co-treated with Arsenic Trioxide] results in decreased expression of BCL2 mRNA more ... CTD PMID:23894143 , PMID:29274334 erythromycin estolate increases expression ISO RGD:2199 6480464 Erythromycin Estolate results in increased expression of BCL2 mRNA CTD PMID:12883083 esculetin affects expression ISO RGD:733100 6480464 esculetin affects the expression of BCL2 protein CTD PMID:24995577 esculetin decreases expression ISO RGD:733100 6480464 esculetin results in decreased expression of BCL2 protein CTD PMID:26388407 estramustine increases phosphorylation ISO RGD:733100 6480464 Estramustine results in increased phosphorylation of BCL2 protein CTD PMID:11763419 ethanol multiple interactions ISO RGD:2199 6480464 [Ethanol co-treated with Carbon Tetrachloride] results in increased expression of BCL2 mRNA more ... CTD PMID:12003908 more ... ethanol increases expression EXP 6480464 Ethanol results in increased expression of BCL2 mRNA CTD PMID:30319688 ethanol multiple interactions EXP 6480464 Cimetidine inhibits the reaction [Ethanol results in decreased expression of BCL2 protein] more ... CTD PMID:27983966 , PMID:29069573 ethanol decreases expression ISO RGD:2199 6480464 Ethanol results in decreased expression of BCL2 mRNA, Ethanol results in decreased expression of BCL2 protein CTD PMID:15353170 more ... ethanol increases expression ISO RGD:2199 6480464 Ethanol results in increased expression of BCL2 mRNA CTD PMID:22446813 more ... ethanol decreases expression EXP 6480464 Ethanol results in decreased expression of BCL2 mRNA, Ethanol results in decreased expression of BCL2 protein CTD PMID:19429258 more ... ethanol decreases expression ISO RGD:733100 6480464 Ethanol results in decreased expression of BCL2 mRNA CTD PMID:21878650 , PMID:31226463 ethanol affects localization ISO RGD:2199 6480464 Ethanol affects the localization of BCL2 protein CTD PMID:16035105 ethanol multiple interactions ISO RGD:733100 6480464 4-benzyl-2-methyl-1 more ... CTD PMID:19429258 more ... ethanol increases expression ISO RGD:733100 6480464 Ethanol results in increased expression of BCL2 protein CTD PMID:21410490 ethanol affects expression ISO RGD:2199 6480464 Ethanol affects the expression of BCL2 mRNA, Ethanol affects the expression of BCL2 protein CTD PMID:25859307 , PMID:29085585 ethidium multiple interactions ISO RGD:733100 6480464 Ethidium inhibits the reaction [Estradiol results in increased expression of BCL2 mRNA] CTD PMID:15897899 ethylbenzene decreases expression ISO RGD:2199 6480464 ethylbenzene results in decreased expression of BCL2 mRNA, ethylbenzene results in decreased expression of BCL2 protein CTD PMID:20137408 more ... Ethylenethiourea decreases expression EXP 6480464 Ethylenethiourea results in decreased expression of BCL2 mRNA CTD PMID:27905518 Ethylenethiourea multiple interactions EXP 6480464 [Chlorpyrifos co-treated with Ethylenethiourea] results in decreased expression of BCL2 mRNA CTD PMID:27905518 etodolac decreases expression ISO RGD:733100 6480464 Etodolac results in decreased expression of BCL2 mRNA, Etodolac results in decreased expression of BCL2 protein CTD PMID:16046235 , PMID:16104877 etoposide multiple interactions ISO RGD:733100 6480464 [Doxorubicin co-treated with Vincristine co-treated with Etoposide co-treated with Mitotane] results in decreased expression of BCL2 protein more ... CTD PMID:12063570 more ... etoposide decreases expression EXP 6480464 Etoposide results in decreased expression of BCL2 mRNA, Etoposide results in decreased expression of BCL2 protein CTD PMID:19408126 etoposide multiple interactions EXP 6480464 [G(M3) Ganglioside results in increased expression of BCL2 protein] which results in decreased susceptibility to Etoposide more ... CTD PMID:16571667 , PMID:19408126 eugenol multiple interactions ISO RGD:733100 6480464 [Eugenol results in increased activity of sulforafan] which results in decreased expression of BCL2, [sulforafan results in increased activity of Eugenol] which results in decreased expression of BCL2 CTD PMID:21382956 eugenol multiple interactions EXP 6480464 Eugenol inhibits the reaction [[9 more ... CTD PMID:20434464 , PMID:20537511 eugenol decreases expression ISO RGD:733100 6480464 Eugenol results in decreased expression of BCL2 mRNA CTD PMID:21939359 Evodiamine multiple interactions ISO RGD:733100 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde promotes the reaction [evodiamine results in increased cleavage of BCL2 protein], evodiamine inhibits the reaction [TNF protein results in increased expression of BCL2 protein] CTD PMID:15710601 , PMID:20005289 Evodiamine increases cleavage ISO RGD:733100 6480464 evodiamine results in increased cleavage of BCL2 protein CTD PMID:20005289 excitatory amino acid agonist multiple interactions EXP 6480464 notoginsenoside R1 inhibits the reaction [Excitatory Amino Acid Agonists results in decreased expression of BCL2 protein] CTD PMID:19224577 excitatory amino acid agonist decreases expression EXP 6480464 Excitatory Amino Acid Agonists results in decreased expression of BCL2 protein CTD PMID:19224577 fasudil hydrochloride increases expression ISO RGD:2199 6480464 fasudil results in increased expression of BCL2 protein CTD PMID:17761835 fasudil hydrochloride multiple interactions ISO RGD:2199 6480464 fasudil inhibits the reaction [Streptozocin results in decreased expression of BCL2 protein] CTD PMID:22429817 febuxostat multiple interactions ISO RGD:2199 6480464 Febuxostat inhibits the reaction [Doxorubicin results in decreased expression of BCL2 protein] CTD PMID:26036690 fenhexamid increases expression ISO RGD:733100 6480464 N-(2, 3-dichloro-4-hydroxyphenyl)-1-methylcyclohexanecarboxamide results in increased expression of BCL2 mRNA CTD PMID:23052036 fenhexamid decreases expression ISO RGD:733100 6480464 N-(2, 3-dichloro-4-hydroxyphenyl)-1-methylcyclohexanecarboxamide results in decreased expression of BCL2 protein CTD PMID:23052036 fenhexamid multiple interactions ISO RGD:733100 6480464 MIR21 mRNA mutant form inhibits the reaction [N-(2, 3-dichloro-4-hydroxyphenyl)-1-methylcyclohexanecarboxamide results in decreased expression of BCL2 protein] CTD PMID:23052036 fenitrothion increases expression ISO RGD:733100 6480464 Fenitrothion results in increased expression of BCL2 mRNA CTD PMID:21298709 fenofibrate multiple interactions ISO RGD:2199 6480464 Fenofibrate inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of BCL2 protein] CTD PMID:26989860 fenofibrate decreases expression ISO RGD:733100 6480464 Fenofibrate results in decreased expression of BCL2 mRNA CTD PMID:15843896 ferric oxide increases expression EXP 6480464 ferric oxide analog results in increased expression of BCL2 protein CTD PMID:25086211 ferric oxide increases phosphorylation ISO RGD:2199 6480464 ferric oxide analog results in increased phosphorylation of BCL2 protein CTD PMID:22995439 ferrosoferric oxide multiple interactions ISO RGD:733100 6480464 [Ferrosoferric Oxide binds to titanium dioxide] which results in decreased expression of BCL2 protein CTD PMID:30098274 finasteride multiple interactions ISO RGD:2199 6480464 Finasteride inhibits the reaction [Testosterone results in increased expression of BCL2 protein] CTD PMID:25714330 more ... fipronil decreases expression ISO RGD:733100 6480464 fipronil results in decreased expression of BCL2 protein CTD PMID:21296133 fisetin multiple interactions ISO RGD:2199 6480464 fisetin inhibits the reaction [Cisplatin results in decreased expression of BCL2 protein] CTD PMID:25184746 fisetin multiple interactions EXP 6480464 fisetin inhibits the reaction [Lead results in decreased expression of BCL2 protein] CTD PMID:31539617 fisetin decreases expression ISO RGD:733100 6480464 fisetin results in decreased expression of BCL2 protein CTD PMID:28181380 fisetin multiple interactions ISO RGD:733100 6480464 [fisetin co-treated with Paclitaxel] results in increased expression of BCL2 mRNA CTD PMID:26884726 flavanones decreases expression ISO RGD:733100 6480464 Flavanones results in decreased expression of BCL2 protein CTD PMID:25446852 flavones increases expression ISO RGD:2199 6480464 Flavones results in increased expression of BCL2 protein CTD PMID:15998571 flavones increases expression ISO RGD:733100 6480464 Flavones analog results in increased expression of BCL2 mRNA CTD PMID:20674374 flavonoids decreases expression ISO RGD:733100 6480464 Flavonoids results in decreased expression of BCL2 mRNA, Flavonoids results in decreased expression of BCL2 protein CTD PMID:23063593 more ... flavonoids multiple interactions EXP 6480464 Flavonoids inhibits the reaction [Carbon Tetrachloride results in decreased expression of BCL2 mRNA] CTD PMID:23279844 flavonoids multiple interactions ISO RGD:733100 6480464 Flavonoids inhibits the reaction [AGT protein results in decreased expression of BCL2 mRNA] more ... CTD PMID:23994555 flavonols increases response to substance ISO RGD:733100 6480464 BCL2 protein results in increased susceptibility to Flavonols CTD PMID:28235426 fluazinam decreases expression ISO RGD:733100 6480464 fluazinam results in decreased expression of BCL2 protein CTD PMID:21907236 flucytosine decreases expression ISO RGD:733100 6480464 Flucytosine results in decreased expression of BCL2 protein CTD PMID:15592511 fludioxonil increases expression ISO RGD:733100 6480464 fludioxonil results in increased expression of BCL2 mRNA CTD PMID:23052036 fludioxonil multiple interactions ISO RGD:733100 6480464 MIR21 mRNA mutant form inhibits the reaction [fludioxonil results in decreased expression of BCL2 protein] CTD PMID:23052036 fludioxonil decreases expression ISO RGD:733100 6480464 fludioxonil results in decreased expression of BCL2 protein CTD PMID:23052036 fluoxetine decreases response to substance ISO RGD:733100 6480464 BCL2 protein results in decreased susceptibility to Fluoxetine CTD PMID:16076491 fluoxetine decreases expression ISO RGD:2199 6480464 Fluoxetine results in decreased expression of BCL2 protein CTD PMID:19298536 fluoxetine decreases expression EXP 6480464 Fluoxetine results in decreased expression of BCL2 mRNA CTD PMID:21497159 flutamide increases expression ISO RGD:2199 6480464 Flutamide results in increased expression of BCL2 mRNA, Flutamide results in increased expression of BCL2 protein CTD PMID:20850791 folic acid affects expression ISO RGD:733100 6480464 Folic Acid affects the expression of BCL2 mRNA CTD PMID:16611376 folic acid decreases expression EXP 6480464 Folic Acid results in decreased expression of BCL2 protein CTD PMID:29068127 folic acid affects expression ISO RGD:2199 6480464 Folic Acid affects the expression of BCL2 protein CTD PMID:16933212 folic acid multiple interactions EXP 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of and results in increased expression of BCL2 more ... CTD PMID:16672315 more ... folic acid multiple interactions ISO RGD:2199 6480464 [Carbon Tetrachloride co-treated with Folic Acid] results in decreased expression of BCL2 mRNA more ... CTD PMID:16933212 more ... formaldehyde increases expression ISO RGD:733100 6480464 Formaldehyde results in increased expression of BCL2 protein CTD PMID:20347000 formaldehyde decreases expression ISO RGD:733100 6480464 Formaldehyde results in decreased expression of BCL2 protein CTD PMID:24140967 formaldehyde increases expression EXP 6480464 Formaldehyde results in increased expression of BCL2 protein CTD PMID:16888403 formaldehyde multiple interactions ISO RGD:733100 6480464 PRDX2 protein inhibits the reaction [Formaldehyde results in increased expression of BCL2 protein] CTD PMID:20347000 formononetin decreases expression ISO RGD:733100 6480464 formononetin results in decreased expression of BCL2 mRNA CTD PMID:23867903 formononetin multiple interactions ISO RGD:2199 6480464 formononetin promotes the reaction [Cisplatin results in increased expression of BCL2 protein] CTD PMID:28414026 formoterol fumarate decreases expression ISO RGD:733100 6480464 Formoterol Fumarate results in decreased expression of BCL2 mRNA, Formoterol Fumarate results in decreased expression of BCL2 protein CTD PMID:14687023 fructose decreases expression EXP 6480464 Fructose results in decreased expression of BCL2 protein CTD PMID:27531227 fructose multiple interactions ISO RGD:2199 6480464 Kangen-karyu inhibits the reaction [Fructose results in increased expression of BCL2 protein] CTD PMID:17883899 fructose increases expression ISO RGD:2199 6480464 Fructose results in increased expression of BCL2 protein CTD PMID:17883899 fructose multiple interactions EXP 6480464 [Fructose co-treated with Dietary Fats] results in decreased expression of BCL2 mRNA more ... CTD PMID:28916335 fulvestrant multiple interactions ISO RGD:733100 6480464 ARTN protein inhibits the reaction [fulvestrant inhibits the reaction [Estradiol results in increased expression of BCL2 protein]] more ... CTD PMID:10545406 more ... fulvestrant increases expression ISO RGD:2199 6480464 fulvestrant results in increased expression of BCL2 protein CTD PMID:16951259 fulvestrant multiple interactions ISO RGD:2199 6480464 [fulvestrant co-treated with Estradiol] results in increased expression of BCL2 protein CTD PMID:16951259 fumagillin multiple interactions ISO RGD:2199 6480464 fumagillin inhibits the reaction [Diethylnitrosamine results in increased expression of BCL2 mRNA] CTD PMID:15682466 furan increases expression ISO RGD:2199 6480464 furan results in increased expression of BCL2 mRNA CTD PMID:22079235 furosemide affects expression ISO RGD:2199 6480464 Furosemide affects the expression of BCL2 mRNA CTD PMID:17497460 Fusarenone X increases expression EXP 6480464 fusarenon-X results in increased expression of BCL2 mRNA CTD PMID:24983900 Fusarenone X decreases expression EXP 6480464 fusarenon-X results in decreased expression of BCL2 mRNA CTD PMID:24983900 galactose decreases expression ISO RGD:2199 6480464 Galactose results in decreased expression of BCL2 protein CTD PMID:25892055 galactose multiple interactions ISO RGD:2199 6480464 Saponins inhibits the reaction [Galactose results in decreased expression of BCL2 protein] CTD PMID:25892055 galactose multiple interactions ISO RGD:733100 6480464 Phycocyanin inhibits the reaction [Galactose results in decreased expression of BCL2 protein] CTD PMID:23036742 galactose decreases expression ISO RGD:733100 6480464 Galactose results in decreased expression of BCL2 protein CTD PMID:23036742 galangin decreases expression ISO RGD:733100 6480464 galangin results in decreased expression of BCL2 protein CTD PMID:25450235 gallic acid multiple interactions ISO RGD:2199 6480464 resveratrol inhibits the reaction [Gallic Acid results in decreased expression of BCL2 protein] CTD PMID:19723098 gallic acid decreases expression ISO RGD:733100 6480464 Gallic Acid results in decreased expression of BCL2 protein CTD PMID:22245431 gallic acid multiple interactions ISO RGD:733100 6480464 Gallic Acid inhibits the reaction [TNF protein results in increased expression of BCL2 mRNA] CTD PMID:21420233 gallic acid decreases expression ISO RGD:2199 6480464 Gallic Acid results in decreased expression of BCL2 protein CTD PMID:19723098 gamma-aminobutyric acid increases expression ISO RGD:2199 6480464 gamma-Aminobutyric Acid results in increased expression of BCL2 protein CTD PMID:29708300 gamma-hexachlorocyclohexane decreases expression ISO RGD:733100 6480464 Hexachlorocyclohexane results in decreased expression of BCL2 protein CTD PMID:14688026 gamma-hexachlorocyclohexane increases expression ISO RGD:733100 6480464 Hexachlorocyclohexane results in increased expression of BCL2 mRNA, Hexachlorocyclohexane results in increased expression of BCL2 protein CTD PMID:14688026 , PMID:18174961 gamma-hexachlorocyclohexane multiple interactions ISO RGD:733100 6480464 [Hexachlorocyclohexane co-treated with Estradiol] results in increased expression of BCL2 protein CTD PMID:18174961 gamma-hexachlorocyclohexane multiple interactions ISO RGD:2199 6480464 Hexachlorocyclohexane promotes the reaction [BECN1 protein binds to BCL2 protein] CTD PMID:19041923 gamma-tocopherol increases expression EXP 6480464 Tocopherols results in increased expression of BCL2 mRNA, Tocopherols results in increased expression of BCL2 protein CTD PMID:8970189 gamma-tocopherol decreases response to substance ISO RGD:733100 6480464 BCL2 protein results in decreased susceptibility to Tocopherols CTD PMID:16001965 ganciclovir decreases expression ISO RGD:733100 6480464 Ganciclovir results in decreased expression of BCL2 protein CTD PMID:15592511 Garcinol decreases expression ISO RGD:733100 6480464 garcinol results in decreased expression of BCL2 protein CTD PMID:16052481 gardenin B decreases expression ISO RGD:733100 6480464 gardenin B results in decreased expression of BCL2 protein CTD PMID:27423764 Gastrodin multiple interactions EXP 6480464 gastrodin promotes the reaction [RELA protein binds to BCL2 promoter] CTD PMID:23578476 Gastrodin increases expression EXP 6480464 gastrodin results in increased expression of BCL2 mRNA CTD PMID:23578476 geldanamycin multiple interactions ISO RGD:733100 6480464 [geldanamycin co-treated with Bortezomib] results in decreased expression of BCL2 protein CTD PMID:15781649 geldanamycin decreases expression ISO RGD:733100 6480464 geldanamycin results in decreased expression of BCL2 protein CTD PMID:28673683 gemcitabine multiple interactions ISO RGD:733100 6480464 [alvocidib co-treated with gemcitabine] results in decreased expression of BCL2 protein more ... CTD PMID:15476743 more ... gemcitabine multiple interactions EXP 6480464 [Curcumin co-treated with gemcitabine] results in decreased expression of BCL2 protein CTD PMID:17440100 gemcitabine decreases expression ISO RGD:733100 6480464 gemcitabine results in decreased expression of BCL2 protein CTD PMID:15476743 Genipin decreases expression ISO RGD:733100 6480464 genipin results in decreased expression of BCL2 mRNA CTD PMID:22245672 Geniposide decreases expression ISO RGD:733100 6480464 geniposide metabolite results in decreased expression of BCL2 mRNA, geniposide metabolite results in decreased expression of BCL2 protein CTD PMID:22245672 genistein multiple interactions ISO RGD:733100 6480464 [Calcitriol co-treated with Genistein] results in decreased expression of BCL2 mRNA more ... CTD PMID:15288519 more ... genistein increases expression EXP 6480464 Genistein results in increased expression of BCL2 mRNA CTD PMID:30056207 genistein multiple interactions ISO RGD:2199 6480464 Genistein inhibits the reaction [Ethanol results in increased expression of BCL2 mRNA], Genistein inhibits the reaction [lead acetate results in decreased expression of BCL2 protein] CTD PMID:23274713 , PMID:26797587 genistein decreases expression ISO RGD:2199 6480464 Genistein results in decreased expression of BCL2 mRNA CTD PMID:21782745 genistein decreases expression ISO RGD:733100 6480464 Genistein results in decreased expression of BCL2 protein CTD PMID:12791511 more ... genistein decreases expression EXP 6480464 Genistein results in decreased expression of BCL2 protein CTD PMID:21078540 genistein multiple interactions EXP 6480464 [Genistein co-treated with Arsenic Trioxide] results in decreased expression of BCL2 protein, Genistein inhibits the reaction [Doxorubicin results in decreased expression of BCL2 protein] CTD PMID:21078540 , PMID:30734460 gentamycin decreases response to substance EXP 6480464 BCL2 protein results in decreased susceptibility to Gentamicins CTD PMID:19151550 gentamycin decreases expression EXP 6480464 Gentamicins results in decreased expression of BCL2 mRNA, Gentamicins results in decreased expression of BCL2 protein CTD PMID:29751043 gentamycin affects expression ISO RGD:2199 6480464 Gentamicins affects the expression of BCL2 mRNA CTD PMID:26779593 gentamycin multiple interactions EXP 6480464 tauroursodeoxycholic acid inhibits the reaction [Gentamicins results in decreased expression of BCL2 mRNA], tauroursodeoxycholic acid inhibits the reaction [Gentamicins results in decreased expression of BCL2 protein] CTD PMID:29751043 gentamycin decreases expression ISO RGD:2199 6480464 Gentamicins results in decreased expression of BCL2 protein CTD PMID:19698708 gentamycin multiple interactions ISO RGD:2199 6480464 Amlodipine inhibits the reaction [Gentamicins results in decreased expression of BCL2 protein] more ... CTD PMID:19698708 , PMID:26779593 Gentiopicrin multiple interactions EXP 6480464 gentiopicroside inhibits the reaction [[Galactosamine co-treated with Lipopolysaccharides] results in decreased expression of BCL2 protein] CTD PMID:20558151 geraniol multiple interactions EXP 6480464 geraniol inhibits the reaction [[Probenecid co-treated with 1-Methyl-4-phenyl-1 more ... CTD PMID:22760862 more ... geraniol increases expression ISO RGD:2199 6480464 geraniol results in increased expression of BCL2 protein CTD PMID:21445532 geraniol decreases expression ISO RGD:733100 6480464 geraniol results in decreased expression of BCL2 mRNA, geraniol results in decreased expression of BCL2 protein CTD PMID:21371438 more ... geranyl acetate decreases expression ISO RGD:733100 6480464 geranyl acetate results in decreased expression of BCL2 protein CTD PMID:29745075 Germacrone multiple interactions ISO RGD:733100 6480464 [germacrone results in increased susceptibility to Doxorubicin] which results in decreased expression of BCL2 CTD PMID:29655913 gingerol multiple interactions ISO RGD:733100 6480464 [gingerol co-treated with Hydrogen Peroxide] results in increased expression of BCL2 protein more ... CTD PMID:18030663 more ... gingerol decreases expression ISO RGD:733100 6480464 gingerol results in decreased expression of BCL2 mRNA, gingerol results in decreased expression of BCL2 protein CTD PMID:18030663 more ... gingerol multiple interactions EXP 6480464 gingerol inhibits the reaction [Testosterone results in increased expression of BCL2 protein] CTD PMID:18030663 ginkgetin multiple interactions EXP 6480464 ginkgetin inhibits the reaction [1-Methyl-4-phenyl-1 more ... CTD PMID:25968939 ginkgetin multiple interactions ISO RGD:733100 6480464 ginkgetin inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of BCL2 protein] CTD PMID:25968939 ginsenoside Rd multiple interactions ISO RGD:2199 6480464 ginsenoside Rd inhibits the reaction [APP protein modified form results in decreased expression of BCL2 mRNA] CTD PMID:26111763 ginsenoside Re increases expression EXP 6480464 ginsenoside Re results in increased expression of BCL2 mRNA, ginsenoside Re results in increased expression of BCL2 protein CTD PMID:15621629 ginsenoside Re multiple interactions EXP 6480464 3-((3 more ... CTD PMID:29467000 ginsenoside Rg1 decreases expression EXP 6480464 ginsenoside Rg1 results in decreased expression of BCL2 protein CTD PMID:28371286 ginsenoside Rg1 multiple interactions ISO RGD:2199 6480464 ginsenoside Rg1 inhibits the reaction [Oxygen deficiency results in decreased expression of BCL2 protein] CTD PMID:26593335 ginsenoside Rg2 multiple interactions ISO RGD:2199 6480464 ginsenoside Rg2 inhibits the reaction [APP protein modified form results in decreased expression of BCL2 protein] CTD PMID:28756148 gliclazide multiple interactions ISO RGD:733100 6480464 Gliclazide inhibits the reaction [Glucose results in decreased expression of BCL2 protein] CTD PMID:18088078 glucaric acid multiple interactions EXP 6480464 [Butyric Acid co-treated with Niacinamide co-treated with Glucaric Acid] inhibits the reaction [9 more ... CTD PMID:25478867 glucose multiple interactions ISO RGD:2199 6480464 15-Hydroxy-11 alpha more ... CTD PMID:21803128 more ... glucose multiple interactions EXP 6480464 [Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of BCL2 mRNA more ... CTD PMID:23108914 more ... glucose decreases expression ISO RGD:2199 6480464 Glucose results in decreased expression of BCL2 mRNA, Glucose results in decreased expression of BCL2 protein CTD PMID:21818840 more ... glucose affects expression ISO RGD:2199 6480464 Glucose affects the expression of BCL2 mRNA, Glucose affects the expression of BCL2 protein CTD PMID:22524206 , PMID:24349266 glucose decreases expression ISO RGD:733100 6480464 Glucose results in decreased expression of BCL2 mRNA, Glucose results in decreased expression of BCL2 protein CTD PMID:18088078 more ... glucose multiple interactions ISO RGD:733100 6480464 [Resveratrol co-treated with Glucose] results in increased expression of BCL2 protein more ... CTD PMID:18088078 more ... glutathione multiple interactions ISO RGD:733100 6480464 Glutathione inhibits the reaction [3-oxo-29-noroleana-1 more ... CTD PMID:17640567 , PMID:24036456 glutathione multiple interactions EXP 6480464 [diethyl maleate results in decreased abundance of Glutathione] which results in increased expression of BCL2 mRNA, Glutathione inhibits the reaction [Acrolein results in decreased expression of BCL2 protein] CTD PMID:22564015 , PMID:24376112 glutathione decreases export EXP 6480464 BCL2 protein results in decreased export of Glutathione CTD PMID:15561710 glyburide multiple interactions ISO RGD:2199 6480464 Glyburide inhibits the reaction [sodium bisulfide results in increased expression of BCL2 protein] CTD PMID:21800153 glycidol decreases expression ISO RGD:2199 6480464 glycidol results in decreased expression of BCL2 mRNA CTD PMID:24915197 glycine betaine affects binding ISO RGD:733100 6480464 Betaine analog binds to BCL2 protein CTD PMID:25765238 glycine betaine increases expression ISO RGD:2199 6480464 Betaine results in increased expression of BCL2 protein CTD PMID:25080425 glycyrrhetinate multiple interactions ISO RGD:2199 6480464 18alpha-glycyrrhetinic acid inhibits the reaction [Methotrexate results in decreased expression of BCL2 protein] CTD PMID:28414158 glycyrrhetinate multiple interactions ISO RGD:733100 6480464 18alpha-glycyrrhetinic acid inhibits the reaction [[PDGFB protein co-treated with PDGFB protein] results in increased expression of BCL2 protein] CTD PMID:31325423 glycyrrhetinic acid multiple interactions ISO RGD:2199 6480464 18alpha-glycyrrhetinic acid inhibits the reaction [Methotrexate results in decreased expression of BCL2 protein] CTD PMID:28414158 glycyrrhetinic acid multiple interactions ISO RGD:733100 6480464 18alpha-glycyrrhetinic acid inhibits the reaction [[PDGFB protein co-treated with PDGFB protein] results in increased expression of BCL2 protein] CTD PMID:31325423 glyphosate increases expression ISO RGD:733100 6480464 glyphosate results in increased expression of BCL2 protein CTD PMID:24073338 glyphosate increases expression EXP 6480464 glyphosate results in increased expression of BCL2 mRNA CTD PMID:30785197 glyphosate decreases expression EXP 6480464 glyphosate results in decreased expression of BCL2 protein CTD PMID:29908847 glyphosate multiple interactions ISO RGD:2199 6480464 [Surface-Active Agents co-treated with glyphosate] results in decreased expression of BCL2 protein CTD PMID:23099315 gold atom multiple interactions ISO RGD:733100 6480464 [Gold analog co-treated with Platinum] results in decreased expression of BCL2 mRNA, [Quercetin analog co-treated with Gold analog] results in decreased expression of BCL2 protein CTD PMID:25846798 , PMID:27470402 gold atom multiple interactions ISO RGD:2199 6480464 [Gold binds to NKCT1 protein, Naja kaouthia] which results in decreased expression of BCL2 protein CTD PMID:27836789 gold(0) multiple interactions ISO RGD:733100 6480464 [Gold analog co-treated with Platinum] results in decreased expression of BCL2 mRNA, [Quercetin analog co-treated with Gold analog] results in decreased expression of BCL2 protein CTD PMID:25846798 , PMID:27470402 gold(0) multiple interactions ISO RGD:2199 6480464 [Gold binds to NKCT1 protein, Naja kaouthia] which results in decreased expression of BCL2 protein CTD PMID:27836789 Goserelin increases expression ISO RGD:733100 6480464 Goserelin results in increased expression of BCL2 protein CTD PMID:16973256 graphene oxide decreases expression ISO RGD:733100 6480464 graphene oxide results in decreased expression of BCL2 protein CTD PMID:30239936 graphite multiple interactions ISO RGD:733100 6480464 [Graphite analog co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of BCL2 protein CTD PMID:25446327 GSK690693 multiple interactions ISO RGD:733100 6480464 GSK690693 promotes the reaction [1, 4-naphthoquinone analog results in decreased expression of BCL2 protein] CTD PMID:30871965 guanidines affects response to substance ISO RGD:733100 6480464 BCL2 protein affects the susceptibility to Guanidines analog CTD PMID:23147571 guggulsterone multiple interactions ISO RGD:733100 6480464 pregna-4 more ... CTD PMID:15322087 Gyrophoric acid decreases expression ISO RGD:733100 6480464 gyrophoric acid results in decreased expression of BCL2 protein CTD PMID:22285236 haloperidol increases expression ISO RGD:2199 6480464 Haloperidol results in increased expression of BCL2 protein CTD PMID:17069804 hemin decreases expression ISO RGD:733100 6480464 Hemin results in decreased expression of BCL2 protein CTD PMID:27815112 heparin increases expression ISO RGD:733100 6480464 Heparin results in increased expression of BCL2 protein CTD PMID:11787776 more ... heparin multiple interactions ISO RGD:733100 6480464 Heparin inhibits the reaction [arsenite results in decreased expression of BCL2 protein] CTD PMID:26677073 heptachlor increases expression ISO RGD:2199 6480464 Heptachlor results in increased expression of BCL2 protein CTD PMID:14678745 hesperetin affects expression ISO RGD:733100 6480464 hesperetin affects the expression of BCL2 protein CTD PMID:15975156 hesperetin multiple interactions EXP 6480464 hesperetin promotes the reaction [Cisplatin results in increased expression of BCL2 protein] CTD PMID:31153982 hesperetin multiple interactions ISO RGD:733100 6480464 hesperetin promotes the reaction [Cisplatin results in increased expression of BCL2 protein] CTD PMID:31153982 hesperetin decreases expression ISO RGD:733100 6480464 hesperetin analog results in decreased expression of BCL2 protein, hesperetin results in decreased expression of BCL2 protein CTD PMID:22142698 hesperetin decreases expression ISO RGD:2199 6480464 hesperetin analog results in decreased expression of BCL2 mRNA CTD PMID:20564462 hesperidin multiple interactions ISO RGD:2199 6480464 Hesperidin inhibits the reaction [2-chloro-5-nitrobenzanilide promotes the reaction [[Streptozocin co-treated with Isoproterenol] affects the expression of BCL2 protein]] more ... CTD PMID:22093918 more ... hesperidin multiple interactions EXP 6480464 Doxorubicin promotes the reaction [Hesperidin results in decreased expression of BCL2 mRNA] CTD PMID:29481770 hesperidin decreases expression EXP 6480464 Hesperidin results in decreased expression of BCL2 mRNA CTD PMID:29481770 hexachlorophene decreases expression ISO RGD:2199 6480464 Hexachlorophene results in decreased expression of BCL2 mRNA CTD PMID:25497112 hexadecanoic acid decreases expression ISO RGD:733100 6480464 Palmitic Acid results in decreased expression of BCL2 CTD PMID:15945276 hexadecanoic acid decreases expression ISO RGD:2199 6480464 Palmitic Acid results in decreased expression of BCL2 CTD PMID:15945276 hexane increases expression ISO RGD:2199 6480464 n-hexane metabolite results in increased expression of BCL2 protein CTD PMID:17492505 homocysteine multiple interactions ISO RGD:733100 6480464 Zeranol inhibits the reaction [Homocysteine results in decreased expression of BCL2 protein] CTD PMID:16757814 homocysteine decreases expression ISO RGD:733100 6480464 Homocysteine results in decreased expression of BCL2 protein CTD PMID:16757814 hydrogen peroxide decreases expression ISO RGD:2199 6480464 Hydrogen Peroxide results in decreased expression of BCL2 mRNA, Hydrogen Peroxide results in decreased expression of BCL2 protein CTD PMID:14505808 more ... hydrogen peroxide affects expression EXP 6480464 Hydrogen Peroxide affects the expression of BCL2 mRNA CTD PMID:27057282 hydrogen peroxide multiple interactions EXP 6480464 Grape Seed Proanthocyanidins inhibits the reaction [Hydrogen Peroxide results in decreased expression of BCL2 protein], procyanidin B2 affects the reaction [Hydrogen Peroxide affects the expression of BCL2 mRNA] CTD PMID:25242411 , PMID:27057282 hydrogen peroxide decreases expression EXP 6480464 Hydrogen Peroxide results in decreased expression of BCL2 protein CTD PMID:25242411 hydrogen peroxide increases phosphorylation ISO RGD:733100 6480464 Hydrogen Peroxide results in increased phosphorylation of BCL2 protein CTD PMID:15142122 hydrogen peroxide decreases expression ISO RGD:733100 6480464 Hydrogen Peroxide results in decreased expression of BCL2 mRNA, Hydrogen Peroxide results in decreased expression of BCL2 protein CTD PMID:12672908 more ... hydrogen peroxide affects expression ISO RGD:2199 6480464 Hydrogen Peroxide affects the expression of BCL2 mRNA, Hydrogen Peroxide affects the expression of BCL2 protein CTD PMID:17204550 , PMID:17570061 hydrogen peroxide increases expression ISO RGD:2199 6480464 Hydrogen Peroxide results in increased expression of BCL2 protein CTD PMID:16157298 hydrogen peroxide affects response to substance EXP 6480464 BCL2 protein affects the susceptibility to Hydrogen Peroxide CTD PMID:15746559 hydrogen peroxide increases expression ISO RGD:733100 6480464 Hydrogen Peroxide results in increased expression of BCL2 protein CTD PMID:8781438 hydrogen peroxide multiple interactions ISO RGD:733100 6480464 2''-galloylhyperin inhibits the reaction [Hydrogen Peroxide results in decreased expression of BCL2 protein] more ... CTD PMID:12672908 more ... hydrogen peroxide decreases response to substance ISO RGD:733100 6480464 BCL2 protein results in decreased susceptibility to Hydrogen Peroxide CTD PMID:9989825 hydrogen peroxide multiple interactions ISO RGD:2199 6480464 2-(4-((dimethylamino)methyl)benzylidene)-5 more ... CTD PMID:14505808 more ... hydroquinone multiple interactions ISO RGD:733100 6480464 [PARP1 protein affects the susceptibility to hydroquinone] which affects the expression of BCL2 protein CTD PMID:28444915 hydroxamic acid decreases expression ISO RGD:733100 6480464 Hydroxamic Acids analog results in decreased expression of BCL2 protein, Hydroxamic Acids results in decreased expression of BCL2 protein CTD PMID:25824412 , PMID:26088127 hydroxytyrosol increases phosphorylation ISO RGD:733100 6480464 3, 4-dihydroxyphenylethanol results in increased phosphorylation of BCL2 protein CTD PMID:12482581 hyperforin increases expression ISO RGD:2199 6480464 hyperforin results in increased expression of BCL2 mRNA CTD PMID:30481499 hyperforin multiple interactions ISO RGD:733100 6480464 hyperforin inhibits the reaction [aluminum maltolate results in decreased expression of BCL2 mRNA] CTD PMID:30481499 hyperforin increases expression ISO RGD:733100 6480464 hyperforin results in increased expression of BCL2 mRNA CTD PMID:30481499 hyperforin multiple interactions ISO RGD:2199 6480464 hyperforin inhibits the reaction [aluminum maltolate results in decreased expression of BCL2 mRNA] CTD PMID:30481499 hypoxanthine multiple interactions ISO RGD:733100 6480464 [3-hydrogenkwadaphnin co-treated with Hypoxanthine] results in decreased expression of BCL2 protein more ... CTD PMID:21396949 icariin affects expression ISO RGD:2199 6480464 icariin affects the expression of BCL2 protein CTD PMID:25472572 icariin multiple interactions ISO RGD:733100 6480464 icariin inhibits the reaction [[Oxygen co-treated with Oxygen deficiency] results in decreased expression of BCL2 protein] CTD PMID:25472572 icariside II decreases expression ISO RGD:733100 6480464 baohuoside I results in decreased expression of BCL2 protein CTD PMID:22687635 ICI 118551 multiple interactions ISO RGD:733100 6480464 [ICI 118551 co-treated with gemcitabine] results in decreased expression of BCL2 protein CTD PMID:21570961 icosanoid multiple interactions ISO RGD:2199 6480464 Eicosanoids analog inhibits the reaction [Cisplatin results in decreased expression of BCL2 mRNA] CTD PMID:23603837 idelalisib multiple interactions ISO RGD:733100 6480464 2-amino-6-chloro-alpha-cyano-3-(ethoxycarbonyl)-4H-1-benzopyran-4-acetic acid ethyl ester inhibits the reaction [[FASLG protein co-treated with idelalisib] results in decreased expression of BCL2 protein], [FASLG protein co-treated with idelalisib] results in decreased expression of BCL2 protein CTD PMID:31445927 ifosfamide multiple interactions ISO RGD:733100 6480464 BCL2 protein inhibits the reaction [Ifosfamide results in increased activity of CASP9 protein] CTD PMID:11723234 ifosfamide decreases expression ISO RGD:2199 6480464 Ifosfamide results in decreased expression of BCL2 mRNA CTD PMID:23213347 ifosfamide multiple interactions ISO RGD:2199 6480464 Carnitine inhibits the reaction [Ifosfamide results in decreased expression of BCL2 mRNA] CTD PMID:23213347 Ilimaquinone decreases expression ISO RGD:733100 6480464 ilimaquinone results in decreased expression of BCL2 protein CTD PMID:24930757 Imipenem-cilastatin increases expression ISO RGD:2199 6480464 Cilastatin, Imipenem Drug Combination results in increased expression of BCL2 protein CTD PMID:30721722 imiquimod decreases expression ISO RGD:733100 6480464 imiquimod results in decreased expression of BCL2 protein CTD PMID:20033192 indole-3-methanol decreases expression ISO RGD:733100 6480464 indole-3-carbinol results in decreased expression of BCL2 CTD PMID:16082211 indole-3-methanol decreases expression EXP 6480464 indole-3-carbinol results in decreased expression of BCL2 protein CTD PMID:29775573 indole-3-methanol multiple interactions ISO RGD:733100 6480464 indole-3-carbinol inhibits the reaction [TNF protein results in increased expression of BCL2 protein] CTD PMID:15811958 indometacin decreases expression ISO RGD:733100 6480464 Indomethacin results in decreased expression of BCL2 mRNA, Indomethacin results in decreased expression of BCL2 protein CTD PMID:10785260 more ... indometacin multiple interactions ISO RGD:733100 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of BCL2 mRNA CTD PMID:28628672 indometacin decreases expression ISO RGD:2199 6480464 Indomethacin results in decreased expression of BCL2 mRNA, Indomethacin results in decreased expression of BCL2 protein CTD PMID:18375387 more ... indometacin multiple interactions ISO RGD:2199 6480464 Indomethacin inhibits the reaction [Hydrogen Peroxide affects the expression of BCL2 mRNA] more ... CTD PMID:17570061 more ... Ioversol decreases expression ISO RGD:2199 6480464 ioversol results in decreased expression of BCL2 mRNA CTD PMID:16828304 Ioversol multiple interactions ISO RGD:2199 6480464 Irbesartan inhibits the reaction [ioversol results in decreased expression of BCL2 mRNA] CTD PMID:16828304 irbesartan multiple interactions ISO RGD:2199 6480464 irbesartan inhibits the reaction [ioversol results in decreased expression of BCL2 mRNA] CTD PMID:16828304 irinotecan affects response to substance ISO RGD:733100 6480464 BCL2 protein affects the susceptibility to Irinotecan CTD PMID:18949393 irinotecan multiple interactions ISO RGD:733100 6480464 [Fluorouracil co-treated with Irinotecan co-treated with Vorinostat] results in decreased expression of BCL2 protein more ... CTD PMID:15754201 , PMID:16391804 iron atom multiple interactions ISO RGD:733100 6480464 [Arachidonic Acid co-treated with Iron] results in decreased expression of BCL2 protein, resveratrol inhibits the reaction [[Arachidonic Acid co-treated with Iron] results in decreased expression of BCL2 protein] CTD PMID:19620254 iron(0) multiple interactions ISO RGD:733100 6480464 [Arachidonic Acid co-treated with Iron] results in decreased expression of BCL2 protein, resveratrol inhibits the reaction [[Arachidonic Acid co-treated with Iron] results in decreased expression of BCL2 protein] CTD PMID:19620254 iron(2+) sulfate (anhydrous) decreases expression ISO RGD:2199 6480464 ferrous sulfate results in decreased expression of BCL2 protein CTD PMID:28583816 iron(2+) sulfate (anhydrous) multiple interactions ISO RGD:2199 6480464 2-tert-butylhydroquinone inhibits the reaction [ferrous sulfate results in decreased expression of BCL2 protein] CTD PMID:28583816 isocarbophos decreases expression ISO RGD:733100 6480464 isocarbophos analog results in decreased expression of BCL2 protein CTD PMID:20688129 isoflavones decreases expression ISO RGD:2199 6480464 Isoflavones results in decreased expression of BCL2 protein CTD PMID:25035168 isoflavones increases expression ISO RGD:2199 6480464 Isoflavones results in increased expression of BCL2 mRNA CTD PMID:25035168 isoflavones multiple interactions ISO RGD:2199 6480464 [Folic Acid co-treated with Isoflavones] results in increased expression of BCL2 protein CTD PMID:20060418 isoflavones multiple interactions ISO RGD:733100 6480464 [Curcumin co-treated with Isoflavones] results in decreased expression of BCL2 protein CTD PMID:18640131 isoflurane multiple interactions ISO RGD:2199 6480464 Dexmedetomidine inhibits the reaction [Isoflurane results in decreased expression of BCL2 protein] more ... CTD PMID:16249675 , PMID:20003127 isoflurane affects expression ISO RGD:2199 6480464 Isoflurane affects the expression of BCL2 protein CTD PMID:29289695 isoflurane decreases expression ISO RGD:2199 6480464 Isoflurane results in decreased expression of BCL2 protein CTD PMID:20003127 isoliquiritigenin decreases phosphorylation ISO RGD:733100 6480464 isoliquiritigenin results in decreased phosphorylation of BCL2 protein CTD PMID:23747687 isoniazide multiple interactions EXP 6480464 [Isoniazid co-treated with Rifampin] results in decreased expression of BCL2 protein, Ursodeoxycholic Acid inhibits the reaction [[Isoniazid co-treated with Rifampin] results in decreased expression of BCL2 protein] CTD PMID:21419764 isoorientin multiple interactions ISO RGD:2199 6480464 homoorientin inhibits the reaction [Ethanol results in increased expression of BCL2 mRNA] CTD PMID:22446813 isoprenaline multiple interactions ISO RGD:2199 6480464 2-chloro-5-nitrobenzanilide promotes the reaction [[Streptozocin co-treated with Isoproterenol] affects the expression of BCL2 protein] more ... CTD PMID:19573579 more ... isoprenaline increases expression ISO RGD:2199 6480464 Isoproterenol results in increased expression of BCL2 mRNA CTD PMID:11218852 isoprenaline decreases expression ISO RGD:2199 6480464 Isoproterenol results in decreased expression of BCL2 protein CTD PMID:12791704 more ... isoprenaline decreases expression EXP 6480464 Isoproterenol results in decreased expression of BCL2 protein CTD PMID:15052282 isoquinoline-1,5-diol multiple interactions ISO RGD:733100 6480464 [1, 5-dihydroxyisoquinoline co-treated with Tretinoin] results in decreased expression of BCL2 protein CTD PMID:10713328 isorhamnetin decreases expression ISO RGD:733100 6480464 3-methylquercetin results in decreased expression of BCL2 mRNA, 3-methylquercetin results in decreased expression of BCL2 protein CTD PMID:22992727 isotretinoin decreases expression ISO RGD:733100 6480464 Isotretinoin results in decreased expression of BCL2, Isotretinoin results in decreased expression of BCL2 protein CTD PMID:16109544 , PMID:16909596 isotretinoin decreases expression EXP 6480464 Isotretinoin results in decreased expression of BCL2, Isotretinoin results in decreased expression of BCL2 mRNA CTD PMID:18380168 , PMID:18652567 isotretinoin increases expression ISO RGD:733100 6480464 Isotretinoin results in increased expression of BCL2 mRNA, Isotretinoin results in increased expression of BCL2 protein CTD PMID:21159604 kaempferol decreases expression ISO RGD:733100 6480464 kaempferol results in decreased expression of BCL2 protein CTD PMID:19028473 kahweol multiple interactions ISO RGD:733100 6480464 kahweol inhibits the reaction [Hydrogen Peroxide results in decreased expression of BCL2 protein] CTD PMID:31306736 kainic acid multiple interactions EXP 6480464 4-benzyl-2-methyl-1 more ... CTD PMID:25453207 kainic acid multiple interactions ISO RGD:2199 6480464 oridonin inhibits the reaction [Kainic Acid results in decreased expression of BCL2 mRNA] CTD PMID:31430510 kainic acid decreases expression ISO RGD:2199 6480464 Kainic Acid results in decreased expression of BCL2 mRNA CTD PMID:31430510 kainic acid decreases expression EXP 6480464 Kainic Acid results in decreased expression of BCL2 protein CTD PMID:25453207 ketoconazole multiple interactions ISO RGD:733100 6480464 Ketoconazole inhibits the reaction [Calcifediol results in increased expression of BCL2 mRNA] CTD PMID:21542014 L-1,4-dithiothreitol multiple interactions ISO RGD:733100 6480464 Dithiothreitol inhibits the reaction [arsenic trioxide results in increased expression of BCL2 protein] CTD PMID:18022205 L-ascorbic acid decreases expression ISO RGD:733100 6480464 Ascorbic Acid results in decreased expression of BCL2 mRNA CTD PMID:21919647 L-ascorbic acid multiple interactions ISO RGD:733100 6480464 [arsenic trioxide co-treated with Ascorbic Acid co-treated with Disulfiram] results in decreased expression of BCL2 protein more ... CTD PMID:17166419 more ... L-ascorbic acid multiple interactions ISO RGD:2199 6480464 Ascorbic Acid inhibits the reaction [Humic Substances results in decreased expression of BCL2 protein] more ... CTD PMID:17959157 more ... L-ascorbic acid increases abundance ISO RGD:733100 6480464 BCL2 protein results in increased abundance of Ascorbic Acid CTD PMID:15449323 L-dehydroascorbic acid multiple interactions ISO RGD:733100 6480464 [Dehydroascorbic Acid co-treated with Lipopolysaccharides] results in increased expression of BCL2 protein CTD PMID:20166893 L-dehydroascorbic acid increases expression ISO RGD:733100 6480464 Dehydroascorbic Acid results in increased expression of BCL2 protein CTD PMID:20166893 L-methionine multiple interactions ISO RGD:2199 6480464 Melatonin inhibits the reaction [Methionine results in decreased expression of BCL2 protein] CTD PMID:16213988 L-methionine multiple interactions EXP 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of and results in increased expression of BCL2 more ... CTD PMID:20938992 L-methionine decreases expression ISO RGD:2199 6480464 Methionine results in decreased expression of BCL2 protein CTD PMID:16213988 L-mimosine affects expression ISO RGD:733100 6480464 Mimosine affects the expression of BCL2 protein CTD PMID:18058236 lactacystin decreases expression ISO RGD:2199 6480464 lactacystin results in decreased expression of BCL2 protein CTD PMID:18640276 lactacystin multiple interactions ISO RGD:733100 6480464 lactacystin inhibits the reaction [sodium bichromate results in decreased expression of BCL2 protein] CTD PMID:18544562 lactacystin multiple interactions ISO RGD:2199 6480464 lactacystin inhibits the reaction [[pirinixic acid results in increased expression of UCP2 protein] which results in increased degradation of BCL2 protein], Sirolimus inhibits the reaction [lactacystin results in decreased expression of BCL2 protein] CTD PMID:18640276 , PMID:19361538 lamivudine multiple interactions EXP 6480464 [Zidovudine co-treated with Lamivudine] results in decreased expression of BCL2 mRNA CTD PMID:18313992 lamotrigine increases expression ISO RGD:2199 6480464 lamotrigine results in increased expression of BCL2 mRNA, lamotrigine results in increased expression of BCL2 protein CTD PMID:18719996 lansoprazole multiple interactions ISO RGD:2199 6480464 Lansoprazole inhibits the reaction [Diatrizoate Meglumine results in decreased expression of BCL2 mRNA], Lansoprazole inhibits the reaction [Indomethacin results in decreased expression of BCL2 protein] CTD PMID:18375387 , PMID:28412091 lapatinib decreases expression ISO RGD:733100 6480464 Lapatinib results in decreased expression of BCL2 protein CTD PMID:29387217 lead diacetate multiple interactions ISO RGD:2199 6480464 [Cadmium Chloride co-treated with lead acetate] results in decreased expression of BCL2 protein more ... CTD PMID:17959157 more ... lead diacetate affects expression ISO RGD:733100 6480464 lead acetate affects the expression of BCL2 protein CTD PMID:26542248 lead diacetate multiple interactions ISO RGD:733100 6480464 NFE2L2 protein inhibits the reaction [lead acetate results in decreased expression of BCL2 protein] CTD PMID:26498409 lead diacetate decreases expression ISO RGD:733100 6480464 lead acetate results in decreased expression of BCL2 protein CTD PMID:26498409 lead diacetate decreases expression ISO RGD:2199 6480464 lead acetate results in decreased expression of BCL2 mRNA, lead acetate results in decreased expression of BCL2 protein CTD PMID:23146751 , PMID:24960054 lead diacetate increases expression ISO RGD:2199 6480464 lead acetate results in increased expression of BCL2 protein CTD PMID:17959157 more ... lead diacetate increases expression EXP 6480464 lead acetate results in increased expression of BCL2 mRNA CTD PMID:22609695 lead diacetate affects expression ISO RGD:2199 6480464 lead acetate affects the expression of BCL2 mRNA CTD PMID:18618274 lead nitrate decreases expression EXP 6480464 lead nitrate results in decreased expression of BCL2 protein CTD PMID:23451106 lead nitrate multiple interactions ISO RGD:733100 6480464 [lead nitrate results in increased abundance of Lead] which results in decreased expression of BCL2 mRNA CTD PMID:30738203 lead nitrate multiple interactions EXP 6480464 mangiferin inhibits the reaction [lead nitrate results in decreased expression of BCL2 protein] CTD PMID:23451106 lead(0) multiple interactions ISO RGD:2199 6480464 Grape Seed Proanthocyanidins inhibits the reaction [Lead results in decreased expression of BCL2 protein], Plant Extracts inhibits the reaction [Lead results in decreased expression of BCL2 protein] CTD PMID:22129743 , PMID:29630945 lead(0) multiple interactions EXP 6480464 fisetin inhibits the reaction [Lead results in decreased expression of BCL2 protein] CTD PMID:31539617 lead(0) decreases expression EXP 6480464 Lead results in decreased expression of BCL2 protein CTD PMID:31539617 lead(0) multiple interactions ISO RGD:733100 6480464 [lead nitrate results in increased abundance of Lead] which results in decreased expression of BCL2 mRNA CTD PMID:30738203 lead(0) decreases expression ISO RGD:2199 6480464 Lead results in decreased expression of BCL2 mRNA, Lead results in decreased expression of BCL2 protein CTD PMID:22129743 more ... lead(2+) multiple interactions ISO RGD:2199 6480464 Grape Seed Proanthocyanidins inhibits the reaction [Lead results in decreased expression of BCL2 protein], Plant Extracts inhibits the reaction [Lead results in decreased expression of BCL2 protein] CTD PMID:22129743 , PMID:29630945 lead(2+) multiple interactions EXP 6480464 fisetin inhibits the reaction [Lead results in decreased expression of BCL2 protein] CTD PMID:31539617 lead(2+) multiple interactions ISO RGD:733100 6480464 [lead nitrate results in increased abundance of Lead] which results in decreased expression of BCL2 mRNA CTD PMID:30738203 lead(2+) decreases expression EXP 6480464 Lead results in decreased expression of BCL2 protein CTD PMID:31539617 lead(2+) decreases expression ISO RGD:2199 6480464 Lead results in decreased expression of BCL2 mRNA, Lead results in decreased expression of BCL2 protein CTD PMID:22129743 more ... lead(II) chloride decreases expression ISO RGD:733100 6480464 lead chloride results in decreased expression of BCL2 protein CTD PMID:24419708 leptomycin B multiple interactions ISO RGD:733100 6480464 leptomycin B inhibits the reaction [Tretinoin results in decreased expression of BCL2 protein] CTD PMID:14592536 leuprolide increases expression ISO RGD:2199 6480464 Leuprolide results in increased expression of BCL2 mRNA CTD PMID:18829022 levamisole decreases expression ISO RGD:733100 6480464 Levamisole results in decreased expression of BCL2 protein CTD PMID:11139434 levonorgestrel decreases expression ISO RGD:733100 6480464 Levonorgestrel results in decreased expression of BCL2 protein CTD PMID:16019350 lignan decreases expression ISO RGD:733100 6480464 Lignans analog results in decreased expression of BCL2 protein, Lignans results in decreased expression of BCL2 protein CTD PMID:26620693 limonene decreases expression ISO RGD:733100 6480464 limonene results in decreased expression of BCL2 protein CTD PMID:12921557 linalool decreases expression ISO RGD:733100 6480464 linalool results in decreased expression of BCL2 mRNA CTD PMID:28567457 linoleic acid multiple interactions ISO RGD:2199 6480464 [Linoleic Acid co-treated with Glucose] affects the reaction [Azoxymethane affects the expression of BCL2 protein], Linoleic Acid affects the reaction [Azoxymethane affects the expression of BCL2 protein] CTD PMID:22467055 linsidomine decreases expression ISO RGD:733100 6480464 linsidomine results in decreased expression of BCL2, linsidomine results in decreased expression of BCL2 protein CTD PMID:16291239 , PMID:23174672 linsidomine decreases expression EXP 6480464 linsidomine results in decreased expression of BCL2 protein CTD PMID:12880480 linsidomine multiple interactions EXP 6480464 [linsidomine results in increased abundance of Nitric Oxide] which results in increased expression of BCL2 mRNA more ... CTD PMID:12880480 , PMID:7706495 linsidomine multiple interactions ISO RGD:733100 6480464 MT1A inhibits the reaction [linsidomine results in decreased expression of BCL2], Plant Extracts inhibits the reaction [linsidomine results in decreased expression of BCL2 protein] CTD PMID:16291239 , PMID:23174672 lipoic acid multiple interactions ISO RGD:733100 6480464 Thioctic Acid inhibits the reaction [Zinc deficiency results in decreased expression of BCL2 protein] more ... CTD PMID:16990509 more ... lipoic acid multiple interactions EXP 6480464 Thioctic Acid inhibits the reaction [Dietary Fats results in decreased expression of BCL2 mRNA] CTD PMID:27260466 lipoic acid multiple interactions ISO RGD:2199 6480464 Thioctic Acid inhibits the reaction [[Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of BCL2 mRNA], Thioctic Acid inhibits the reaction [cadmium acetate results in decreased expression of BCL2 protein] CTD PMID:23830814 , PMID:30605698 lipoic acid decreases response to substance ISO RGD:733100 6480464 BCL2 protein results in decreased susceptibility to Thioctic Acid CTD PMID:16990509 lipopolysaccharide multiple interactions ISO RGD:733100 6480464 (+)-JQ1 compound inhibits the reaction [Lipopolysaccharides results in increased expression of BCL2 mRNA] more ... CTD PMID:11805214 more ... lipopolysaccharide affects expression EXP 6480464 Lipopolysaccharides affects the expression of BCL2 protein CTD PMID:30261164 lipopolysaccharide increases expression EXP 6480464 Lipopolysaccharides results in increased expression of BCL2 protein CTD PMID:21299906 lipopolysaccharide increases expression ISO RGD:2199 6480464 Lipopolysaccharides results in increased expression of BCL2 protein CTD PMID:12704018 more ... lipopolysaccharide decreases expression ISO RGD:2199 6480464 Lipopolysaccharides results in decreased expression of BCL2 protein CTD PMID:23200736 more ... lipopolysaccharide affects expression ISO RGD:2199 6480464 Lipopolysaccharides affects the expression of BCL2 mRNA CTD PMID:21127968 lipopolysaccharide decreases expression EXP 6480464 Lipopolysaccharides results in decreased expression of BCL2 protein CTD PMID:23170834 more ... lipopolysaccharide multiple interactions EXP 6480464 2-(3-benzoyl)-4-hydroxy-1 more ... CTD PMID:10205001 more ... lipopolysaccharide multiple interactions ISO RGD:2199 6480464 [Diosmin co-treated with Lipopolysaccharides] results in increased expression of BCL2 protein more ... CTD PMID:12704018 more ... lipopolysaccharide increases expression ISO RGD:733100 6480464 Lipopolysaccharides results in increased expression of BCL2 mRNA, Lipopolysaccharides results in increased expression of BCL2 protein CTD PMID:20166893 , PMID:25725100 lipopolysaccharide decreases expression ISO RGD:733100 6480464 Lipopolysaccharides results in decreased expression of BCL2 protein CTD PMID:11805214 more ... lipoxin A4 multiple interactions ISO RGD:733100 6480464 lipoxin A4 inhibits the reaction [Lipopolysaccharides results in decreased expression of BCL2 protein] CTD PMID:23063943 liraglutide multiple interactions ISO RGD:733100 6480464 Liraglutide inhibits the reaction [Hydrogen Peroxide results in decreased expression of BCL2 protein], Wortmannin inhibits the reaction [Liraglutide inhibits the reaction [Hydrogen Peroxide results in decreased expression of BCL2 protein]] CTD PMID:31173752 lisinopril dihydrate decreases expression ISO RGD:733100 6480464 Lisinopril results in decreased expression of BCL2 CTD PMID:10075388 lithium atom multiple interactions ISO RGD:2199 6480464 Lithium inhibits the reaction [APP protein alternative form results in decreased expression of BCL2 protein] more ... CTD PMID:10762662 more ... lithium atom multiple interactions ISO RGD:733100 6480464 Lithium inhibits the reaction [Ethanol results in decreased expression of BCL2 mRNA] CTD PMID:21878650 lithium atom increases expression ISO RGD:2199 6480464 Lithium results in increased expression of BCL2 more ... CTD PMID:10762662 more ... lithium chloride increases expression ISO RGD:733100 6480464 Lithium Chloride results in increased expression of BCL2 mRNA, Lithium Chloride results in increased expression of BCL2 protein CTD PMID:18830594 , PMID:19101580 lithium chloride increases expression ISO RGD:2199 6480464 Lithium Chloride results in increased expression of BCL2 mRNA CTD PMID:17404573 lithium chloride multiple interactions EXP 6480464 Lithium Chloride inhibits the reaction [Etoposide results in decreased expression of BCL2 mRNA] more ... CTD PMID:19408126 , PMID:30171970 lithium hydride multiple interactions ISO RGD:2199 6480464 Lithium inhibits the reaction [APP protein alternative form results in decreased expression of BCL2 protein] more ... CTD PMID:10762662 more ... lithium hydride multiple interactions ISO RGD:733100 6480464 Lithium inhibits the reaction [Ethanol results in decreased expression of BCL2 mRNA] CTD PMID:21878650 lithium hydride increases expression ISO RGD:2199 6480464 Lithium results in increased expression of BCL2 more ... CTD PMID:10762662 more ... lonafarnib multiple interactions ISO RGD:733100 6480464 lonafarnib inhibits the reaction [TNF protein results in increased expression of BCL2 protein], lonafarnib promotes the reaction [Bortezomib results in increased cleavage of BCL2 protein modified form] CTD PMID:15090542 , PMID:16118318 Longikaurin A decreases expression ISO RGD:733100 6480464 longikaurin A results in decreased expression of BCL2 protein CTD PMID:28801140 lonidamine multiple interactions ISO RGD:733100 6480464 BCL2 protein inhibits the reaction [[arsenic trioxide co-treated with lonidamine] results in increased cleavage of and results in increased activity of CASP8 protein] more ... CTD PMID:21889928 losartan multiple interactions ISO RGD:2199 6480464 Losartan promotes the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of BCL2 mRNA] CTD PMID:15502641 losartan affects expression ISO RGD:2199 6480464 Losartan affects the expression of BCL2 protein CTD PMID:22000973 losartan increases expression ISO RGD:2199 6480464 Losartan results in increased expression of BCL2 protein CTD PMID:19298698 , PMID:21153712 losartan decreases expression ISO RGD:2199 6480464 Losartan results in decreased expression of BCL2 protein CTD PMID:12623880 lovastatin decreases expression ISO RGD:2199 6480464 Lovastatin results in decreased expression of BCL2 protein CTD PMID:11178870 lovastatin multiple interactions ISO RGD:2199 6480464 Mevalonic Acid inhibits the reaction [Lovastatin results in decreased expression of BCL2 protein] CTD PMID:11178870 lovastatin multiple interactions ISO RGD:733100 6480464 Mevalonic Acid inhibits the reaction [Lovastatin results in decreased expression of BCL2 protein] CTD PMID:12094262 lovastatin decreases expression ISO RGD:733100 6480464 Lovastatin results in decreased expression of BCL2 protein CTD PMID:10473109 , PMID:12094262 LSM-2726 decreases expression ISO RGD:2199 6480464 Dextromethorphan results in decreased expression of BCL2 protein CTD PMID:28916251 LSM-2726 multiple interactions ISO RGD:2199 6480464 traxoprodil mesylate inhibits the reaction [Dextromethorphan results in decreased expression of BCL2 protein] CTD PMID:28916251 lupeol multiple interactions ISO RGD:733100 6480464 lupeol inhibits the reaction [mancozeb results in decreased expression of BCL2 mRNA] CTD PMID:27235710 lupeol decreases expression ISO RGD:733100 6480464 lupeol results in decreased expression of BCL2 mRNA, lupeol results in decreased expression of BCL2 protein CTD PMID:30506710 , PMID:31112703 lutein decreases expression ISO RGD:733100 6480464 Lutein results in decreased expression of BCL2 protein CTD PMID:17455471 luteolin multiple interactions ISO RGD:733100 6480464 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Luteolin results in decreased expression of BCL2 protein] more ... CTD PMID:19557821 more ... luteolin decreases expression ISO RGD:733100 6480464 Luteolin results in decreased expression of BCL2 protein CTD PMID:27474067 LY 364947 multiple interactions ISO RGD:2199 6480464 Ly-364947 inhibits the reaction [arsenic trioxide results in decreased expression of BCL2 protein] CTD PMID:23542815 LY294002 multiple interactions ISO RGD:2199 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [5-aminoisoquinolinone inhibits the reaction [Hydrogen Peroxide results in decreased expression of BCL2 protein]] more ... CTD PMID:21800153 more ... LY294002 multiple interactions EXP 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [rottlerin inhibits the reaction [trimethyltin results in decreased expression of BCL2 protein]] CTD PMID:25895139 LY294002 decreases expression ISO RGD:733100 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in decreased expression of BCL2 protein CTD PMID:20386985 , PMID:21130731 LY294002 increases expression ISO RGD:733100 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in increased expression of BCL2 mRNA CTD PMID:22046442 LY294002 increases phosphorylation ISO RGD:2199 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in increased phosphorylation of BCL2 protein CTD PMID:16018989 LY294002 multiple interactions ISO RGD:733100 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one affects the reaction [Emodin affects the expression of BCL2 protein] more ... CTD PMID:20856197 more ... lycopene multiple interactions ISO RGD:2199 6480464 [S-allylcysteine co-treated with Lycopene] inhibits the reaction [[Methylnitronitrosoguanidine co-treated with Sodium Chloride] results in increased expression of BCL2 protein] more ... CTD PMID:16030430 more ... lycopene multiple interactions EXP 6480464 lycopene inhibits the reaction [Sodium Fluoride results in decreased expression of BCL2 mRNA] CTD PMID:27871895 magnesium oxide multiple interactions ISO RGD:733100 6480464 [Selenium analog co-treated with Magnesium Oxide analog] inhibits the reaction [Diazinon results in decreased expression of BCL2 mRNA], Magnesium Oxide analog inhibits the reaction [Diazinon results in decreased expression of BCL2 mRNA] CTD PMID:27920530 Magnolol multiple interactions EXP 6480464 magnolol inhibits the reaction [trimethyltin results in decreased expression of BCL2 protein] CTD PMID:26756313 malathion decreases expression ISO RGD:2199 6480464 Malathion results in decreased expression of BCL2 mRNA CTD PMID:23774768 malathion multiple interactions ISO RGD:733100 6480464 Acetylcysteine inhibits the reaction [Malathion results in decreased expression of BCL2 protein] CTD PMID:30769050 malathion decreases expression ISO RGD:733100 6480464 Malathion results in decreased expression of BCL2 protein CTD PMID:30769050 malonic acid decreases expression ISO RGD:2199 6480464 malonic acid results in decreased expression of BCL2 mRNA CTD PMID:16242643 malvidin decreases expression ISO RGD:733100 6480464 malvidin results in decreased expression of BCL2 protein CTD PMID:15964118 mancozeb decreases expression ISO RGD:733100 6480464 mancozeb results in decreased expression of BCL2 mRNA, mancozeb results in decreased expression of BCL2 protein CTD PMID:22289270 , PMID:27235710 mancozeb multiple interactions ISO RGD:733100 6480464 lupeol inhibits the reaction [mancozeb results in decreased expression of BCL2 mRNA] CTD PMID:27235710 mancozeb multiple interactions ISO RGD:2199 6480464 alpha-Tocopherol inhibits the reaction [mancozeb results in decreased expression of BCL2 protein] CTD PMID:16005924 mancozeb decreases expression ISO RGD:2199 6480464 mancozeb results in decreased expression of BCL2 protein CTD PMID:16005924 maneb multiple interactions EXP 6480464 [Maneb co-treated with Paraquat] results in decreased expression of BCL2 mRNA more ... CTD PMID:23963992 maneb increases expression ISO RGD:733100 6480464 Maneb results in increased expression of BCL2 mRNA, Maneb results in increased expression of BCL2 protein CTD PMID:18266926 manganese atom multiple interactions ISO RGD:2199 6480464 [manganese chloride results in increased abundance of Manganese] promotes the reaction [Ethanol results in decreased expression of BCL2 protein] more ... CTD PMID:30844427 , PMID:30951808 manganese(0) multiple interactions ISO RGD:2199 6480464 [manganese chloride results in increased abundance of Manganese] promotes the reaction [Ethanol results in decreased expression of BCL2 protein] more ... CTD PMID:30844427 , PMID:30951808 manganese(II) chloride decreases expression ISO RGD:2199 6480464 manganese chloride results in decreased expression of BCL2 mRNA, manganese chloride results in decreased expression of BCL2 protein CTD PMID:17623882 , PMID:25732873 manganese(II) chloride increases expression ISO RGD:2199 6480464 manganese chloride results in increased expression of BCL2 mRNA CTD PMID:28801915 manganese(II) chloride increases expression ISO RGD:733100 6480464 manganese chloride results in increased expression of BCL2 protein CTD PMID:30578841 manganese(II) chloride decreases expression EXP 6480464 manganese chloride results in decreased expression of BCL2 protein CTD PMID:29183790 manganese(II) chloride multiple interactions ISO RGD:733100 6480464 corynoxine B inhibits the reaction [manganese chloride promotes the reaction [BCL2 protein binds to BECN1 protein]] more ... CTD PMID:28856835 , PMID:30578841 manganese(II) chloride increases nitrosation ISO RGD:733100 6480464 manganese chloride results in increased nitrosation of BCL2 protein CTD PMID:28856835 manganese(II) chloride multiple interactions ISO RGD:2199 6480464 [manganese chloride results in increased abundance of Manganese] promotes the reaction [Ethanol results in decreased expression of BCL2 protein] more ... CTD PMID:21704098 more ... manganese(II) chloride multiple interactions EXP 6480464 [Plant Extracts co-treated with manganese chloride] affects the expression of BCL2 protein more ... CTD PMID:26064043 , PMID:29183790 mangiferin multiple interactions ISO RGD:733100 6480464 mangiferin inhibits the reaction [TNF protein results in increased expression of BCL2 mRNA] CTD PMID:21420233 mangiferin multiple interactions ISO RGD:2199 6480464 mangiferin inhibits the reaction [Galactosamine results in decreased expression of BCL2 protein] CTD PMID:22118634 mangiferin multiple interactions EXP 6480464 mangiferin inhibits the reaction [1-Methyl-4-phenyl-1 more ... CTD PMID:23451106 , PMID:24095822 Matrine multiple interactions ISO RGD:733100 6480464 Arsenic Trioxide promotes the reaction [matrine results in decreased expression of BCL2 protein] more ... CTD PMID:23700110 , PMID:31112718 Matrine decreases expression ISO RGD:733100 6480464 matrine results in decreased expression of BCL2 protein CTD PMID:23700110 , PMID:31112718 mebendazole affects response to substance ISO RGD:733100 6480464 BCL2 protein affects the susceptibility to Mebendazole CTD PMID:18667591 mebendazole multiple interactions ISO RGD:733100 6480464 [Mebendazole results in increased phosphorylation of BCL2 protein] inhibits the reaction [BCL2 protein binds to BAX protein] CTD PMID:18667591 mebendazole increases phosphorylation ISO RGD:733100 6480464 Mebendazole results in increased phosphorylation of BCL2 protein CTD PMID:18667591 Mecamylamine multiple interactions ISO RGD:733100 6480464 Mecamylamine inhibits the reaction [N'-nitrosonornicotine results in increased expression of BCL2 mRNA] CTD PMID:16835749 mechlorethamine decreases expression ISO RGD:733100 6480464 Mechlorethamine results in decreased expression of BCL2 protein CTD PMID:16738803 , PMID:22285227 meglumine amidotrizoate increases expression ISO RGD:733100 6480464 Diatrizoate Meglumine results in increased expression of BCL2 protein CTD PMID:17173243 meglumine amidotrizoate multiple interactions ISO RGD:2199 6480464 Lansoprazole inhibits the reaction [Diatrizoate Meglumine results in decreased expression of BCL2 mRNA] CTD PMID:28412091 meglumine amidotrizoate decreases expression ISO RGD:2199 6480464 Diatrizoate Meglumine results in decreased expression of BCL2 mRNA CTD PMID:28412091 MeIQx increases expression ISO RGD:733100 6480464 2-amino-3 more ... CTD PMID:23810796 melamine decreases expression ISO RGD:733100 6480464 melamine results in decreased expression of BCL2 protein CTD PMID:22915474 Melarsoprol decreases expression ISO RGD:733100 6480464 Melarsoprol results in decreased expression of BCL2 mRNA, Melarsoprol results in decreased expression of BCL2 protein CTD PMID:9226155 melatonin multiple interactions ISO RGD:733100 6480464 [Doxorubicin co-treated with Melatonin] results in decreased expression of BCL2 protein more ... CTD PMID:10965999 more ... melatonin decreases expression ISO RGD:2199 6480464 Melatonin results in decreased expression of BCL2 mRNA CTD PMID:16499559 melatonin multiple interactions ISO RGD:2199 6480464 [Puromycin Aminonucleoside co-treated with Melatonin] results in increased expression of BCL2 protein more ... CTD PMID:14993511 more ... melatonin decreases expression EXP 6480464 Melatonin results in decreased expression of BCL2 protein CTD PMID:14690559 melatonin multiple interactions EXP 6480464 Melatonin inhibits the reaction [[Maneb co-treated with Paraquat] results in decreased expression of BCL2 mRNA], Melatonin inhibits the reaction [S-Nitroso-N-Acetylpenicillamine results in decreased expression of BCL2 protein] CTD PMID:21138475 , PMID:23963992 melatonin increases expression EXP 6480464 Melatonin results in increased expression of BCL2 protein CTD PMID:12220328 melatonin increases expression ISO RGD:733100 6480464 Melatonin results in increased expression of BCL2 protein CTD PMID:18078454 melatonin affects localization ISO RGD:733100 6480464 Melatonin affects the localization of BCL2 protein CTD PMID:18339127 melittin multiple interactions EXP 6480464 Melitten affects the reaction [TGFB1 protein affects the localization of BCL2 protein] CTD PMID:21871910 melittin multiple interactions ISO RGD:2199 6480464 Melitten inhibits the reaction [[IL6 protein co-treated with IL6R protein] results in increased expression of BCL2 mRNA], Melitten inhibits the reaction [[IL6 protein co-treated with IL6R protein] results in increased expression of BCL2 protein] CTD PMID:21354845 melittin decreases expression ISO RGD:733100 6480464 Melitten analog results in decreased expression of BCL2 mRNA more ... CTD PMID:21456063 more ... melphalan decreases expression ISO RGD:733100 6480464 Melphalan results in decreased expression of BCL2 protein CTD PMID:22285227 menadione multiple interactions ISO RGD:733100 6480464 [sodium arsenite co-treated with Vitamin K 3] results in decreased expression of BCL2 protein more ... CTD PMID:19082730 , PMID:25005833 menadione decreases expression ISO RGD:733100 6480464 Vitamin K 3 results in decreased expression of BCL2 protein CTD PMID:25005833 menadione decreases expression ISO RGD:2199 6480464 Vitamin K 3 results in decreased expression of BCL2 mRNA, Vitamin K 3 results in decreased expression of BCL2 protein CTD PMID:19265712 menadione multiple interactions ISO RGD:2199 6480464 Acetaminophen inhibits the reaction [Vitamin K 3 results in decreased expression of BCL2 mRNA], Acetaminophen inhibits the reaction [Vitamin K 3 results in decreased expression of BCL2 protein] CTD PMID:19265712 menaquinone multiple interactions ISO RGD:2199 6480464 Vitamin K 2 inhibits the reaction [[Warfarin co-treated with Vitamin K 1] results in decreased expression of BCL2 protein] CTD PMID:27212383 mercaptopurine decreases expression EXP 6480464 Mercaptopurine results in decreased expression of BCL2 protein CTD PMID:9058596 mercaptopurine multiple interactions ISO RGD:733100 6480464 [Doxorubicin co-treated with Dexamethasone co-treated with Vincristine co-treated with Cytarabine co-treated with Mercaptopurine co-treated with Methotrexate co-treated with Cyclophosphamide co-treated with Enzymes and Coenzymes] results in increased expression of BCL2 protein CTD PMID:21182165 mercury atom decreases expression ISO RGD:2199 6480464 Mercury results in decreased expression of BCL2 protein CTD PMID:21186712 mercury dichloride decreases expression EXP 6480464 Mercuric Chloride results in decreased expression of BCL2 mRNA, Mercuric Chloride results in decreased expression of BCL2 protein CTD PMID:21373768 , PMID:23202902 mercury dichloride decreases expression ISO RGD:2199 6480464 Mercuric Chloride results in decreased expression of BCL2 protein CTD PMID:24751971 , PMID:25600690 mercury dichloride multiple interactions ISO RGD:2199 6480464 Berberine inhibits the reaction [Mercuric Chloride results in decreased expression of BCL2 protein] CTD PMID:24751971 , PMID:25600690 mercury dichloride increases expression ISO RGD:2199 6480464 Mercuric Chloride results in increased expression of BCL2 mRNA CTD PMID:8872981 mercury dichloride increases expression ISO RGD:733100 6480464 Mercuric Chloride results in increased expression of BCL2 protein CTD PMID:11068922 mercury(0) decreases expression ISO RGD:2199 6480464 Mercury results in decreased expression of BCL2 protein CTD PMID:21186712 mesalamine multiple interactions ISO RGD:2199 6480464 Mesalamine inhibits the reaction [Acetic Acid results in decreased expression of BCL2 mRNA] more ... CTD PMID:24637189 , PMID:29518435 metaproterenol decreases expression EXP 6480464 Metaproterenol results in decreased expression of BCL2 protein CTD PMID:15052282 metformin decreases expression ISO RGD:733100 6480464 Metformin results in decreased expression of BCL2 protein CTD PMID:21388661 metformin multiple interactions ISO RGD:2199 6480464 Metformin inhibits the reaction [Glucose results in decreased expression of BCL2 protein], Metformin inhibits the reaction [Testosterone results in increased expression of BCL2 mRNA] CTD PMID:26492952 , PMID:30144576 metformin multiple interactions ISO RGD:733100 6480464 [Paclitaxel co-treated with Metformin] results in decreased expression of BCL2 mRNA, Cisplatin promotes the reaction [Metformin results in decreased expression of BCL2 protein] CTD PMID:21388661 , PMID:29309887 methamphetamine affects response to substance EXP 6480464 BCL2 protein affects the susceptibility to Methamphetamine CTD PMID:12050851 methamphetamine decreases expression ISO RGD:2199 6480464 Methamphetamine results in decreased expression of BCL2 protein CTD PMID:15276877 more ... methamphetamine multiple interactions ISO RGD:733100 6480464 [N-Methyl-3 more ... CTD PMID:23820845 more ... methamphetamine decreases expression ISO RGD:733100 6480464 Methamphetamine results in decreased expression of BCL2 mRNA, Methamphetamine results in decreased expression of BCL2 protein CTD PMID:23820845 more ... methamphetamine multiple interactions EXP 6480464 3-((3 more ... CTD PMID:11457507 , PMID:29467000 methamphetamine decreases expression EXP 6480464 Methamphetamine results in decreased expression of BCL2 protein CTD PMID:11457507 , PMID:29467000 methamphetamine multiple interactions ISO RGD:2199 6480464 BBC3 protein affects the reaction [Methamphetamine results in decreased expression of BCL2 protein] more ... CTD PMID:15276877 more ... methotrexate decreases expression ISO RGD:733100 6480464 Methotrexate results in decreased expression of BCL2 mRNA, Methotrexate results in decreased expression of BCL2 protein CTD PMID:17132110 , PMID:23799623 methotrexate affects expression ISO RGD:733100 6480464 Methotrexate affects the expression of BCL2 mRNA CTD PMID:23792648 , PMID:25330300 methotrexate decreases expression ISO RGD:2199 6480464 Methotrexate results in decreased expression of BCL2 mRNA, Methotrexate results in decreased expression of BCL2 protein CTD PMID:18803016 more ... methotrexate multiple interactions ISO RGD:2199 6480464 18alpha-glycyrrhetinic acid inhibits the reaction [Methotrexate results in decreased expression of BCL2 protein] more ... CTD PMID:18803016 more ... methotrexate multiple interactions ISO RGD:733100 6480464 [Doxorubicin co-treated with Dexamethasone co-treated with Vincristine co-treated with Cytarabine co-treated with Mercaptopurine co-treated with Methotrexate co-treated with Cyclophosphamide co-treated with Enzymes and Coenzymes] results in increased expression of BCL2 protein more ... CTD PMID:21182165 more ... methoxsalen multiple interactions ISO RGD:733100 6480464 Methoxsalen inhibits the reaction [Aflatoxin B1 results in decreased expression of BCL2 protein] CTD PMID:22743290 methoxsalen decreases expression ISO RGD:733100 6480464 Methoxsalen results in decreased expression of BCL2 protein CTD PMID:22796345 methoxychlor decreases response to substance EXP 6480464 BCL2 protein results in decreased susceptibility to Methoxychlor CTD PMID:14973267 , PMID:16081520 methoxychlor multiple interactions EXP 6480464 [ESR1 gene mutant form results in increased susceptibility to Methoxychlor] which results in increased expression of BCL2 mRNA CTD PMID:22306526 methoxychlor increases expression EXP 6480464 Methoxychlor metabolite results in increased expression of BCL2 protein, Methoxychlor results in increased expression of BCL2 protein CTD PMID:15525693 methoxychlor decreases expression EXP 6480464 Methoxychlor results in decreased expression of BCL2 mRNA CTD PMID:16081520 methyl caffeate multiple interactions ISO RGD:733100 6480464 methyl caffeate binds to and results in decreased expression of BCL2 protein CTD PMID:26415618 methyl methanesulfonate decreases expression EXP 6480464 Methyl Methanesulfonate results in decreased expression of BCL2 protein CTD PMID:16019050 methylene blue multiple interactions ISO RGD:2199 6480464 Methylene Blue inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of BCL2 protein] CTD PMID:31428839 methylglyoxal multiple interactions ISO RGD:733100 6480464 naringenin inhibits the reaction [Pyruvaldehyde results in decreased expression of BCL2 protein], salvin inhibits the reaction [Pyruvaldehyde results in decreased expression of BCL2 protein] CTD PMID:26577515 , PMID:31254498 methylglyoxal decreases expression ISO RGD:733100 6480464 Pyruvaldehyde results in decreased expression of BCL2 mRNA, Pyruvaldehyde results in decreased expression of BCL2 protein CTD PMID:26577515 more ... methylisothiazolinone increases expression ISO RGD:733100 6480464 2-methyl-4-isothiazolin-3-one results in increased expression of BCL2 protein CTD PMID:29110394 methylmercury chloride decreases expression EXP 6480464 methylmercuric chloride results in decreased expression of BCL2 mRNA CTD PMID:23202902 methylmercury chloride increases expression ISO RGD:733100 6480464 methylmercuric chloride results in increased expression of BCL2 mRNA CTD PMID:28001369 methylmercury chloride decreases expression ISO RGD:2199 6480464 methylmercuric chloride results in decreased expression of BCL2 protein CTD PMID:28821999 methylseleninic acid affects expression ISO RGD:2199 6480464 methylselenic acid affects the expression of BCL2 protein CTD PMID:12017302 metipranolol multiple interactions ISO RGD:2199 6480464 Metipranolol inhibits the reaction [Zinc results in increased expression of BCL2 protein], Metipranolol inhibits the reaction [Zinc Sulfate results in increased expression of BCL2 protein] CTD PMID:16799065 microcystin increases expression ISO RGD:2199 6480464 microcystin results in increased expression of BCL2 CTD PMID:12411203 microcystin decreases expression ISO RGD:2199 6480464 Microcystins results in decreased expression of BCL2 mRNA, Microcystins results in decreased expression of BCL2 protein CTD PMID:19760617 microcystin RR decreases expression EXP 6480464 microcystin RR results in decreased expression of BCL2 protein CTD PMID:20196164 microcystin-LR increases expression ISO RGD:733100 6480464 cyanoginosin LR results in increased expression of BCL2 CTD PMID:16624733 microcystin-LR increases phosphorylation ISO RGD:733100 6480464 cyanoginosin LR results in increased phosphorylation of BCL2 protein CTD PMID:27352821 microcystin-LR multiple interactions ISO RGD:2199 6480464 Buthionine Sulfoximine promotes the reaction [cyanoginosin LR results in decreased expression of BCL2 protein] CTD PMID:25410294 microcystin-LR decreases expression ISO RGD:2199 6480464 cyanoginosin LR results in decreased expression of BCL2 protein CTD PMID:25410294 microcystin-LR multiple interactions ISO RGD:733100 6480464 cyanoginosin LR results in increased expression of and results in increased phosphorylation of BCL2 protein CTD PMID:26506538 microcystin-LR increases phosphorylation EXP 6480464 cyanoginosin LR results in increased phosphorylation of BCL2 protein CTD PMID:23891578 microcystin-LR decreases expression ISO RGD:733100 6480464 cyanoginosin LR results in decreased expression of BCL2 protein CTD PMID:18214937 midazolam increases expression ISO RGD:2199 6480464 Midazolam results in increased expression of BCL2 CTD PMID:17715682 mifepristone multiple interactions ISO RGD:733100 6480464 Mifepristone inhibits the reaction [Dexamethasone results in increased expression of BCL2] CTD PMID:21244764 mifepristone multiple interactions EXP 6480464 Mifepristone inhibits the reaction [Dexamethasone results in decreased expression of BCL2 mRNA], Mifepristone inhibits the reaction [Dexamethasone results in decreased expression of BCL2 protein] CTD PMID:16644695 mifepristone decreases expression ISO RGD:733100 6480464 Mifepristone results in decreased expression of BCL2 mRNA, Mifepristone results in decreased expression of BCL2 protein CTD PMID:16009178 more ... miglustat multiple interactions EXP 6480464 miglustat inhibits the reaction [ST8SIA1 protein results in increased expression of BCL2 protein] CTD PMID:11574545 minocycline multiple interactions ISO RGD:733100 6480464 [Minocycline co-treated with Hydrogen Peroxide co-treated with TGFB2 protein] results in increased expression of BCL2 mRNA, [Minocycline co-treated with Hydrogen Peroxide co-treated with TGFB2] results in increased expression of BCL2 protein CTD PMID:20606027 minocycline increases expression ISO RGD:2199 6480464 Minocycline results in increased expression of BCL2 mRNA, Minocycline results in increased expression of BCL2 protein CTD PMID:15004018 more ... minocycline multiple interactions ISO RGD:2199 6480464 [Minocycline results in increased expression of BCL2 protein] which binds to BAK1 protein more ... CTD PMID:15004018 mitomycin C affects expression ISO RGD:733100 6480464 Mitomycin affects the expression of BCL2 CTD PMID:19834285 mitomycin C multiple interactions ISO RGD:733100 6480464 silybin inhibits the reaction [Mitomycin affects the expression of BCL2], Tamoxifen promotes the reaction [Mitomycin results in increased expression of BCL2 mRNA] CTD PMID:19757172 , PMID:19834285 mitomycin C increases expression ISO RGD:733100 6480464 Mitomycin results in increased expression of BCL2 mRNA, Mitomycin results in increased expression of BCL2 protein CTD PMID:11867586 more ... Mitotane increases expression ISO RGD:2199 6480464 Mitotane results in increased expression of BCL2 mRNA CTD PMID:23485034 Mitotane multiple interactions ISO RGD:733100 6480464 [Doxorubicin co-treated with Vincristine co-treated with Etoposide co-treated with Mitotane] results in decreased expression of BCL2 protein CTD PMID:9815696 mitoxantrone multiple interactions ISO RGD:733100 6480464 [Cladribine co-treated with Cyclophosphamide co-treated with Mitoxantrone] results in decreased expression of BCL2 protein more ... CTD PMID:15582267 , PMID:8840993 mitoxantrone decreases expression ISO RGD:733100 6480464 Mitoxantrone results in decreased expression of BCL2 mRNA CTD PMID:8219202 mono(2-ethylhexyl) phthalate decreases expression ISO RGD:733100 6480464 mono-(2-ethylhexyl)phthalate results in decreased expression of BCL2 mRNA, mono-(2-ethylhexyl)phthalate results in decreased expression of BCL2 protein CTD PMID:12927354 more ... mono(2-ethylhexyl) phthalate multiple interactions ISO RGD:733100 6480464 MIR16-1 mRNA affects the reaction [mono-(2-ethylhexyl)phthalate results in decreased expression of BCL2 protein] CTD PMID:26597031 mono(2-ethylhexyl) phthalate multiple interactions EXP 6480464 [mono-(2-ethylhexyl)phthalate co-treated with Estradiol] results in decreased expression of BCL2 mRNA CTD PMID:24412242 monocrotophos multiple interactions ISO RGD:2199 6480464 resveratrol inhibits the reaction [Monocrotophos results in decreased expression of BCL2 mRNA], resveratrol inhibits the reaction [Monocrotophos results in decreased expression of BCL2 protein] CTD PMID:23833438 monocrotophos increases expression ISO RGD:2199 6480464 Monocrotophos results in increased expression of BCL2 mRNA, Monocrotophos results in increased expression of BCL2 protein CTD PMID:21445290 monocrotophos decreases expression ISO RGD:2199 6480464 Monocrotophos results in decreased expression of BCL2 mRNA, Monocrotophos results in decreased expression of BCL2 protein CTD PMID:20957986 , PMID:23833438 montelukast multiple interactions EXP 6480464 montelukast inhibits the reaction [Streptozocin results in decreased expression of BCL2 protein] CTD PMID:27702591 morin multiple interactions ISO RGD:2199 6480464 morin inhibits the reaction [Acetaminophen results in decreased expression of BCL2 protein] more ... CTD PMID:19931519 more ... morin decreases expression ISO RGD:733100 6480464 morin results in decreased expression of BCL2 mRNA CTD PMID:28689916 morphine multiple interactions ISO RGD:733100 6480464 [[Morphine results in increased expression of BAX protein] co-treated with [Morphine results in decreased expression of BCL2 protein]] results in increased activity of CASP3 protein more ... CTD PMID:10534122 more ... morphine decreases expression ISO RGD:733100 6480464 Morphine results in decreased expression of BCL2 protein CTD PMID:10534122 more ... morphine decreases expression ISO RGD:2199 6480464 Morphine results in decreased expression of BCL2 mRNA, Morphine results in decreased expression of BCL2 protein CTD PMID:12196588 , PMID:18976035 morphine multiple interactions ISO RGD:2199 6480464 Lithium inhibits the reaction [Morphine results in decreased expression of BCL2 mRNA] CTD PMID:18976035 mycophenolic acid multiple interactions ISO RGD:733100 6480464 [Mycophenolic Acid co-treated with Hypoxanthine] results in decreased expression of BCL2 protein, Mycophenolic Acid inhibits the reaction [BCL2 protein results in decreased susceptibility to Dexamethasone] CTD PMID:16505121 , PMID:21396949 myricetin decreases expression ISO RGD:733100 6480464 myricetin results in decreased expression of BCL2 protein CTD PMID:15748703 , PMID:29698783 myricetin multiple interactions ISO RGD:733100 6480464 Tetradecanoylphorbol Acetate inhibits the reaction [myricetin results in decreased expression of BCL2 protein] CTD PMID:15748703 myricitrin multiple interactions ISO RGD:733100 6480464 myricitrin inhibits the reaction [Hydrogen Peroxide results in decreased expression of BCL2 protein] CTD PMID:23639522 myristicin decreases expression ISO RGD:733100 6480464 myristicin results in decreased expression of BCL2 mRNA CTD PMID:29174417 N'-Nitrosonornicotine increases expression ISO RGD:733100 6480464 N'-nitrosonornicotine results in increased expression of BCL2 mRNA CTD PMID:16582591 , PMID:16835749 N'-Nitrosonornicotine multiple interactions ISO RGD:733100 6480464 Mecamylamine inhibits the reaction [N'-nitrosonornicotine results in increased expression of BCL2 mRNA] CTD PMID:16835749 N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine multiple interactions ISO RGD:733100 6480464 N more ... CTD PMID:19887557 N,N-dimethylsphingosine multiple interactions ISO RGD:733100 6480464 N, N-dimethylsphingosine inhibits the reaction [ASAH2 protein results in increased expression of BCL2 protein] CTD PMID:15498114 N-(6-acetamidohexyl)acetamide affects expression ISO RGD:733100 6480464 hexamethylene bisacetamide affects the expression of BCL2 CTD PMID:15543656 N-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]-N-(2-pyridinyl)cyclohexanecarboxamide multiple interactions EXP 6480464 N-(2-(4-(2-methoxyphenyl)-1-piperazinyl)ethyl)-N-(2-pyridinyl)cyclohexanecarboxamide inhibits the reaction [8-Hydroxy-2-(di-n-propylamino)tetralin results in decreased expression of BCL2 protein] CTD PMID:30366073 N-[2-amino-6-[(4-fluorophenyl)methylamino]-3-pyridinyl]carbamic acid ethyl ester increases expression ISO RGD:733100 6480464 flupirtine results in increased expression of BCL2 protein CTD PMID:9804146 N-acetyl-L-cysteine multiple interactions ISO RGD:733100 6480464 4-phenylbutyric acid promotes the reaction [Acetylcysteine inhibits the reaction [tris(1 more ... CTD PMID:11341981 more ... N-acetyl-L-cysteine multiple interactions ISO RGD:2199 6480464 Acetylcysteine inhibits the reaction [7-ketocholesterol results in decreased expression of BCL2 protein] more ... CTD PMID:17041759 more ... N-acetyl-L-cysteine multiple interactions EXP 6480464 Acetylcysteine inhibits the reaction [1 more ... CTD PMID:21549813 more ... N-acetyl-L-cysteine decreases response to substance ISO RGD:733100 6480464 BCL2 results in decreased susceptibility to Acetylcysteine CTD PMID:17395010 N-acetyl-L-cysteine decreases expression ISO RGD:733100 6480464 Acetylcysteine results in decreased expression of BCL2 protein CTD PMID:17395010 N-acetylsphingosine multiple interactions ISO RGD:733100 6480464 BCL2 protein inhibits the reaction [N-acetylsphingosine results in decreased phosphorylation of and results in decreased activity of AKT1 protein] more ... CTD PMID:16215670 N-acetylsphingosine decreases expression ISO RGD:733100 6480464 N-acetylsphingosine results in decreased expression of BCL2 protein CTD PMID:9295281 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal multiple interactions ISO RGD:733100 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Arachidonic Acid results in decreased expression of BCL2 protein] more ... CTD PMID:19540902 more ... N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal multiple interactions EXP 6480464 benzyloxycarbonyl-valyl-alanyl-aspartic acid promotes the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased expression of BCL2 protein] CTD PMID:20449726 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal decreases expression EXP 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased expression of BCL2, benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased expression of BCL2 protein CTD PMID:20100472 , PMID:20449726 N-ethyl-N-nitrosourea increases expression EXP 6480464 Ethylnitrosourea results in increased expression of BCL2 mRNA CTD PMID:30944280 N-methyl-4-phenylpyridinium multiple interactions ISO RGD:2199 6480464 [1-Methyl-4-phenylpyridinium co-treated with Quercetin] results in increased expression of BCL2 mRNA more ... CTD PMID:19135049 more ... N-methyl-4-phenylpyridinium decreases expression ISO RGD:2199 6480464 1-Methyl-4-phenylpyridinium results in decreased expression of BCL2 mRNA, 1-Methyl-4-phenylpyridinium results in decreased expression of BCL2 protein CTD PMID:18496573 more ... N-methyl-4-phenylpyridinium increases expression ISO RGD:733100 6480464 1-Methyl-4-phenylpyridinium results in increased expression of BCL2 mRNA CTD PMID:24399507 N-methyl-4-phenylpyridinium decreases expression ISO RGD:733100 6480464 1-Methyl-4-phenylpyridinium results in decreased expression of BCL2 mRNA, 1-Methyl-4-phenylpyridinium results in decreased expression of BCL2 protein CTD PMID:17266988 more ... N-methyl-4-phenylpyridinium decreases expression EXP 6480464 1-Methyl-4-phenylpyridinium results in decreased expression of BCL2 mRNA, 1-Methyl-4-phenylpyridinium results in decreased expression of BCL2 protein CTD PMID:12880480 , PMID:26300475 N-methyl-4-phenylpyridinium multiple interactions ISO RGD:733100 6480464 2 more ... CTD PMID:17266988 
Gene-Chemical Interaction Annotations
